<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Open Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Open Biol</journal-id>
<journal-id journal-id-type="publisher-id">RSOB</journal-id>
<journal-id journal-id-type="hwp">royopenbio</journal-id>
<journal-title-group>
<journal-title>Open Biology</journal-title>
</journal-title-group>
<issn pub-type="epub">2046-2441</issn>
<publisher>
<publisher-name>The Royal Society</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31185809</article-id>
<article-id pub-id-type="pmc">6597757</article-id>
<article-id pub-id-type="doi">10.1098/rsob.180265</article-id>
<article-id pub-id-type="publisher-id">rsob180265</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>42</subject>
<subject>133</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
<subj-group subj-group-type="leader">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Understanding intellectual disability and autism spectrum disorders from common mouse models: synapses to behaviour</article-title>
<alt-title alt-title-type="short">ID/ASD_synapses to behaviour_Clement JP</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Verma</surname>
<given-names>Vijaya</given-names>
</name>
<xref ref-type="author-notes" rid="an1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Paul</surname>
<given-names>Abhik</given-names>
</name>
<xref ref-type="author-notes" rid="an1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Amrapali Vishwanath</surname>
<given-names>Anjali</given-names>
</name>
<xref ref-type="author-notes" rid="an1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vaidya</surname>
<given-names>Bhupesh</given-names>
</name>
<xref ref-type="author-notes" rid="an1">†</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-7625-6430</contrib-id>
<name>
<surname>Clement</surname>
<given-names>James P.</given-names>
</name>
<xref ref-type="corresp" rid="cor1"></xref>
</contrib>
</contrib-group>
<aff><institution>Neuroscience Unit, Jawaharlal Nehru Centre for Advanced Scientific Research</institution>, <country>Jakkur, Bengaluru 560 064, Karnataka, India</country></aff>
<author-notes>
<corresp id="cor1">e-mail: <email>clement@jncasr.ac.in</email></corresp>
<fn fn-type="con" id="an1">
<label>†</label>
<p>These authors contributed equally to this study.</p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>12</day>
<month>6</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>9</volume>
<issue>6</issue>
<elocation-id>180265</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>12</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>5</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 The Authors.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>Published by the Royal Society under the terms of the Creative Commons Attribution License <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>, which permits unrestricted use, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="rsob-9-180265.pdf"></self-uri>
<self-uri xlink:href="rsob180265.thumb.gif" xlink:role="icon"></self-uri>
<self-uri content-type="reviewer_comments" xlink:href="rsob180265_review_history.pdf"></self-uri>
<abstract>
<p>Normal brain development is highly dependent on the timely coordinated actions of genetic and environmental processes, and an aberration can lead to neurodevelopmental disorders (NDDs). Intellectual disability (ID) and autism spectrum disorders (ASDs) are a group of co-occurring NDDs that affect between 3% and 5% of the world population, thus presenting a great challenge to society. This problem calls for the need to understand the pathobiology of these disorders and to design new therapeutic strategies. One approach towards this has been the development of multiple analogous mouse models. This review discusses studies conducted in the mouse models of five major monogenic causes of ID and ASDs: <italic>Fmr1, Syngap1, Mecp2, Shank2/3</italic> and <italic>Neuroligins/Neurnexins.</italic> These studies reveal that, despite having a diverse molecular origin, the effects of these mutations converge onto similar or related aetiological pathways, consequently giving rise to the typical phenotype of cognitive, social and emotional deficits that are characteristic of ID and ASDs. This convergence, therefore, highlights common pathological nodes that can be targeted for therapy. Other than conventional therapeutic strategies such as non-pharmacological corrective methods and symptomatic alleviation, multiple studies in mouse models have successfully proved the possibility of pharmacological and genetic therapy enabling functional recovery.</p>
</abstract>
<kwd-group>
<kwd>autism spectrum disorders</kwd>
<kwd>intellectual disability</kwd>
<kwd>SYNGAP1</kwd>
<kwd>fragile X mental retardation protein</kwd>
<kwd>MECP2</kwd>
<kwd>NEUROLIGIN</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>June 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1">
<label>1.</label>
<title>Introduction</title>
<p>The human brain is a complex organ with a wide array of functions. An adult brain has approximately 86 billion neurons and 85 billion non-neuronal cells [<xref ref-type="bibr" rid="RSOB180265C1">1</xref>]. Synchronized activity among neuronal and non-neuronal cells enables us to perform from mundane yet straightforward tasks to an overly complicated range of activities. Development of the human brain is a tightly regulated process. Any change can lead to precarious and detrimental developmental deficits such as neurodevelopmental disorders (NDDs). To name a few, NDDs include, but are not limited to, autism spectrum disorder (ASD), intellectual disability (ID) and attention deficit hyperactivity disorder (ADHD), which affect 3–4% of the world's population [<xref ref-type="bibr" rid="RSOB180265C2">2</xref>]. On average, NDD is diagnosed when a child is six months to 1 year old in the absence of well-defined biomarkers as the child is not fulfilling developmental milestones. The <italic>Diagnostic and Statistical Manual of Mental Disorders</italic> (DSM V), published by the American Psychiatric Association in 2013, has suggested the following for the diagnosis of ID: children often present with difficulty in learning and memory, and exhibit deficits in self-care and social behaviour [<xref ref-type="bibr" rid="RSOB180265C3">3</xref>].</p>
<p>Studies over the past few decades have shown that there is a strong genetic correlation between specific genes encoding protein synthesis that regulates synaptic function and ASD/ID [<xref ref-type="bibr" rid="RSOB180265C4">4</xref>]. Mutations in such genes, along with gene–gene and gene–environmental interactions, are responsible for ASDs and ID. The resulting pathophysiological mechanisms of many of these overlap with those of ID and ASD, such as <italic>SYNGAP1</italic>, <italic>FMRP</italic>, <italic>MECP2, NEUROLIGINS/NEURONEXINS</italic> and <italic>SHANK2/3</italic>. Apart from the overlapping pathophysiology, patients with ASD and ID have some comorbid conditions which include schizophrenia, allergic disorders, food sensitivity and autoimmune disorders to name a few [<xref ref-type="bibr" rid="RSOB180265C5">5</xref>–<xref ref-type="bibr" rid="RSOB180265C8">8</xref>].</p>
<p>While the distribution of specific proteins such as FMRP is widespread, the SYNGAP1 protein is expressed only in the brain, not in any other organ [<xref ref-type="bibr" rid="RSOB180265C9">9</xref>,<xref ref-type="bibr" rid="RSOB180265C10">10</xref>]. The variation in the tissue, cellular and subcellular localization and expression of these genes implicated in ID and ASDs may be one of the reasons for the type of phenotypes observed in ID/ASD individuals. Genes such as <italic>FMRP</italic> present with the syndromic type of ID while others such as <italic>SYNGAP1</italic>, <italic>MECP2 <italic>and</italic> SHANK3</italic> are mostly linked to the non-syndromic type [<xref ref-type="bibr" rid="RSOB180265C11">11</xref>,<xref ref-type="bibr" rid="RSOB180265C12">12</xref>]. The environmental factors which can lead to ID and ASDs include the use of certain drugs during pregnancy like valproate and alcohol as well as infections, exposure to heavy metals, such as lead and mercury, and malnutrition [<xref ref-type="bibr" rid="RSOB180265C13">13</xref>–<xref ref-type="bibr" rid="RSOB180265C16">16</xref>]. Although a complex interplay of environmental and genetic factors are known to have a role in the pathophysiology of ID/ASDs, most cases are idiopathic [<xref ref-type="bibr" rid="RSOB180265C17">17</xref>].</p>
<p>Precise control of synapse formation and development is essential for correct brain development and function. Abnormalities, if any, can lead to various biochemical and behavioural deficits. In this review, we have discussed the convergence of the pathophysiological hallmarks and phenotypic characteristics with emphasis on the changes in the synaptic morphology (<xref ref-type="fig" rid="RSOB180265F1">figure 1</xref>). For instance, alterations in the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor/<italic>N</italic>-methyl-<sc>d</sc>-aspartate receptor (AMPA/NMDA) ratio, induction and maintenance of long-term potentiation (LTP) and long-term depression (LTD), and changes in the basal synaptic transmission are some of the common characteristics associated with ID and ASDs of different genetic backgrounds, which are discussed in detail in this review [<xref ref-type="bibr" rid="RSOB180265C18">18</xref>]. The current report further highlights the importance of the critical period of development and its alteration due to pathogenic mutations [<xref ref-type="bibr" rid="RSOB180265C19">19</xref>].
<fig id="RSOB180265F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Common pathophysiological features observed in genes implicated in ID/ASDs. Diagram illustrating morphological, synaptic and circuit properties of neurons along with behavioural alterations observed in different key transgenic mouse models. As mentioned in the main discussion, although the mutations were observed in different genes that are implicated in ASDs/ID, there are many common features found in these mutations. Therefore, it is imperative to understand the mechanism of these mutations about neuronal function before prescribing therapeutics to patients with any of these mutations. E/I, excitation–inhibition; GABA, gamma-aminobutyric acid; GDP, giant depolarization potential; D1-MSN, D1 receptors in medium spiny neurons (MSN); AMPAR, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; mEPSC, miniature excitatory postsynaptic current; mIPSC; miniature inhibitory postsynaptic current.</p></caption><graphic xlink:href="rsob-9-180265-g1"></graphic></fig></p>
<p>Although the importance of the proper function of neurons during a critical period of development is known, the role of non-neuronal cells such as astrocytes has been barely studied, but this has been changing in recent years. It has been observed that the timing of astrocyte maturation coincides well with the formation of excitatory synapses in the brain. Secretion of molecules such as glypicans by astrocytes helps in the conversion of silent to functional synapses, thereby facilitating the insertion of AMPA receptors [<xref ref-type="bibr" rid="RSOB180265C20">20</xref>]. Although the expression of synaptic proteins such as FMRP and NEUROLIGIN has been studied in astrocytes, a complete understanding of their underlying roles in ID and ASDs is still under investigation [<xref ref-type="bibr" rid="RSOB180265C21">21</xref>]. Here, we give an overview of the importance of astrocytes during the critical period of development, and how alteration in these impacts neuronal function.</p>
<p>To further our understanding of the physiological relevance of mutations implicated in ID and ASDs, the use of transgenic animal models has provided insights into different pathophysiological aspects of ID and ASDs. These transgenic mice models had been validated at various levels to ensure their efficacy in the replication of not only the pathophysiology but also the behavioural phenotypes [<xref ref-type="bibr" rid="RSOB180265C22">22</xref>]. Although there are limitations, they have been useful in understanding the novel mechanisms contributing to the progression and development of these disorders and in finding novel therapeutic targets.</p>
<p>As with most neurological disorders, the exact prevalence and epidemiology of NDDs are not entirely known yet. Meta-analysis studies, which make use of statistical procedures to analyse data from already existing reports, have highlighted the procedural limitations and underreporting cases from several parts of the world [<xref ref-type="bibr" rid="RSOB180265C23">23</xref>,<xref ref-type="bibr" rid="RSOB180265C24">24</xref>]. However, current studies have shown the prevalence to be higher in low- and middle-income countries, which can be attributed to the lack of essential diagnostic and management resources in these geographical locations [<xref ref-type="bibr" rid="RSOB180265C23">23</xref>,<xref ref-type="bibr" rid="RSOB180265C24">24</xref>]. Considering that NDDs require early diagnosis, an exhaustive study done in children from birth until 12 years of age found the prevalence to be as high as one in six children in the USA. Moreover, in the same study, the incidence was higher among the males than among females [<xref ref-type="bibr" rid="RSOB180265C25">25</xref>].</p>
<p>Nevertheless, according to a recent report by the World Health Organization, about one in every 160 individuals has an ASD/ID [<xref ref-type="bibr" rid="RSOB180265C26">26</xref>]. The numbers are remarkably alarming as they are only expected to become worse in the absence of any effective therapeutic strategy. With more laboratories now working on NDDs, insights into possible new therapeutic targets and their mechanisms may aid finding mitigation strategies in the future.</p>
<p>Drug repurposing is one of the impending fields; this involves finding a new indication for an already approved drug [<xref ref-type="bibr" rid="RSOB180265C27">27</xref>]. Drug development is an expensive and time-consuming process that could be shortened with the help of this approach. In this review, we have highlighted studies done on drugs with a known indication in some other diseases. Targeting them at the preclinical and clinical stages may prove to be a useful strategy in search of new medications for ID and ASDs.</p>
<p>Although there are several unexplored mechanisms associated with ID/ASDs, the involvement of synaptic function and plasticity in ID and ASDs is well characterized [<xref ref-type="bibr" rid="RSOB180265C28">28</xref>]. Technological advancement to measure neuronal activity (electrophysiology and deep-brain imaging) and understanding of the mechanisms which modulate synaptic plasticity may aid in further expanding our knowledge to decipher the pathophysiology of ID and ASDs. In this review, we will discuss the implications of monogenic mutations on the physiological, molecular and biochemical, and morphological aspects of neuronal and non-neuronal development using different mouse models studied over the past few decades.</p>
</sec>
<sec id="s2">
<label>2.</label>
<title>Aetiology/causes of intellectual disability</title>
<p>The causes of ID and ASDs are diverse and involve a range of genetic and environmental factors [<xref ref-type="bibr" rid="RSOB180265C29">29</xref>]. Although the nature of the cause for about 60% of all known cases of ID and ASDs remains unknown [<xref ref-type="bibr" rid="RSOB180265C30">30</xref>,<xref ref-type="bibr" rid="RSOB180265C31">31</xref>], studies where the cause is known have demonstrated that aberrations leading to ID/ASDs mainly occur during the developmental time period, but have a lifelong effect, including in adulthood. The vulnerable range of time includes the pre-, peri- and post-natal stages of development [<xref ref-type="bibr" rid="RSOB180265C32">32</xref>]. Environmental stress factors such as poor nutrition, hygiene, infection, familial instability and socio-economic causes may affect brain development, contributing to ID/ASDs [<xref ref-type="bibr" rid="RSOB180265C33">33</xref>,<xref ref-type="bibr" rid="RSOB180265C34">34</xref>]. For example, it is now believed that oxidative stress as a result of environmental stressors such as heavy metals affects sulfur metabolism, which leads to alteration of the epigenetic mechanisms of gene expression. Hence, the complex interplay of genetic and environmental factors has a crucial role in the pathology of ASDs/ID [<xref ref-type="bibr" rid="RSOB180265C17">17</xref>].</p>
<p>Other than environmental factors, about a quarter to half of the identified causes of ID are the result of mutations in genes [<xref ref-type="bibr" rid="RSOB180265C32">32</xref>]. These mutations can be either inherited or acquired genetic defects due to metabolic genetic defects as observed in cases such as phenylketonuria and Tay–Sachs disease that can disrupt healthy brain development [<xref ref-type="bibr" rid="RSOB180265C33">33</xref>]. These genetic changes can occur on various scales based on size (and thereby ease of detection)—the largest being microscopically visible aberrations at the chromosomal level and 15% of all cases of ID were attributed to these chromosomal defects [<xref ref-type="bibr" rid="RSOB180265C30">30</xref>,<xref ref-type="bibr" rid="RSOB180265C35">35</xref>–<xref ref-type="bibr" rid="RSOB180265C38">38</xref>]. This review will provide a brief overview of the current understanding of ID/ASDs with regard to the critical period of development, molecular and biochemical signalling, and electrophysiological aberrations concerning monogenic mutations.</p>
</sec>
<sec id="s3">
<label>3.</label>
<title>The critical period of plasticity</title>
<p>A remarkable property of the brain is its capability to undergo changes based on experiences (stimuli) through a process called synaptic plasticity, particularly during the early stages of development [<xref ref-type="bibr" rid="RSOB180265C39">39</xref>]. Synaptic plasticity is a biological process in which a stimulus or experience induces synaptic activity that results in changes in synaptic strength and contributes to learning and memory. It includes the formation, storage and retention of sensory memories, and occurs throughout life starting from birth and continues into adulthood to an extent. This process allows us to do everyday activities such as performing mathematical calculations, decision making and more complex multi-tasking activities, which are coordinated by proper neuronal connections in the brain that act as the central processing unit of the body. However, at the time of birth, there are fewer synaptic connections, but, as the brain matures, there is a massive surge in the number of neuronal connections that enables a child to learn tasks rapidly [<xref ref-type="bibr" rid="RSOB180265C40">40</xref>]. During this stage of development, the synaptic connections are highly vulnerable to changes in environmental stimuli. However, at the end of adolescence, only active connections (upon repeated or stronger stimulation) will be strengthened, and less active connections (upon weaker or not repeated stimulation) will be eliminated [<xref ref-type="bibr" rid="RSOB180265C41">41</xref>]. For example, a child may learn a new language in a few months to a year, but it might take months to a few years for an adult to master the same language. [<xref ref-type="bibr" rid="RSOB180265C42">42</xref>]. These observations postulated the phenomenon of a critical period of neuronal development. Different experiences during early post-natal life determine the process of formation, maturation and elimination of neuronal connections in the brain. Windows of heightened neuronal plasticity during brain development are termed as critical or sensitive periods, which predominantly occur in early life, and, hence, learning any new paradigms is relatively easy and quick in childhood, although it continues at a reduced level in adulthood. A critical period is a time when environmental or sensory input is required for the proper development of particular neuronal connections in different regions of the brain [<xref ref-type="bibr" rid="RSOB180265C43">43</xref>,<xref ref-type="bibr" rid="RSOB180265C44">44</xref>]. If these connections are unstimulated, the brain function served by that circuit will be permanently compromised [<xref ref-type="bibr" rid="RSOB180265C43">43</xref>,<xref ref-type="bibr" rid="RSOB180265C44">44</xref>]. For example, the critical period for the visual cortex begins soon after a baby is born in humans or soon after eye opening in animals such as rats or mice. Similarly, the onset of hearing triggers a critical period of development of the auditory cortex in humans. Perturbation in neuronal connections of these regions before the end of the critical period might permanently compromise their function. In the last decade or so, several laboratories have used visual, auditory and thalamocortical regions of the brain as models to understand the importance of the critical period in the plasticity and development of an individual [<xref ref-type="bibr" rid="RSOB180265C41">41</xref>,<xref ref-type="bibr" rid="RSOB180265C45">45</xref>–<xref ref-type="bibr" rid="RSOB180265C47">47</xref>].</p>
<p>An important contribution to using the visual cortex as a model came from studies by Hubel and Wiesel in 1962; they emphasized the importance of the stimulus-dependent response by a population of neurons. They observed that, for cortical cells, the most effective stimulus configurations dictated by the spatial arrangement of excitatory and inhibitory regions were long narrow rectangles of light (slits), straight line borders between areas of different brightness (edges) and dark rectangular bars against a light background. To attain the maximum response, the shape, area and orientation of these stimuli were critical [<xref ref-type="bibr" rid="RSOB180265C48">48</xref>]. Recordings from different stages of development in normal kittens and those with monocular dominance (MD), where one eyelid was sutured during the early time window of development, concluded that kittens with MD had almost irreversible changes in the functional properties of the visual cortex area V1, suggesting the importance of sensory-dependent activation of neurons during the critical period of development and its relevance to neuronal connections [<xref ref-type="bibr" rid="RSOB180265C41">41</xref>]. These studies have demonstrated the importance of the critical period in the visual cortex and the modulation of neuronal plasticity based on experience/sensory information. For a better understanding of the molecular mechanisms underlying the critical period of development and plasticity in the primary visual cortex, studies using various animal models are discussed extensively in [<xref ref-type="bibr" rid="RSOB180265C41">41</xref>,<xref ref-type="bibr" rid="RSOB180265C48">48</xref>–<xref ref-type="bibr" rid="RSOB180265C53">53</xref>], and similar information can be obtained for thalamocortical studies from [<xref ref-type="bibr" rid="RSOB180265C54">54</xref>–<xref ref-type="bibr" rid="RSOB180265C57">57</xref>].</p>
<p>Studies have shown that changes at the synaptic receptor number and subunit expression of both excitatory and inhibitory neurons signal the opening or closure of a critical period of neuronal development [<xref ref-type="bibr" rid="RSOB180265C58">58</xref>]. For example, based on these studies, NMDARs are considered as one of the molecular determinants of the critical period of plasticity as NMDAR-mediated synaptic transmission is developmentally regulated, and their expression can modify neuronal activity [<xref ref-type="bibr" rid="RSOB180265C58">58</xref>–<xref ref-type="bibr" rid="RSOB180265C61">61</xref>]. In the visual cortex, the percentage of total NMDAR-mediated current can be described by a slow exponential decay between the first and fifth post-natal week. Dark rearing of pups delays the developmental shortening of NMDAR-mediated currents, suggesting that the change in the 2A/2B ratio requires stimulus-based experiences in the visual cortex, and impairs the closure of the critical period. Pups reared in the dark displayed longer duration of NMDAR-mediated currents similar to younger animals bred in normal conditions, suggesting an altered critical period of development [<xref ref-type="bibr" rid="RSOB180265C62">62</xref>]. Apart from the visual cortex, various laboratories have studied the critical period of development in the thalamocortical region of the brain. By focusing on the NR2B to NR2A switch, which is developmentally regulated, NMDAR-mediated currents were recorded in layer IV of rat somatosensory cortex and found to be decayed more rapidly in PND7 than in PND3, which further suggests NMDAR-mediated, mainly subunit switch, modulation of the critical period [<xref ref-type="bibr" rid="RSOB180265C63">63</xref>–<xref ref-type="bibr" rid="RSOB180265C65">65</xref>].</p>
<p>Another key factor that regulates the critical period of plasticity during development is the function of gamma-aminobutyric acid (GABA) in the neuron. The function of GABA is carried out by two Cl<sup>−</sup> cotransporters, NKCC1 and KCC2, and its expression varies during the early stages of development [<xref ref-type="bibr" rid="RSOB180265C66">66</xref>]. Several studies using the gene disruption method to modulate the function of GABA and chloride concentration suggested the possibility to target NKCC1 and KCC2 for the rewiring of neuronal connections in the brain post-critical period of development, and, hence, a potential target for therapeutics [<xref ref-type="bibr" rid="RSOB180265C67">67</xref>–<xref ref-type="bibr" rid="RSOB180265C69">69</xref>]. In various NDDs, such as ID, ASDs and schizophrenia, one of the common features observed is an imbalance of the excitation–inhibition (E/I) ratio, which can serve as a key factor in understanding the major cause of these disorders, and how manipulating the critical period, particularly targeting GABA, would help to resolve the associated defects [<xref ref-type="bibr" rid="RSOB180265C70">70</xref>,<xref ref-type="bibr" rid="RSOB180265C71">71</xref>]. It has been known for decades that maturation of the inhibitory cortical circuits in the brain parallels the opening of the critical period [<xref ref-type="bibr" rid="RSOB180265C72">72</xref>–<xref ref-type="bibr" rid="RSOB180265C76">76</xref>]. With the help of glutamate decarboxylase (GAD)–knockout (KO) mice (GAD is a GABA-synthesizing enzyme), it has been demonstrated how inhibitory signalling regulates the critical period. For example, GAD-65 KO mice have impaired ocular dominance shift when one eye is deprived of vision [<xref ref-type="bibr" rid="RSOB180265C72">72</xref>]; visions was restored by the application of diazepam (benzodiazepine), which enhances GABA activity, within the critical period window by enhancing GABAR activity. These experiments suggest that ocular dominance plasticity is regulated by inhibitory neuronal signalling in the brain, apart from the excitatory signalling as discussed earlier. GAD-65 KO mice had shown reduced NR2A levels and slower NMDAR-mediated currents in the visual cortex, which plays an important role in the critical period of plasticity [<xref ref-type="bibr" rid="RSOB180265C74">74</xref>]. Other studies have focused on the ectopic expression of BDNF in mice, which is also known to regulate GABAergic inhibitory interneurons and related synaptic strength and has been shown to induce early opening and premature closing of the critical period of plasticity [<xref ref-type="bibr" rid="RSOB180265C73">73</xref>,<xref ref-type="bibr" rid="RSOB180265C77">77</xref>]. These studies suggest that there are different molecular determinants of the critical period of plasticity that are developmentally regulated. Here, we have briefly discussed the role of different proteins, especially GABAR, which are developmentally regulated and, in turn, modulate the critical period of plasticity. Thus, altering GABAR-mediated functions could be a potential therapeutic approach in the rewiring of synaptic connections and rescuing the pathophysiology of NDDs, particularly after a critical period of development, which is one of the major challenges faced by many neuroscientists.</p>
</sec>
<sec id="s4">
<label>4.</label>
<title>Animal models of intellectual disability</title>
<p>The use of animal models to understand disease pathogenesis and to design treatment strategies has been long been a practice in biology and related disciplines. Despite the substantial ethical debate surrounding the use of animals in research, and the argument of interspecific variations, data from animal models remain the most positive attribute of biomedical research [<xref ref-type="bibr" rid="RSOB180265C78">78</xref>]. With technological advancements and the advent of transgenic mice, the ability to study more complex biological problems became feasible as a result of genetic modifications [<xref ref-type="bibr" rid="RSOB180265C79">79</xref>]. More recently, the use of Cre-Lox technology to generate tissue-specific KOs and other methods of modulating gene transcription <italic>in vivo</italic> has further contributed to our understanding of the mechanisms of human disease [<xref ref-type="bibr" rid="RSOB180265C80">80</xref>,<xref ref-type="bibr" rid="RSOB180265C81">81</xref>].</p>
<p>Although it is not possible to mimic all aspects of a disorder or disease in any one animal model, a suitable animal model should be able to replicate the clinical hallmarks of the disease with the paramount degree of robustness. Therefore, for a given condition, a range of animal models are usually defined, characterized and then validated. A good animal model should meet the following criteria: internal validity, external validity, construct validity, face validity and predictive validity. Internal validity refers to the reliability and reproducibility of the model with regard to consistency in the experimental measurements. Face validity describes the degree of similarity between the symptoms shown in human populations and those expressed in the animal model. Predictive validity involves the extrapolation of a particular experimental manipulation done in a species or a specific situation to the other species and situation. Construct validity refers to the degree of similarity in the mechanisms underlying the behavioural similarities between the animal model and those seen in patient populations. External validity involves the generalizability of the results obtained in the animal studies in relation to the general population [<xref ref-type="bibr" rid="RSOB180265C22">22</xref>,<xref ref-type="bibr" rid="RSOB180265C82">82</xref>].</p>
<p>Different reviews have discussed the commonly available and used animal models for ID [<xref ref-type="bibr" rid="RSOB180265C82">82</xref>–<xref ref-type="bibr" rid="RSOB180265C84">84</xref>]. Some of the widely used mouse models that replicate the pathophysiology of ID are listed in <xref ref-type="table" rid="RSOB180265TB1">table 1</xref> along with the morphological, biochemical and behavioural alterations associated with them. Nevertheless, citing the failure of pharmacological agents in those clinical trials which otherwise showed efficacy in the preclinical studies, it becomes clear that the existing models have their limitations [<xref ref-type="bibr" rid="RSOB180265C79">79</xref>]. Hence, there is a need to look for new animal models of ID/ASDs that display different mutations and not only reproduce the clinical features of a disease but also guarantee a higher degree of translational success.
<table-wrap id="RSOB180265TB1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Tabulation of behavioural, synaptic and biochemical alterations used in transgenic mouse models of different ID/ASD-related genes (<italic>Fmr1, Syngap1, Shank, Neuroligin3 and Mecp2</italic>). LTD, long-term depression; Pv, parvalbumin; N/D, not defined or determined; EPSC, excitatory postsynaptic current; MSN, medium spiny neurons; IPSC, inhibitory postsynaptic current; E/I, exctiation–inhibitory; GTP, guanosine-5′-triphosphate.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead valign="bottom"><tr><th align="left" colspan="1" rowspan="1">genetic modification</th><th align="left" colspan="1" rowspan="1">behavioural changes</th><th align="left" colspan="1" rowspan="1">changes in synaptic morphology and function</th><th align="left" colspan="1" rowspan="1">biochemical alterations</th><th align="left" colspan="1" rowspan="1">references</th></tr></thead><tbody><tr><td colspan="5" rowspan="1"><italic>Syngap1</italic> mutation</td></tr><tr><td colspan="1" rowspan="1"> exon 7/8 in <italic>Syngap1</italic><sup>+/−</sup>mice<break></break>B6.129-<italic>Syngap1<sup>tm1Rlh</sup></italic>/J<break></break><bold>MGI:</bold> 3822367</td><td colspan="1" rowspan="1">stereotypic behaviour, anxiety↓, memory deficits and social interaction↓</td><td colspan="1" rowspan="1">LTP↓,<break></break>AMPA/NMDA↑</td><td colspan="1" rowspan="1">N/D</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C85">85</xref>,<xref ref-type="bibr" rid="RSOB180265C86">86</xref>]</td></tr><tr><td colspan="1" rowspan="1"> exon 4–9 in <italic>Syngap1</italic><sup>+/−</sup>mice,<break></break>Syngap1<sup>tm1.1Mabk</sup><break></break><bold>MGI:</bold> 3511175</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">mEPSPs↑<break></break>early maturation of the spines</td><td colspan="1" rowspan="1">altered clustering of PSD-95 protein and their movement into the spine head, dysregulation of Ras, activation of the Rho family of GTP-binding proteins and phosphatidylinositol-3- kinase</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C87">87</xref>]</td></tr><tr><td colspan="1" rowspan="1"> exon 5/6 and 7/8 in <italic>Syngap1</italic><sup>+/−</sup>mice<break></break>B6.129S2 <italic>Syngap1<sup>tm2Geno</sup></italic>/RumbJ<break></break><bold>MGI:</bold> 5796355<break></break>STOCK Syngap1<sup>tm1.1Geno</sup>/RumbJ<break></break><bold>MGI:</bold> 5796354</td><td colspan="1" rowspan="1">seizure threshold↓, altered context discrimination behaviour, locomotor activity↑</td><td colspan="1" rowspan="1">early spine maturation, AMPA/NMDA↑,<break></break>LTP↓</td><td colspan="1" rowspan="1">N/D</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C88">88</xref>]</td></tr><tr><td colspan="5" rowspan="1"><italic>Fmr1</italic> mutations</td></tr><tr><td colspan="1" rowspan="1"> <italic>Fmr1</italic>-KO (neomycin cassette inserted into exon 5)<break></break>B6.129P2-<italic>Fmr1<sup>tm1Cgr</sup></italic>/J<break></break><bold>MGI:</bold> 2162650</td><td colspan="1" rowspan="1">cognition↓ and activity↑ seizure threshold↓, sensitivity to sensory stimuli, anxiety↑ social interaction↓</td><td colspan="1" rowspan="1">spine density, immature thin, elongated spines↑</td><td colspan="1" rowspan="1">group I mGluR-mediated LTD↑ local protein synthesis↑</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C89">89</xref>,<xref ref-type="bibr" rid="RSOB180265C90">90</xref>]</td></tr><tr><td colspan="1" rowspan="1"> <italic>Fmr1</italic>-KO2 (germline ablation of promoter and first coding exon)<break></break>Fmr1<sup>tm1.1Cidz</sup><break></break><bold>MGI:</bold> 3808885</td><td colspan="1" rowspan="1">hyperactivity<break></break>altered emotional processing<break></break>memory deficits<break></break>hypersensory response<break></break>ultrasonic vocalizations↓</td><td colspan="1" rowspan="1">spine heads↓ and wider spine necks</td><td colspan="1" rowspan="1">AMPA/NMDA↓<break></break>NMDAR-mediated LTP↓</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C91">91</xref>–<xref ref-type="bibr" rid="RSOB180265C93">93</xref>]</td></tr><tr><td colspan="1" rowspan="1"> <italic>Fmr1</italic>-CKO (promoter and first coding exon are floxed, can be removed with conditional cre-expression)<break></break>Fmr1<sup>tm1Cidz</sup><break></break><bold>MGI:</bold> 3603442</td><td colspan="1" rowspan="1">hippocampus-dependent learning deficits<break></break>cerebellar eyelid conditioning↓</td><td colspan="1" rowspan="1">immature spine number↑</td><td colspan="1" rowspan="1">LTD↑</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C94">94</xref>,<xref ref-type="bibr" rid="RSOB180265C95">95</xref>]</td></tr><tr><td colspan="5" rowspan="1"><italic>Mecp2</italic> mutation</td></tr><tr><td colspan="1" rowspan="1"> <italic>Mecp2</italic> KO<break></break>B6.129P2(C)-<italic>Mecp2<sup>tm1.1Bird</sup></italic>/J<break></break><bold>MGI:</bold> 2165230</td><td colspan="1" rowspan="1">movement↓, improper gait, hind limb clasping, respiratory disorder</td><td colspan="1" rowspan="1">number of dopaminergic neurons↓,<break></break>soma size↓,<break></break>precocious opening of critical period in visual cortex and accelerated maturation of GABAergic PV(+) neurons</td><td colspan="1" rowspan="1">deficit in GABA and glutamate synthesis pathway, spatio-temporal alteration of NMDAR expression, alteration in activity-dependent global chromatin dynamics</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C96">96</xref>–<xref ref-type="bibr" rid="RSOB180265C102">102</xref>]</td></tr><tr><td colspan="1" rowspan="1"> <italic>Mecp2</italic>-CKO <italic>TH-Cre, Mecp2 <sup>flox</sup></italic><break></break>B6.129P2-<italic>Mecp2<sup>tm1Bird</sup></italic>/J<break></break><bold>MGI:</bold> 3702570</td><td colspan="1" rowspan="1">total distance and vertical activity in open field↓, performance in dowel walking test↓</td><td colspan="1" rowspan="1">dopamine, norepinephrine, serotonin release↓</td><td colspan="1" rowspan="1">expression of <italic>TH</italic> and <italic>Tph2</italic>↓</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C103">103</xref>]</td></tr><tr><td colspan="1" rowspan="1"> <italic>MeCP2</italic> KI<break></break>FVB-Tg(MECP2)1Hzo/J<break></break><bold>MGI:</bold> 3817212</td><td colspan="1" rowspan="1">homozygous animals show tremors, gait ataxia↑<break></break>heterozygous animals show rescue from RTT-like symptoms</td><td colspan="1" rowspan="1">neuronal cell number and brain size is rescued to wild-type littermates</td><td colspan="1" rowspan="1">N/D</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C104">104</xref>]</td></tr><tr><td colspan="1" rowspan="1"><italic> MeCP2<sup>R168X</sup></italic> point mutation;<break></break>STOCK <italic>Mecp2<sup>tm1.1Jtc</sup></italic>/SchvJ<break></break><bold>MGI:</bold> 5568127</td><td colspan="1" rowspan="1">stereotyped behaviour↑, hypoactivity, breathing problems</td><td colspan="1" rowspan="1">N/D</td><td colspan="1" rowspan="1">no change in the <italic>Ube3A</italic> mRNA level</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C105">105</xref>]</td></tr><tr><td colspan="5" rowspan="1"><italic>Shank3</italic> mutation</td></tr><tr><td colspan="1" rowspan="1"> <italic>Shank3 <sup>e4–9</sup></italic> homozygous<break></break>B6.129S7-Shank3<sup>tm1Yhj</sup>/J<break></break><bold>MGI:</bold> 5295948</td><td colspan="1" rowspan="1">social interaction↓, repetitive behaviour↑, impaired memory</td><td colspan="1" rowspan="1">activity-dependent redistribution of GluA1 AMPAR↓, thin long dendritic spines↑, LTP↓</td><td colspan="1" rowspan="1">GKAP, PSD95, Homer protein level↓</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C106">106</xref>]</td></tr><tr><td colspan="1" rowspan="1"> <italic>Shank3 <sup>e4–9</sup></italic> heterozygous<break></break>B6[36]-<italic>Shank3<sup>tm1.2Bux</sup></italic>/J<break></break><bold>MGI:</bold> 5317118</td><td colspan="1" rowspan="1">social behaviour, social sniffing, ultrasonic vocalization↓</td><td colspan="1" rowspan="1">mEPSC, basal neurotransmission, LTP↓</td><td colspan="1" rowspan="1">AMPAR expression↓</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C107">107</xref>]</td></tr><tr><td colspan="1" rowspan="1"> <italic>Shank3B<sup>−/−</sup></italic><break></break>B6.129-Shank3<sup>tm2Gfng</sup>/J<break></break><bold>MGI:</bold> 5444207</td><td colspan="1" rowspan="1">repetitive grooming↑, social interaction↓</td><td colspan="1" rowspan="1">complexity↑ of dendritic length, dendritic arborization↑ and ↓surface area of MSN, caudate volume, cortico-striatal synaptic transmission, mEPSC frequency in MSN</td><td colspan="1" rowspan="1">SAPAP3, PSD93, Homer, NR2B, GluA2, NR2A expression↓</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C108">108</xref>]</td></tr><tr><td colspan="5" rowspan="1"><italic>Neuroligin</italic></td></tr><tr><td colspan="1" rowspan="1"> <italic>Neuroligin3</italic> R451C knockin mice<break></break>B6.129-Nlgn3<sup>tm1Sud</sup>/J<break></break><bold>MGI:</bold> 3820515</td><td colspan="1" rowspan="1">rotarod-mediated motor behaviour↑</td><td colspan="1" rowspan="1">dendritic complexity and dendritic branching in hippocampus↑. mEPSC in CA1, mIPSC in somatosensory cortex, LTP↑. mIPSC in CA3, GABA release, GDP frequency↑. GABAergic synaptic transmission↑ and IPSC amplitude↓ in barrel cortex and hippocampus. IPSC and E/I ratio in D1-MSN</td><td colspan="1" rowspan="1"> NLGN3 protein misfolding and trafficking defects, NLGN3 expression was 90%↓. Alteration of NMDAR subunit composition and expression of NMDAR subunit 2B↑. IPSC amplitude and success rate at the same synapse failed to respond to AM251 (CB1 receptor antagonist)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C109">109</xref>–<xref ref-type="bibr" rid="RSOB180265C114">114</xref>]</td></tr><tr><td colspan="1" rowspan="1"><italic>Neuroligin3</italic> R704C knockin mice STOCK Nlgn3<sup>tm3.1Sud</sup>/J<break></break><bold>MGI:</bold> 5437466</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">AMPAR-mediated synaptic response↓ and unaltered NMADR or GABAR-mediated response. Unaltered NMDAR-mediated LTP, EPSC frequency↓ and NMDA/AMPA, in cultured hippocampal neurons↑</td><td colspan="1" rowspan="1">levels of AMPAR subunits GluA1 and GluA3↑</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C115">115</xref>]</td></tr></tbody></table></table-wrap></p>
</sec>
<sec id="s5">
<label>5.</label>
<title>Gene mutation in intellectual disability and autistic spectrum disorders</title>
<sec id="s5a">
<label>5.1.</label>
<title>SYNGAP1</title>
<p>SYNGAP1 is a 135 kDa protein that was shown by Chen <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180265C116">116</xref>] and Kim <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180265C10">10</xref>] to be one of the targets of phosphorylation by Ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CaMKII) in the post-synaptic density (PSD) in the rat brain. It has several different isoforms which arise as a result of alternative splicing owing to different start sites. Though the existence of SYNGAP1 isoforms was first identified in 1998, detailed characterization and analysis were done much later [<xref ref-type="bibr" rid="RSOB180265C82">82</xref>,<xref ref-type="bibr" rid="RSOB180265C116">116</xref>,<xref ref-type="bibr" rid="RSOB180265C117">117</xref>]. The functions of different isoforms and physiological functions of <italic>Syngap1</italic>, particularly in regard to the <italic>Syngap1</italic> mutation and its implications in ID and ASDs, are extensively discussed in another comprehensive review by Jeyabalan &amp; Clement [<xref ref-type="bibr" rid="RSOB180265C82">82</xref>].</p>
<sec id="s5a1">
<label>5.1.1.</label>
<title>Behavioural changes associated with <italic>Syngap1</italic> mutation</title>
<p><italic>Syngap1</italic><sup>+/−</sup> was found to be associated with several behavioural abnormalities, including cognitive and learning deficits, reduced seizure threshold, hyperactivity and increased locomotion [<xref ref-type="bibr" rid="RSOB180265C118">118</xref>,<xref ref-type="bibr" rid="RSOB180265C119">119</xref>]. Behavioural tests such as the Morris water maze, radial arm maze, spontaneous alternation test and the Y-maze novel arm test have been used to compare learning- and memory-related impairments in <italic>Syngap1</italic><sup>+/−</sup> mice [<xref ref-type="bibr" rid="RSOB180265C87">87</xref>,<xref ref-type="bibr" rid="RSOB180265C120">120</xref>]. <italic>Syngap1</italic><sup>+/−</sup> mice showed a significant decline in working memory; however, the performance was comparable to wild-type (WT) animals in the reference memory tasks, suggesting only specific memories are impaired [<xref ref-type="bibr" rid="RSOB180265C121">121</xref>]. These mice further presented with deficits in the remote memory when tested on the contextual fear learning procedure [<xref ref-type="bibr" rid="RSOB180265C119">119</xref>]. These findings have been verified physiologically by Clement <italic>et al.</italic> [<xref ref-type="bibr" rid="RSOB180265C88">88</xref>] by measuring basal synaptic transmission from the dentate gyrus and relating it to learning and memory deficits observed in these mice and patients.</p>
<p>Apart from cognitive decline, <italic>Syngap1</italic><sup>+/−</sup> mice also exhibited stereotypic behaviour, hyperactivity and reduced anxiety-like behaviour, which was estimated experimentally using an open field test and elevated plus maze [<xref ref-type="bibr" rid="RSOB180265C85">85</xref>,<xref ref-type="bibr" rid="RSOB180265C121">121</xref>]. These mice spent more time in the open arms of the elevated plus maze than the WT animals, thereby displaying enhanced overall locomotion [<xref ref-type="bibr" rid="RSOB180265C85">85</xref>,<xref ref-type="bibr" rid="RSOB180265C119">119</xref>,<xref ref-type="bibr" rid="RSOB180265C121">121</xref>]. These behavioural abnormalities suggest impairment in learning and memory. To further validate these findings related to the <italic>Syngap1</italic> heterozygous mutation, a study made use of the cliff avoidance test in which latency to jump off the cliff was higher in the case of the <italic>Syngap1</italic><sup>+/−</sup> mice than in the normal WT animals, suggesting the lack of competency to judge the depth [<xref ref-type="bibr" rid="RSOB180265C122">122</xref>]. Similarly, patients with the <italic>SYNGAP1</italic> mutation exhibited a non-syndromic form of ID that had been linked to a decline in sociability, and this was reinforced with the help of sociability tests done in transgenic mice [<xref ref-type="bibr" rid="RSOB180265C85">85</xref>].</p>
<p>Studies from patients with the <italic>SYNGAP1</italic> heterozygous mutation have shown that approximately 80% of patients have epileptic seizures [<xref ref-type="bibr" rid="RSOB180265C82">82</xref>,<xref ref-type="bibr" rid="RSOB180265C123">123</xref>,<xref ref-type="bibr" rid="RSOB180265C124">124</xref>]. Indeed, electroencephalogram monitoring combined with video monitoring assays in patients showed spontaneous abnormal cortical activity in patients with the <italic>Syngap1</italic> heterozygous mutation [<xref ref-type="bibr" rid="RSOB180265C119">119</xref>]. Similarly, <italic>Syngap1</italic><sup>+/−</sup> mice exhibited a reduction in the seizure threshold and induction of myoclonic seizures as a result of mutations in the <italic>Syngap1</italic> gene, which is in agreement with the epileptic seizures observed in patients [<xref ref-type="bibr" rid="RSOB180265C88">88</xref>,<xref ref-type="bibr" rid="RSOB180265C119">119</xref>]. Additionally, reduced levels of SYNGAP1 in the inhibitory GABAergic neurons exhibited reduced inhibitory synaptic activity and cortical gamma oscillation power and resulted in cognitive and social deficits [<xref ref-type="bibr" rid="RSOB180265C125">125</xref>].</p>
<p>A recent report has shown the impairment of sensory processing and touch-related deficits observed in patients as a result of reduced activity within the upper lamina somatosensory cortex (SSC) circuits in <italic>Syngap1</italic><sup>+/−</sup> mice [<xref ref-type="bibr" rid="RSOB180265C126">126</xref>]. On the contrary, an earlier finding suggested that <italic>Syngap1</italic> heterozygous mutation resulted in increased overall excitability of neurons [<xref ref-type="bibr" rid="RSOB180265C126">126</xref>]. These studies demonstrate the fact that <italic>Syngap1</italic><sup>+/−</sup> mutations lead to abnormal neuronal activity, thereby causing excitatory and inhibitory imbalance.</p>
<p>In addition, the clinical findings were similar to the behavioural phenotypes observed in mice. For example, patients with <italic>SYNGAP1</italic><sup>+/−</sup> reported delated psychomotor symptoms and developmental delays [<xref ref-type="bibr" rid="RSOB180265C127">127</xref>–<xref ref-type="bibr" rid="RSOB180265C129">129</xref>]. They also manifested reduced seizure threshold and increased chances of epileptogenesis [<xref ref-type="bibr" rid="RSOB180265C124">124</xref>,<xref ref-type="bibr" rid="RSOB180265C129">129</xref>–<xref ref-type="bibr" rid="RSOB180265C131">131</xref>]. Identification of different splice variants of the <italic>SYNGAP1</italic> gene in patients would help to understand the implication of this gene mutation in humans and the translational success of studies done in rodents [<xref ref-type="bibr" rid="RSOB180265C132">132</xref>,<xref ref-type="bibr" rid="RSOB180265C133">133</xref>].</p>
</sec>
<sec id="s5a2">
<label>5.1.2.</label>
<title>Synaptic function and morphology</title>
<p>SYNGAP1 protein has been shown to regulate postsynaptic cytoskeletal changes and AMPA receptor trafficking onto the surface of the postsynaptic membrane [<xref ref-type="bibr" rid="RSOB180265C86">86</xref>]. It was reported that <italic>Syngap1</italic><sup>−/−</sup> mice died within a week of their birth, while the survival of <italic>Syngap1</italic><sup>+/−</sup> mice was similar to WT [<xref ref-type="bibr" rid="RSOB180265C86">86</xref>]. The latter further showed a reduction in LTP in comparison with the WT littermates, suggesting impaired learning and memory abilities [<xref ref-type="bibr" rid="RSOB180265C86">86</xref>]. Non-viability of the <italic>Syngap1</italic><sup>−/−</sup> mice has been attributed to increased apoptosis as a result of CASPASE-3 activation [<xref ref-type="bibr" rid="RSOB180265C134">134</xref>]. This could explain the reasons for not identifying any homozygous mutations in human patients, to date, and corroborates well with the preclinical mouse model, suggesting its impact on translational research. <italic>Syngap1</italic><sup>+/−</sup> mice, on the other hand, exhibited premature spine maturation, leading to an overall increase in neuronal excitability [<xref ref-type="bibr" rid="RSOB180265C87">87</xref>]. Research has also pointed out the involvement of SYNGAP1 in the ACTIN-mediated steady-state regulation of spine morphology, which is necessary for spine maturation [<xref ref-type="bibr" rid="RSOB180265C135">135</xref>]. Clement <italic>et al.</italic> [<xref ref-type="bibr" rid="RSOB180265C88">88</xref>] confirmed the association of behavioural abnormalities with premature spine maturation in the hippocampus. They observed a higher number of mushroom-shaped spines and a lesser number of stubby spines at the beginning of the second post-natal week in comparison with the WT littermates [<xref ref-type="bibr" rid="RSOB180265C88">88</xref>]. This confirmed the role of SYNGAP1 in the control of cytoskeleton rearrangement and spine maturation. A follow-up study went on to suggest the crucial role of SYNGAP1 during the critical period of development [<xref ref-type="bibr" rid="RSOB180265C136">136</xref>]. Apart from early spine maturation as previously reported, somatosensory neurons in the <italic>Syngap1</italic><sup>+/−</sup> mice showed adult neuron-like characteristics, including increased arbour complexity, total length and occupational volume [<xref ref-type="bibr" rid="RSOB180265C19">19</xref>]. Similar observations were made in another report, which studied the development of layer II/III of the medial prefrontal cortex (mPFC) in <italic>Syngap1</italic><sup>+/−</sup> mice. They found an elevated AMPA/NMDA ratio during the early stages of development, which was correlated to the prematuration of excitatory synapses in the cortex [<xref ref-type="bibr" rid="RSOB180265C136">136</xref>].</p>
<p>Maturation of the spines from filopodia to mushroom-shaped requires un-silencing of synapses mediated by an increase in the insertion of AMPA receptors. This change leads to an increase in the level of basal synaptic transmission, which has already been discussed in detail elsewhere [<xref ref-type="bibr" rid="RSOB180265C137">137</xref>]. It was initially demonstrated that the basal synaptic transmission remained unaffected in the adult <italic>Syngap1</italic><sup>+/−</sup> mice. However, a follow-up study by Clement <italic>et al.</italic> [<xref ref-type="bibr" rid="RSOB180265C88">88</xref>] showed that AMPAR-mediated currents increased in P14–16, equivalent to that of WT, but otherwise remained unchanged in young (P7–9) and adult mice [<xref ref-type="bibr" rid="RSOB180265C88">88</xref>]. This suggested that the alteration in the insertion of AMPA receptors could lead to changes in the excitatory and inhibitory balance and altered the critical period of development which eventually causes various behavioural defects as reported by patients with <italic>SYNGAP1</italic><sup>+/−</sup>.</p>
<p>As a part of the NMDAR-mediated signalling pathway, a heterozygous mutation in <italic>Syngap1</italic> may impair the NMDAR-mediated current. However, it remained unaffected when NMDAR-mediated currents were measured from different stages of development, suggesting a role for <italic>Syngap1</italic> in synapse formation and function without altering the characteristics of NMDARs [<xref ref-type="bibr" rid="RSOB180265C138">138</xref>]. An <italic>in vitro</italic> study performed later went on to show an increase in the amplitude and frequency of the mEPSCs as a result of an increase in the number of AMPA receptors at the post-synapse and, hence, the surge in the AMPAR-mediated current [<xref ref-type="bibr" rid="RSOB180265C87">87</xref>]. In a similar study done <italic>in vivo</italic>, comparable results were obtained, though only at the P14–16 stages [<xref ref-type="bibr" rid="RSOB180265C88">88</xref>]. These studies further suggested that an increase in the AMPA/NMDA ratio at P14–16 in <italic>Syngap1</italic><sup>+/−</sup> mice correlated with an increase in the number of functional synapses in the hippocampus. Experiments involving other areas of the brain such as mPFC have also yielded similar results with an overall increase in glutamatergic activity [<xref ref-type="bibr" rid="RSOB180265C119">119</xref>].</p>
<p>As a result of increased basal synaptic transmission and excitability due to increased AMPA receptor insertion at the post-synapse, LTP generation and maintenance were impaired in the adult <italic>Syngap1</italic><sup>+/−</sup> mice [<xref ref-type="bibr" rid="RSOB180265C86">86</xref>,<xref ref-type="bibr" rid="RSOB180265C119">119</xref>,<xref ref-type="bibr" rid="RSOB180265C138">138</xref>]. On the other hand, the effect of <italic>Syngap1</italic><sup>+/−</sup> on LTD induction has been studied less extensively. Acute application of NMDA had been widely used to induce LTD in acute brain slices [<xref ref-type="bibr" rid="RSOB180265C139">139</xref>]. The same protocol when used in <italic>Syngap1</italic><sup>+/−</sup> mice yielded poor maintenance of the LTD in comparison with the WT control animals where stable LTD was maintained throughout the experiment [<xref ref-type="bibr" rid="RSOB180265C135">135</xref>]. Nevertheless, the paired-pulse protocol used elsewhere did not show significant differences in LTD induction in <italic>Syngap1</italic><sup>+/−</sup> mice, which suggests that the release probability was not affected by SYNGAP1 and it was an altered function of post-synapses [<xref ref-type="bibr" rid="RSOB180265C86">86</xref>]. To study the role mGluR-mediated LTD, Barnes <italic>et al.</italic> [<xref ref-type="bibr" rid="RSOB180265C18">18</xref>] stimulated group I mGluRs with dihydroxyphenylglycine (DHPG) in the hippocampus and showed mGluR-LTD was significantly increased independent of protein synthesis in <italic>Syngap1</italic><sup>+/−</sup> mice at PND 25–32. Our unpublished data, at the time of writing this review, further confirmed that increased mGluR-LTD is persistent in adulthood. However, the mechanisms of how SYNGAP1 regulates mGluR-LTD are yet to be elucidated. One of the possible mechanisms proposed by Barnes <italic>et al.</italic> suggests the presence of convergence in the biochemical signalling pathway downstream of mGluR- and NMDAR-mediated signalling proteins, although this needs to be further investigated in detail.</p>
</sec>
<sec id="s5a3">
<label>5.1.3.</label>
<title>Biochemical pathways and their alteration in the <italic>SYNGAP1</italic> haploinsufficiency</title>
<p>SYNGAP1 is a postsynaptic protein that is downstream of NMDA receptors and the postsynaptic scaffolding protein PSD-95 [<xref ref-type="bibr" rid="RSOB180265C10">10</xref>]. It negatively regulates RAS-GTPase activity, thereby regulating the insertion of AMPARs at the post-synapses [<xref ref-type="bibr" rid="RSOB180265C10">10</xref>]. Furthermore, its activity is regulated by the phosphorylation of CaMKII [<xref ref-type="bibr" rid="RSOB180265C10">10</xref>]. Based on these initial findings, the possible phosphorylation sites of SYNGAP1 were recognized, and the levels of phosphorylation increased activation of NMDARs [<xref ref-type="bibr" rid="RSOB180265C140">140</xref>]. Studies performed using <italic>Syngap1</italic><sup>+/−</sup> mice to identify the signalling cascades downstream of SYNGAP1 demonstrated that it is a negative regulator of extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK) signalling and a positive modulator of the p38–MAPK signalling pathway, thereby regulating activity-induced synaptic plasticity (<xref ref-type="fig" rid="RSOB180265F2">figure 2</xref> compares the signalling mechanisms impaired in different mutations in ID that are discussed in this review) [<xref ref-type="bibr" rid="RSOB180265C138">138</xref>,<xref ref-type="bibr" rid="RSOB180265C141">141</xref>]. Additionally, the activity of proteins such as p21-activated kinase [<xref ref-type="bibr" rid="RSOB180265C27">27</xref>], RAC and p-Cofilin, which are regulated by the SYNGAP1, were also elevated in <italic>Syngap1</italic><sup>+/−</sup> mice under the basal conditions [<xref ref-type="bibr" rid="RSOB180265C135">135</xref>]. Thus, SYNGAP1 regulates spine morphology and function by modulating cytoskeletal dynamics. It was clear from these studies that the signalling pathways downstream of NMDARs were impaired in <italic>Syngap1<sup>+/−</sup></italic>, causing various sensory, cognitive and social deficits as observed in patients.
<fig id="RSOB180265F2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Illustration depicting primary signalling mechanisms of different neuronal and astrocytic proteins encoded by genes implicated in ID/ASDs. Activation of the pre-synapse leads to neurotransmitter release. The neurotransmitter binds to the corresponding receptors; these allow the influx of divalent ions that trigger several downstream signalling cascades. (1) Activation of group I mGluRs leads to dephosphorylation of FMRP by PP2A. This dephosphorylation displaces FMRP from mRNA promoting their translation. Simultaneously, PP2A inhibits extracellular signal-regulated kinase (ERK)-mediated protein synthesis. On a slower time scale, mGluR activation stimulates the mTOR pathway, which, consequently, re-phosphorylates FMRP and inhibits mRNA translation. (2) NMDAR activation leads to phosphorylation of CaMKII, which in turn phosphorylates SYNGAP1and traffics AMPARs to the postsynaptic membrane via ERK. (3) SHANK3 is expressed downstream of group I mGluRs and regulates signalling via HOMER, which might also regulate NMDAR-mediated signalling. In addition, SHANK3 interacts with NMDAR via GKAP and PSD95, thereby regulating synaptic plasticity. (4) NEUROLIGIN3 interacts directly with NEUREXINS and maintains the stability of the excitatory synapse, whereas NEUROLIGIN2 regulates inhibitory synapse function via GEPHYRIN and COLLYBISTIN. (5) MeCP2 regulates expression of different plasticity-related genes in neurons as well as in astrocytes.</p></caption><graphic xlink:href="rsob-9-180265-g2"></graphic></fig></p>
</sec>
<sec id="s5a4">
<label>5.1.4.</label>
<title>The critical period of plasticity</title>
<p><italic>Syngap1</italic> is shown to have a developmentally regulated expression in mice wherein the expression peaks at PND14 and stabilizes subsequently. In <italic>Syngap1<sup>+/−</sup></italic>, at PND14–16, the SYNGAP1 expression was half of that of WT. Electrophysiological studies in acute hippocampal brain slices have shown an increased AMPA/NMDA ratio which was further corroborated by an increased number of mushroom-shaped spines at PND14, increased basal synaptic transmission and increased mEPSC and mIPSC (increase in amplitude and frequency, which suggests that the number of functional AMPAR/GABAR, respectively, in the post-synapse) at PND14 in <italic>Syngap1</italic><sup>+/−</sup> when compared with WT (matures at PND21) [<xref ref-type="bibr" rid="RSOB180265C88">88</xref>]. Overall, this study suggests that early maturation of dendritic spines, which indirectly illustrates the altered critical period of plasticity and development in <italic>Syngap1</italic><sup>+/−</sup>. Clement <italic>et al.</italic> in 2012 [<xref ref-type="bibr" rid="RSOB180265C88">88</xref>], using the conditional Cre-lox system to create haploinsufficiency of SYNGAP1, measured AMPA/NMDA in neonatal and young adult mice. Surprisingly, they observed that the AMPA/NMDA ratio in <italic>Syngap1</italic><sup>+/−</sup> young adults was the same as WT adults, which contradicts increased AMPA/NMDA for neonatal mice. This study further confirms that the critical period of SYNGAP1 protein function is in the first two weeks of hippocampal development. In 2013, a similar study [<xref ref-type="bibr" rid="RSOB180265C136">136</xref>] by the same group demonstrated an altered critical period of development in mPFC and thalamocortical connections in <italic>Syngap1</italic><sup>+/−</sup> during development, further validating early excitatory synaptic maturation in mPFC and, thereby, restricting the duration of the critical period of plasticity window [<xref ref-type="bibr" rid="RSOB180265C136">136</xref>]. This study further suggests that, owing to a mutation in <italic>Syngap1</italic><sup>+/−</sup>, an altered critical period of plasticity and early maturation of dendritic spine structures might prevent remapping of connections, particularly to any experience, during development. In a study by Aceti <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180265C19">19</xref>], tracking of dendritic arborization in the somatosensory cortex in <italic>Syngap1</italic><sup>+/−</sup> at PND21 unveiled several adult-like features of neurons, such as higher order branching, arborization and adult-like dendritic length, suggesting early maturation of neurons [<xref ref-type="bibr" rid="RSOB180265C19">19</xref>]. A filopodia to spine structure transition is often associated with functional remapping of sensory circuits in response to experiences [<xref ref-type="bibr" rid="RSOB180265C142">142</xref>]. Whisker deprivation indicated a 2.5-fold increase in filopodia density at PND21 in WT which was absent in <italic>Syngap1</italic><sup>+/−</sup>; this further suggests a limited capacity to organize cortical circuits or remapping cortical circuits in <italic>Syngap1</italic><sup>+/−</sup>. To further study the developmental regulation of SYNGAP1 and early maturation of neuronal spines, Aceti and group did genetic rescue by inducible Cre-allele post-critical period. Different behavioural phenotypes such as risk-taking, novelty-induced hyperlocomotion and long-term memory were rescued in neonatal mice (tamoxifen injected in PND1), whereas the young adult (PND21) counterpart showed partial rescue of brain dysfunction in <italic>Syngap1</italic><sup>+/−</sup> [<xref ref-type="bibr" rid="RSOB180265C19">19</xref>]. Overall, these studies suggest that there is indeed a heightened period of development and plasticity of SYNGAP1 protein in different brain regions within the critical period window, which is irreversible in <italic>Syngap1</italic>.</p>
</sec>
</sec>
<sec id="s5b">
<label>5.2.</label>
<title>FMR1</title>
<p>Fragile X syndrome is the most common monogenic form of ID [<xref ref-type="bibr" rid="RSOB180265C143">143</xref>,<xref ref-type="bibr" rid="RSOB180265C144">144</xref>]. It is an X-linked disorder [<xref ref-type="bibr" rid="RSOB180265C145">145</xref>] and, therefore, generally affects males more prevalently (1 in 4000) than females (1 in 8000) [<xref ref-type="bibr" rid="RSOB180265C146">146</xref>,<xref ref-type="bibr" rid="RSOB180265C147">147</xref>]. It is caused by the loss of function of the fragile X mental retardation protein (FMRP) [<xref ref-type="bibr" rid="RSOB180265C148">148</xref>]. The absence of FMRP is most often the result of transcriptional silencing of the locus containing the <italic>FMR1</italic> gene [<xref ref-type="bibr" rid="RSOB180265C149">149</xref>]. Typically, the <italic>FMR1</italic> gene consists of a polymorphic repeat region present in the 5′-UTR (untranslated) non-coding region of the <italic>FMR1</italic> gene [<xref ref-type="bibr" rid="RSOB180265C148">148</xref>,<xref ref-type="bibr" rid="RSOB180265C150">150</xref>]. It consists of a stretch of trinucleotide CGG repeats that varies between six and 54 in normal alleles [<xref ref-type="bibr" rid="RSOB180265C150">150</xref>]. Such trinucleotide repeats were found to be susceptible to expansion and contraction events during the process of DNA replication [<xref ref-type="bibr" rid="RSOB180265C151">151</xref>,<xref ref-type="bibr" rid="RSOB180265C152">152</xref>]. When this region consists of more than 200 trinucleotide repeats, it leads to epigenetic silencing owing to hypermethylation of the repeat region, and the neighbouring CpG islands present in the promoter region leading to heterochromatin formation [<xref ref-type="bibr" rid="RSOB180265C149">149</xref>,<xref ref-type="bibr" rid="RSOB180265C153">153</xref>–<xref ref-type="bibr" rid="RSOB180265C156">156</xref>]. The formation of condensed heterochromatin in this region creates a microscopically visible constriction in the corresponding site on the X-chromosome, from which the disease derives its name [<xref ref-type="bibr" rid="RSOB180265C148">148</xref>,<xref ref-type="bibr" rid="RSOB180265C157">157</xref>]. Alleles containing 54–200 CGG repeats do not lead to silencing but are more likely to expand further and, thus, are termed pre-mutations [<xref ref-type="bibr" rid="RSOB180265C158">158</xref>]. Although pre-mutations do not cause fragile X syndrome, they were found to be responsible for causing fragile-X-related disorders such as fragile-X associated tremors/ataxia syndrome (FXTAS) [<xref ref-type="bibr" rid="RSOB180265C159">159</xref>,<xref ref-type="bibr" rid="RSOB180265C160">160</xref>] and fragile X-related primary ovarian insufficiency (FXPOI) [<xref ref-type="bibr" rid="RSOB180265C161">161</xref>,<xref ref-type="bibr" rid="RSOB180265C162">162</xref>] (<xref ref-type="boxed-text" rid="RSOB180265BX1">box 1</xref>).</p>
<boxed-text id="RSOB180265BX1" orientation="portrait" position="float">
<label>Box 1.</label>
<caption>
<title>Mechanism of trinucleotide expansion.</title>
</caption>
<p>Although the mechanism is unknown, it is thought to occur as a result of the formation of secondary hairpin loop structures by these repeats in the daughter strand. During replication, DNA polymerase synthesizes a new complementary strand of DNA along the original parent strand, which then bind to each other. When a long stretch of DNA has newly synthesized trinucleotide repeat-sequence contacts and attaches to itself due to self-complementarity, it forms a secondary hairpin loop structure, leaving the just-copied parent strand unbound. As a result of this gap, the DNA polymerase slips back and re-replicates the same sequence. In this manner, the daughter strand now contains an extra set of trinucleotide repeats, i.e. expansion takes place [<xref ref-type="bibr" rid="RSOB180265C151">151</xref>].</p>
</boxed-text>
<p>Other than having an ID, patients with fragile X syndrome exhibit a range of morphological abnormalities such as macroorchidism (enlarged testis), macrocephaly, elongated face, prominent jaws and forehead, and a highly arched palate and contain loose connective tissue leading to highly extendable joints, flat feet and soft skin [<xref ref-type="bibr" rid="RSOB180265C163">163</xref>–<xref ref-type="bibr" rid="RSOB180265C165">165</xref>]. To further understand the pathophysiology and aetiology of this disorder, the most commonly used mouse model is the <italic>Fmr1-</italic>KO mouse, which was first developed in 1994 [<xref ref-type="bibr" rid="RSOB180265C166">166</xref>].</p>
<sec id="s5b1">
<label>5.2.1.</label>
<title>Behavioural changes associated with <italic>Fmr1</italic> mutation</title>
<p>Patients with fragile X syndrome display a variety of neuropsychiatric symptoms that mainly include cognitive deficits, delayed language development, hyperactivity, social anxiety, impulsivity and a subset of autistic behaviours such as stereotypic and repetitive behaviour, shyness, poor eye contact and hypersensitivity to sound. Other than ID/ASD, fragile X syndrome frequently co-occurs with additional neuropsychiatric disorders such as epilepsy, sleep disorders and ADHD [<xref ref-type="bibr" rid="RSOB180265C163">163</xref>,<xref ref-type="bibr" rid="RSOB180265C164">164</xref>,<xref ref-type="bibr" rid="RSOB180265C167">167</xref>–<xref ref-type="bibr" rid="RSOB180265C171">171</xref>].</p>
<p>Numerous studies have been performed to study the emergence and nature of behavioural characteristics in the <italic>Fmr1-</italic>KO mouse model. Various types of fear-conditioning studies that test memory (hippocampus, amygdala and mPFC dependent) have revealed mild impairments in <italic>Fmr1-</italic>KO mice [<xref ref-type="bibr" rid="RSOB180265C172">172</xref>–<xref ref-type="bibr" rid="RSOB180265C176">176</xref>]. Additionally, in the Morris water maze test, which requires intact long-term hippocampus-dependent memory, <italic>Fmr1-</italic>KO showed learning deficits during the phases of acquisition and reversal memory [<xref ref-type="bibr" rid="RSOB180265C166">166</xref>,<xref ref-type="bibr" rid="RSOB180265C177">177</xref>]. <italic>Fmr1-</italic>KO mice failed to discriminate during the novel object recognition task, a well-established short-term memory task [<xref ref-type="bibr" rid="RSOB180265C178">178</xref>,<xref ref-type="bibr" rid="RSOB180265C179">179</xref>]. Additionally, <italic>Fmr1-</italic>KO mice showed exaggerated inhibitory (passive) avoidance extinction, demonstrating impaired emotional memory processing [<xref ref-type="bibr" rid="RSOB180265C173">173</xref>,<xref ref-type="bibr" rid="RSOB180265C180">180</xref>–<xref ref-type="bibr" rid="RSOB180265C182">182</xref>]. Thus, the <italic>Fmr1-</italic>KO mice were found to display various forms of memory impairments and cognitive deficits such as increased locomotor activity, anxiety, poor communication based on the ultrasound test, repetitive behaviour, defective sensory motor gating and seizures and to prefer social isolation [<xref ref-type="bibr" rid="RSOB180265C166">166</xref>,<xref ref-type="bibr" rid="RSOB180265C173">173</xref>,<xref ref-type="bibr" rid="RSOB180265C183">183</xref>–<xref ref-type="bibr" rid="RSOB180265C192">192</xref>]. <italic>Fmr1-</italic>KO mice further showed increased stereotypic and repetitive behaviours as observed from self-grooming [<xref ref-type="bibr" rid="RSOB180265C186">186</xref>,<xref ref-type="bibr" rid="RSOB180265C193">193</xref>] and marble-burying tendencies [<xref ref-type="bibr" rid="RSOB180265C194">194</xref>]. Based on these studies, it is evident that the biochemical, molecular, physiological and behavioural findings in mice are similar to phenotypes observed in human patients. Therefore, many of the <italic>Fmr1</italic> mouse models are useful tools to study the effect of monogenic mutations in pathophysiology and synaptic deficits as well as behaviour, and can be a potential preclinical model to find novel therapeutic targets [<xref ref-type="bibr" rid="RSOB180265C195">195</xref>,<xref ref-type="bibr" rid="RSOB180265C196">196</xref>]. However, caution should be shown to determine a suitable mouse model as it should fulfil the criteria discussed in the animal model section earlier.</p>
</sec>
<sec id="s5b2">
<label>5.2.2.</label>
<title>Synaptic function and morphology</title>
<p>During development, spine morphology gradually changes from thin, motile immature, elongated spines to larger, more stable, mature, stubby, mushroom-shaped spines [<xref ref-type="bibr" rid="RSOB180265C197">197</xref>–<xref ref-type="bibr" rid="RSOB180265C199">199</xref>]. Golgi staining of post-mortem brain tissue of patients with fragile X syndrome revealed dysgenesis in the spine morphology. Neurons in these tissues showed increased spine density, most of which were thin and elongated, indicating an immature spinal phenotype [<xref ref-type="bibr" rid="RSOB180265C200">200</xref>]. A similar observation was made in neurons from multiple cortical areas [<xref ref-type="bibr" rid="RSOB180265C201">201</xref>]. <italic>Fmr1-</italic>KO mice also exhibit a similar spine morphology such as the increased density of thin, long, immature spines in many cortical regions and the hippocampus [<xref ref-type="bibr" rid="RSOB180265C202">202</xref>,<xref ref-type="bibr" rid="RSOB180265C203">203</xref>]. This change in the spines may result from impaired synaptic turnover and maturation of spines during development, leading to retention of an immature spinal phenotype during the adult stages [<xref ref-type="bibr" rid="RSOB180265C204">204</xref>]. Studies have indeed found that increased spine turnover fails to decrease after the first two weeks of post-natal development and persists until four weeks of age, and even until adulthood [<xref ref-type="bibr" rid="RSOB180265C205">205</xref>,<xref ref-type="bibr" rid="RSOB180265C206">206</xref>]. The number of mature dendritic spines (those opposed to pre-synapse) is also reduced in <italic>Frmr1-</italic>KO mice [<xref ref-type="bibr" rid="RSOB180265C207">207</xref>]. This general lack of spine maturation is corroborated using electrophysiological evidence [<xref ref-type="bibr" rid="RSOB180265C208">208</xref>,<xref ref-type="bibr" rid="RSOB180265C209">209</xref>].</p>
<p>The morphology of spines correlates with the functional properties of synapses such as plasticity. Studies of basal synaptic transmission in <italic>Fmr1-</italic>KO mice did not show any difference in mEPSC amplitude [<xref ref-type="bibr" rid="RSOB180265C210">210</xref>], input–output (IO) curve or paired-pulse ratios (PPRs). However, a difference was observed in evoked spontaneous events, indicating that knockdown of FMRP does not change intrinsic synaptic electrophysiological properties, but reduces or delays the number of functional synaptic connections [<xref ref-type="bibr" rid="RSOB180265C210">210</xref>]. <italic>Fmr1-</italic>KO mice also showed a reduced AMPA/NMDA receptor ratio during the developmental stages [<xref ref-type="bibr" rid="RSOB180265C209">209</xref>,<xref ref-type="bibr" rid="RSOB180265C211">211</xref>]. Concerning plasticity, <italic>Fmr1-</italic>KO mice exhibited enhanced group I mGluR-dependent LTD [<xref ref-type="bibr" rid="RSOB180265C212">212</xref>]. However, no impairments were observed in NMDAR-mediated LTD [<xref ref-type="bibr" rid="RSOB180265C213">213</xref>].</p>
<p>On the other hand, NMDAR-mediated LTP was impaired in many cortical areas of <italic>Fmr1</italic>-KO mice. In the hippocampus, NMDAR-mediated LTP induced by theta-burst stimulation was also reduced in <italic>Fmr1-</italic>KO mice [<xref ref-type="bibr" rid="RSOB180265C214">214</xref>–<xref ref-type="bibr" rid="RSOB180265C218">218</xref>]. Both mGluR-mediated LTD and sustained theta-burst-mediated LTP require local synaptic protein synthesis, showing that FMRP may play a role in the regulation of synaptic protein synthesis. Large-scale forms of plasticity such as homeostatic plasticity have also been reported to be impaired in <italic>Fmr1-</italic>KO mice [<xref ref-type="bibr" rid="RSOB180265C219">219</xref>,<xref ref-type="bibr" rid="RSOB180265C220">220</xref>]. Other than glutamatergic synaptic impairments, <italic>Fmr1-</italic>KO mice further show reduced dopamine- [<xref ref-type="bibr" rid="RSOB180265C221">221</xref>] and GABAR-mediated signalling, and the number of GABARs were altered in <italic>Fmr1-</italic>KO mice [<xref ref-type="bibr" rid="RSOB180265C222">222</xref>]. These alterations in GABAR cause aberrant GABAR-mediated signalling, contributing to an altered E/I balance [<xref ref-type="bibr" rid="RSOB180265C223">223</xref>–<xref ref-type="bibr" rid="RSOB180265C226">226</xref>]. These studies suggest that the impaired group I mGluR-mediated protein synthesis and altered E/I balance lead to the decreased seizure threshold and learning and memory deficits observed in patients.</p>
<p>Impaired synaptic morphology and function may lead to abnormal neuronal circuit phenotype and subsequent behaviours. The E/I balance is altered in <italic>Fmr1-</italic>KO mice [<xref ref-type="bibr" rid="RSOB180265C226">226</xref>]. In general, reduced inhibition and increased excitation levels were observed in these mice, corroborating the increased susceptibility to seizures and epileptogenesis [<xref ref-type="bibr" rid="RSOB180265C90">90</xref>,<xref ref-type="bibr" rid="RSOB180265C227">227</xref>–<xref ref-type="bibr" rid="RSOB180265C229">229</xref>]. Thus, these alterations in the spine morphology and synaptic function could lead to ID and ASDs in human patients.</p>
</sec>
<sec id="s5b3">
<label>5.2.3.</label>
<title>Biochemical pathways</title>
<p>The <italic>FMR1</italic> gene present at locus Xq27.3 in humans codes for the FMRP protein [<xref ref-type="bibr" rid="RSOB180265C148">148</xref>]. FMRP was found to be majorly expressed in the brain and testes [<xref ref-type="bibr" rid="RSOB180265C230">230</xref>]. It consists of three RNA binding domains—two of which are K homology domains (KH1 and KH2), the third being the RGG (arginine–glycine–glycine) domain [<xref ref-type="bibr" rid="RSOB180265C231">231</xref>,<xref ref-type="bibr" rid="RSOB180265C232">232</xref>]. Thus, FMRP binds to RNA and regulates many of its dynamics. FMRP binds to almost approximately 4% of the neuronal RNA population and regulates the expression of their proteins, thereby affecting many neuronal and synaptic properties [<xref ref-type="bibr" rid="RSOB180265C231">231</xref>,<xref ref-type="bibr" rid="RSOB180265C232">232</xref>]. Once bound to mRNA, FMRP negatively regulates its translation [<xref ref-type="bibr" rid="RSOB180265C233">233</xref>]. This is hypothesized to take place by one or a combination of three mechanisms: (i) FMRP binds to secondary G-quadruplex structures in mRNA, stalling ribosomes [<xref ref-type="bibr" rid="RSOB180265C234">234</xref>–<xref ref-type="bibr" rid="RSOB180265C237">237</xref>]; (ii) FMRP recruits CYFIP-mediated inhibition of translation [<xref ref-type="bibr" rid="RSOB180265C238">238</xref>]; and (iii) FMRP recruits inhibitory miRNA containing AGO2 (Argonaute 2) complex to the mRNA, leading to RNA-induced silencing complex (RISC)-induced silencing [<xref ref-type="bibr" rid="RSOB180265C239">239</xref>–<xref ref-type="bibr" rid="RSOB180265C242">242</xref>]. FMRP additionally has nuclear import and export signals [<xref ref-type="bibr" rid="RSOB180265C243">243</xref>]. FMRP has been reported to bind mRNA in the nucleus and regulate RNA's transport to dendritic spines [<xref ref-type="bibr" rid="RSOB180265C244">244</xref>,<xref ref-type="bibr" rid="RSOB180265C245">245</xref>]. Finally, the two tandem Agenet domains were found to recognize trimethylated serine residues, and, thereby, have been reported to interact with histones and modify chromatin dynamics in the nucleus [<xref ref-type="bibr" rid="RSOB180265C245">245</xref>,<xref ref-type="bibr" rid="RSOB180265C246">246</xref>]. It is evident from these studies that FMRP binds to different RNA domains, thereby regulating the strength of synapses in response to a stimulus.</p>
<p>An important physiological function of FMRP in neurons is the activity-dependent group I mGluR-mediated repression of local protein synthesis in dendritic spines [<xref ref-type="bibr" rid="RSOB180265C247">247</xref>]. FMRP, in its phosphorylated form, represses translation [<xref ref-type="bibr" rid="RSOB180265C248">248</xref>,<xref ref-type="bibr" rid="RSOB180265C249">249</xref>]. Neurotransmitter-mediated activation of group I mGluRs leads to the activation of a phosphatase PP2A which dephosphorylates FMRP [<xref ref-type="bibr" rid="RSOB180265C250">250</xref>]. This change in PP2A leads to removal of FMRP from the mRNA, enabling local protein synthesis of various plasticity-related proteins, including those involved in AMPAR endocytosis [<xref ref-type="bibr" rid="RSOB180265C249">249</xref>,<xref ref-type="bibr" rid="RSOB180265C251">251</xref>,<xref ref-type="bibr" rid="RSOB180265C252">252</xref>]. On a slower time scale, mGluR activates mTOR, which, in turn, inactivates PP2A and activates S6 kinase, leading to re-phosphorylation of FMRP and repression of translation [<xref ref-type="bibr" rid="RSOB180265C253">253</xref>,<xref ref-type="bibr" rid="RSOB180265C254">254</xref>]. Thus, knockout of <italic>Fmr1</italic> leads to elevated levels of protein synthesis, causing dendritic spine dysmorphogenesis and impaired mGluR-mediated LTD [<xref ref-type="bibr" rid="RSOB180265C161">161</xref>,<xref ref-type="bibr" rid="RSOB180265C255">255</xref>]. In conclusion, such changes at the biochemical and molecular level impacts synaptic function and behaviour.</p>
</sec>
<sec id="s5b4">
<label>5.2.4.</label>
<title>The critical period of plasticity</title>
<p>The critical period of plasticity is often found to be disrupted in many of the NDDs. One of the first studies in the somatosensory cortex by Harlow <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180265C256">256</xref>] has shown the impairment of the critical period of plasticity in the <italic>Fmr1</italic>-KO mouse model. Behaviourally, <italic>Fmr1</italic>-KO mice showed altered sensory processing, as discussed above. Previous studies have shown an abundance of long thin immature dendritic spines in the somatosensory cortex [<xref ref-type="bibr" rid="RSOB180265C257">257</xref>,<xref ref-type="bibr" rid="RSOB180265C258">258</xref>]. However, these observations were correlative and unclear regarding the mechanism for various behavioural abnormalities. Using voltage clamp recordings, Harlow <italic>et al.</italic> [<xref ref-type="bibr" rid="RSOB180265C256">256</xref>] measured the ratio of NMDAR- and AMPAR-mediated current (NMDA/AMPA ratio) from the spiny stellate cells of the somatosensory cortex. In WT mice, the NMDA/AMPA ratio decreased progressively from PND4 to PND7, marking the closure of the critical period, whereas in <italic>Fmr1<sup>−/Y</sup></italic> mice the NMDA/AMPA ratio increased between PND4 and P7 and returned to the WT level at PND10–14 [<xref ref-type="bibr" rid="RSOB180265C256">256</xref>]. In addition, loss of LTP induction was shown to be a manifestation of the closure of the critical period in the somatosensory cortex [<xref ref-type="bibr" rid="RSOB180265C63">63</xref>], which was delayed in <italic>Fmr1<sup>−/Y</sup></italic> mice [<xref ref-type="bibr" rid="RSOB180265C256">256</xref>]. These data suggest a delay in the maturation of the thalamocortical synapses in fragile X syndrome, which could be the reason for impaired sensory processing, learning and memory. Along the same lines, altered ocular dominance plasticity in the visual cortex of <italic>Fmr1<sup>−/Y</sup></italic> mice was shown by measuring visual evoked potentials (VEPs) [<xref ref-type="bibr" rid="RSOB180265C182">182</xref>,<xref ref-type="bibr" rid="RSOB180265C259">259</xref>]. Later, a maladaptive auditory response manifested by patients with fragile X syndrome and in <italic>Fmr1</italic>-KO animals was shown to be a result of the impaired critical period of plasticity in the primary auditory cortex [<xref ref-type="bibr" rid="RSOB180265C229">229</xref>]. In conclusion, alteration in the critical period of synaptic plasticity is a significant contributor to the behavioural and synaptic pathophysiology, which may prevent neuronal remapping in the fragile X syndrome.</p>
</sec>
</sec>
<sec id="s5c">
<label>5.3.</label>
<title>MeCP2</title>
<p>X-linked heterozygous mutations in <italic>methyl CpG binding protein 2</italic> (<italic>MeCP2</italic>) has been shown to cause Rett syndrome (RTT) in humans [<xref ref-type="bibr" rid="RSOB180265C260">260</xref>–<xref ref-type="bibr" rid="RSOB180265C263">263</xref>]. <italic>MeCP2</italic> has one of the longest known 3′-UTRs of the human genome and contains four exons [<xref ref-type="bibr" rid="RSOB180265C264">264</xref>]. It is believed that the diverse and complex function of <italic>MeCP2</italic> partly lies in its 3′-UTR. Studies have shown that different polyadenylation signals also bring changes in the expression pattern of <italic>MeCP2</italic> [<xref ref-type="bibr" rid="RSOB180265C265">265</xref>].</p>
<sec id="s5c1">
<label>5.3.1.</label>
<title>Behavioural alterations</title>
<p>Studies have shown that approximately 1 in 10 000 females is affected by RTT [<xref ref-type="bibr" rid="RSOB180265C266">266</xref>–<xref ref-type="bibr" rid="RSOB180265C268">268</xref>]. Studies on human patients between 7 and 18 months of age showed phenotypes of deteriorated higher cognitive and social functions, stagnancy of brain development, severe dementia, autism, ataxia and repetitive hand movements [<xref ref-type="bibr" rid="RSOB180265C266">266</xref>–<xref ref-type="bibr" rid="RSOB180265C268">268</xref>]. Constitutive <italic>MeCP2</italic> hemizygous KO and conditional KO mouse models showed motor deficits such as improper gait, hindlimb clasping, irregular breathing [<xref ref-type="bibr" rid="RSOB180265C98">98</xref>] and microcephaly [<xref ref-type="bibr" rid="RSOB180265C98">98</xref>,<xref ref-type="bibr" rid="RSOB180265C269">269</xref>], and did not survive for more than 12 weeks after birth. Apart from the motor and social impairment, a mouse model of <italic>Mecp2</italic> also manifested impaired hippocampus-dependent spatial memory, and contextual fear memory [<xref ref-type="bibr" rid="RSOB180265C270">270</xref>]. Post-mitotic neuron-specific KO and overexpression of <italic>Mecp2</italic> displayed a similar phenotype to patients with RTT. These animals showed deficits in motor behaviour, an increase in anxiety-related behaviour, impaired social interaction and alteration in learning and memory [<xref ref-type="bibr" rid="RSOB180265C269">269</xref>,<xref ref-type="bibr" rid="RSOB180265C271">271</xref>]. In addition, a C-terminal deletion mouse model of <italic>MeCP2</italic> also displayed a similar kind of phenotype, with impaired motor learning, social deficits and epileptic seizures [<xref ref-type="bibr" rid="RSOB180265C272">272</xref>]. All these results describe successful representation of RTT in mouse models, opening the possibility for effective pre-clinical studies.</p>
</sec>
<sec id="s5c2">
<label>5.3.2.</label>
<title>Synaptic function and morphology</title>
<p>Post-mortem studies from patients with RTT revealed reduced axonal and dendritic processes and decreased dendritic spine density in CA1 pyramidal neurons [<xref ref-type="bibr" rid="RSOB180265C273">273</xref>,<xref ref-type="bibr" rid="RSOB180265C274">274</xref>]. A similar phenotype, i.e. reduced neuronal soma size and decreased dendritic arborization, was observed in the cortical pyramidal neurons of layer II/III of the <italic>MeCP2</italic> null mouse [<xref ref-type="bibr" rid="RSOB180265C275">275</xref>]. Thus, reduced complexity and size of the neurons could be one of the underlying reasons for the impaired behavioural phenotypes in the animal models similar to the patients. Considering the function of MeCP2, it can be speculated that dysregulation in the expression of many genes such as <italic>Bdnf,</italic> which is important for neuronal growth, may lead to altered neuronal morphology in <italic>Mecp2</italic> mutant mouse models. However, a mouse model overexpressing <italic>MeCP2</italic> had shown similar spine morphology to the <italic>MeCP2</italic> null mouse and patients with RTT. This study suggests that the excess level of the protein affects the synaptic functions, which, in turn, may lead to learning and memory deficits [<xref ref-type="bibr" rid="RSOB180265C276">276</xref>].</p>
<p>Patients with RTT show cognitive deficits, which could be due to impairment in the synaptic functions [<xref ref-type="bibr" rid="RSOB180265C266">266</xref>–<xref ref-type="bibr" rid="RSOB180265C268">268</xref>]. Synaptic functions were altered in the <italic>MeCP2</italic> mutant mouse models, consistent with the structural and behavioural alterations [<xref ref-type="bibr" rid="RSOB180265C277">277</xref>–<xref ref-type="bibr" rid="RSOB180265C279">279</xref>], thereby causing E/I imbalance. In addition, modification in basal synaptic transmission has resulted in impaired hippocampal LTP, not only in KO but also in knockin studies [<xref ref-type="bibr" rid="RSOB180265C270">270</xref>,<xref ref-type="bibr" rid="RSOB180265C279">279</xref>,<xref ref-type="bibr" rid="RSOB180265C280">280</xref>]. It is clear from these studies that any fluctuation in the level of MeCP2 can alter not only behaviour but also synaptic function.</p>
</sec>
<sec id="s5c3">
<label>5.3.3.</label>
<title>Biochemical pathways</title>
<p>MeCP2 regulates transcription through DNA methylation and histone acetylation. As the name suggests, it binds to the methylated cytosine residues on DNA through its methyl CpG binding domain (MBD) [<xref ref-type="bibr" rid="RSOB180265C281">281</xref>–<xref ref-type="bibr" rid="RSOB180265C283">283</xref>]. Another domain, the transcriptional repression domain (TRD), interacts with HDACs and mSin3a to regulate transcription of the downstream genes [<xref ref-type="bibr" rid="RSOB180265C281">281</xref>]. These proteins act as a corepressor of transcription. Therefore, the interactions are necessary to bring about transcription regulation through MeCP2. MeCP2 is shown to regulate many genes such as <italic>Bdnf, Dlx5</italic>, <italic>Dlx6</italic>, <italic>Reln</italic> and <italic>Ube3A</italic>, which are crucial for neuronal maturation and development, and the protein product is enriched in synapses [<xref ref-type="bibr" rid="RSOB180265C284">284</xref>–<xref ref-type="bibr" rid="RSOB180265C287">287</xref>].</p>
<p>MeCP2 is a master regulator of the transcription that regulates the neuronal maturation process by controlling the expression of the genes mentioned above. Besides its role in transcription regulation, MeCP2 has been shown to localize in heterochromatin by associating with chromatin remodelling complexes such as SWI/SNF, ATRX and histone methyl-transferase [<xref ref-type="bibr" rid="RSOB180265C282">282</xref>,<xref ref-type="bibr" rid="RSOB180265C288">288</xref>–<xref ref-type="bibr" rid="RSOB180265C291">291</xref>]. Association of MeCP2 with these different complexes allows the possibility of a global role in the regulation of gene expression. For a detailed review of the biochemical functions of MEPC2, please refer to Singh <italic>et al.</italic> [<xref ref-type="bibr" rid="RSOB180265C292">292</xref>] and Guy <italic>et al.</italic> [<xref ref-type="bibr" rid="RSOB180265C293">293</xref>].</p>
<p>Therefore, MeCP2, being a transcription regulator, regulates the expression of a wide array of synaptic plasticity-related genes. Hence, it modulates the neuronal/synaptic function which is crucial for healthy brain functions. However, a perturbation in MeCP2-mediated regulation due to a pathogenic mutation alters synaptic function and behaviour, resulting in RTT-related pathophysiology.</p>
</sec>
<sec id="s5c4">
<label>5.3.4.</label>
<title>The critical period of plasticity</title>
<p>MeCP2 is required at different stages of brain development from increasing dendritic complexity to synaptogenesis and astrocyte maturation. Disrupting MECP2 at any of these stages has been linked to RTT-like phenotypes [<xref ref-type="bibr" rid="RSOB180265C294">294</xref>]. The maturation of the cortical GABA inhibitory circuitry, particularly parvalbumin+ (PV+) fast-spiking interneurons, is a key regulator for the initiation and termination of the critical period. MECP2 KOs exhibited accelerated functional maturation of PV interneurons, which correlated with a precocious onset and closure of the critical period and deficient binocular visual function in mature animals [<xref ref-type="bibr" rid="RSOB180265C99">99</xref>]. The findings to validate the role of MeCP2 in the critical period came from another study which observed that specific <italic>Mecp2</italic> deletion in GABAergic PV cells abolished the visual experience-dependent plasticity during the critical period in post-natal development of the visual cortex, while conditional <italic>Mecp2</italic> deletion in somatostatin-expressing GABAergic cells or glutamatergic pyramidal cells had no such effect [<xref ref-type="bibr" rid="RSOB180265C295">295</xref>]. Their study demonstrated that, during the critical period, selective deletion of the RTT-related gene <italic>Mecp2</italic> in GABAergic PV neurons could result in defective inhibitory PV neuronal circuits in the developing visual cortex, which leads to the absence of experience-dependent critical period plasticity [<xref ref-type="bibr" rid="RSOB180265C295">295</xref>].</p>
</sec>
</sec>
<sec id="s5d">
<label>5.4.</label>
<title>SHANK</title>
<p>SH3 and multiple ankyrin repeat domain proteins (SHANKs), also known as ProSAPs, are a family of post-synaptic scaffolding proteins present in the excitatory glutamatergic synapses [<xref ref-type="bibr" rid="RSOB180265C296">296</xref>]. Being a primary scaffolding protein, SHANKs organize other proteins in the synapse. Thus, they are essential for normal neuronal development and function [<xref ref-type="bibr" rid="RSOB180265C297">297</xref>]. Mutations in different <italic>Shank</italic> genes (<italic>SHANK1</italic>, <italic>SHANK2</italic> and <italic>SHANK3),</italic> especially <italic>SHANK2</italic> and <italic>SHANK3</italic>, are associated with ASDs [<xref ref-type="bibr" rid="RSOB180265C298">298</xref>], and co-occurrences with ID [<xref ref-type="bibr" rid="RSOB180265C299">299</xref>]. A recent meta-analysis study has proposed that around 1% of all patients with ID/ASDs had a mutation in <italic>SHANK</italic> genes [<xref ref-type="bibr" rid="RSOB180265C300">300</xref>]. Thus, it is vital to understand the pathophysiology of such mutations to develop the correct treatment.</p>
<sec id="s5d1">
<label>5.4.1.</label>
<title>Behavioural alterations</title>
<p>A study on the <italic>Shank1</italic> null mouse model showed reduced social interaction (social sniffing), reduced ultrasonic vocalization, increased self-grooming and repetitive behaviour, enhanced spatial learning and impaired fear conditioning [<xref ref-type="bibr" rid="RSOB180265C301">301</xref>,<xref ref-type="bibr" rid="RSOB180265C302">302</xref>]. Although deletions in exons 6–7 and 7 of <italic>Shank2</italic> mouse models showed contradictory deficits in the synaptic functions, comparable behavioural phenotypes were seen. Both the mouse models displayed increased locomotor activity, increased anxiety-like behaviour and impaired social behaviour [<xref ref-type="bibr" rid="RSOB180265C303">303</xref>,<xref ref-type="bibr" rid="RSOB180265C304">304</xref>]. However, exon 7 deletion of <italic>Shank2</italic> resulted in increased self-grooming but normal working memory [<xref ref-type="bibr" rid="RSOB180265C304">304</xref>].</p>
<p>A mouse model of <italic>Shank3</italic> with exon 4–9 deletion showed impaired social behaviour, reduced ultrasonic vocalization, increased self-grooming and impaired novel object recognition [<xref ref-type="bibr" rid="RSOB180265C107">107</xref>,<xref ref-type="bibr" rid="RSOB180265C305">305</xref>]. Other models of <italic>Shank3</italic> mutation displayed similar behavioural deficits, which are summarized in <xref ref-type="table" rid="RSOB180265TB1">table 1</xref>. Thus, it is evident that the mouse models for different <italic>Shank</italic> mutations can represent many of the behavioural deficits observed in humans.</p>
</sec>
<sec id="s5d2">
<label>5.4.2.</label>
<title>Synaptic function and morphology</title>
<p>Mutation in the PDZ domain of <italic>Shank3</italic> showed reduced dendritic spine density during maturation, whereas mutation in the <italic>Ank</italic> and <italic>Sh3</italic> domains led to a reduced spine head volume [<xref ref-type="bibr" rid="RSOB180265C306">306</xref>]. Therefore, SHANK3 plays an essential role in dendritic spine maturation and morphology. An <italic>in vitro</italic> study using cultured rat neurons showed impairment in mGluR5-dependent plasticity and signalling, demonstrating the importance of SHANK3 downstream to mGluR5-mediated signalling [<xref ref-type="bibr" rid="RSOB180265C307">307</xref>]. A mouse model of <italic>Shank1</italic> exhibited reduced basal synaptic transmission, whereas LTP and LTD were not altered [<xref ref-type="bibr" rid="RSOB180265C302">302</xref>]. On the contrary, opposing effects were observed when exon 6–7 and exon 7 were deleted from <italic>Shank2</italic>, suggesting that there may be a possibility for an isoform/transcript-specific function of this gene, but it is unclear whether splice variation has any implications for human patients. A study by Schmeisser <italic>et al</italic>. [<xref ref-type="bibr" rid="RSOB180265C304">304</xref>] showed reduced spine density and synaptic transmission in the CA1 region of the hippocampus when exon 7 was deleted. In addition, a decreased I/O ratio and mEPSC frequency were seen in the exon 7 deletions, suggesting an impairment in pre-synaptic neurotransmitter release upon exon 7 deletion. I/O is the measure of basal synaptic transmission, indicating a corresponding output to every input provided to a neuron. In contrast to the increased NMDA/AMPA ratio in exon 7 deletion, decreased NMDA/AMPA was observed in the exon 6–7 deletion model of <italic>Shank2</italic> mutation [<xref ref-type="bibr" rid="RSOB180265C303">303</xref>,<xref ref-type="bibr" rid="RSOB180265C304">304</xref>]. Again, these observations show that the different exons in the gene might have opposite effects on the synaptic functions.</p>
<p>A <italic>Shank3</italic> mouse model with exon 4–9 deletion had severe defects in synaptic function. For example, activity-mediated spine remodelling was impaired in the hippocampal CA1 region, leading to learning and memory dysfunctions. AMPAR functions were affected in these mouse models, which was manifested by reduced AMPAR-mediated basal transmission. However, the study showed that the decreased mEPSC amplitude was accompanied by a subsequent increase in mEPSC frequency. The increase in mEPSC frequency suggests an impairment in the level of pre-synaptic function or an increase in the number of functional synapses. Owing to impaired AMPAR-mediated synaptic function, LTP was reduced significantly. These results can be corroborated with impaired learning and memory observed in patients. However, no change in NMDAR- and mGluR-mediated LTD was observed in these mouse models [<xref ref-type="bibr" rid="RSOB180265C107">107</xref>,<xref ref-type="bibr" rid="RSOB180265C305">305</xref>]. These data reiterate the fact that SHANK3 plays an essential role in synaptic signalling and function. Also, the data indicate the role of SHANK3 not only in mGluR-mediated signalling but also in AMPAR-mediated synaptic transmission. Several other mouse models of <italic>Shank3</italic> show deficits in different synaptic functions and are summarized in <xref ref-type="table" rid="RSOB180265TB1">table 1</xref>.</p>
</sec>
<sec id="s5d3">
<label>5.4.3.</label>
<title>Biochemical pathways and signalling</title>
<p>SHANK proteins are postsynaptic scaffolding proteins associated with the PSD complex in excitatory glutamatergic synapses [<xref ref-type="bibr" rid="RSOB180265C308">308</xref>–<xref ref-type="bibr" rid="RSOB180265C310">310</xref>]. Structurally, the SHANK family of proteins consists of five distinct motifs/domains: ankyrin repeat domain (ANK), Src homology 3 (SH3) domain, PSD-95/disc-large/ZO-1 (PDZ) domain, proline-rich (Pro) and sterile alpha motif (SAM) domain [<xref ref-type="bibr" rid="RSOB180265C311">311</xref>]. Studies that have taken place over decades have identified at least 30 proteins interacting with SHANK proteins, including different receptors, ion channels, cytoskeletal proteins and signalling molecules [<xref ref-type="bibr" rid="RSOB180265C297">297</xref>,<xref ref-type="bibr" rid="RSOB180265C307">307</xref>,<xref ref-type="bibr" rid="RSOB180265C308">308</xref>,<xref ref-type="bibr" rid="RSOB180265C312">312</xref>–<xref ref-type="bibr" rid="RSOB180265C314">314</xref>]. A study on <italic>Shank3</italic> KO showed an alteration in the mGluR5-HOMER scaffolding that in turn affected the neuronal connections in the brain [<xref ref-type="bibr" rid="RSOB180265C315">315</xref>]. However, knockdown of <italic>Shank3</italic> led to decreased mGluR5-mediated phosphorylation of ERK1/2 and CREB [<xref ref-type="bibr" rid="RSOB180265C307">307</xref>]. These independent observations link the importance of SHANK3 in mGluR5-mediated signalling and, in turn, are associated with regulation of synaptic functions.</p>
<p>Mouse models of the <italic>Shank1</italic> mutation showed a decreased synapse-associated protein-90/postsynaptic density-95 associated protein (SAPAP), guanylate kinase-associated protein (GKAP) and HOMER protein level in the PSD complex [<xref ref-type="bibr" rid="RSOB180265C302">302</xref>]. Exon 6–7 deletion in the <italic>Shank2</italic> model showed reduced phosphorylation of calcium/calmodulin-dependent kinase II (CaMKII), extracellular signal-regulated kinase (ERK) and the AMPAR subunit, GluA1, but increased expression of the NMDAR subunit, GluN1 [<xref ref-type="bibr" rid="RSOB180265C303">303</xref>]. Deletion of exon 7 from <italic>Shank2</italic> increased NMDAR subunit, GluN2B, expression in the hippocampus, whereas, in the striatum, GluN1, GluN2A, SHANK3 and GluA1 levels were increased [<xref ref-type="bibr" rid="RSOB180265C304">304</xref>]. These data show that there could be a different function for SHANKs in different brain regions. Also, by modulating the expression of different NMDAR subunits, synaptic properties involved in learning and memory were modulated by different SHANKs. Studies from a mouse model of <italic>Shank3</italic> with exon 4–9 deletion showed a robust reduction in the level of GluA1 subunit [<xref ref-type="bibr" rid="RSOB180265C107">107</xref>,<xref ref-type="bibr" rid="RSOB180265C305">305</xref>]. <italic>Shank3</italic> knockdown in cultured hippocampal neurons showed reduced expression of mGluR5 but not NMDAR or ERK [<xref ref-type="bibr" rid="RSOB180265C307">307</xref>], whereas analysis from the striatal PSD fractions of the <italic>Shank3B</italic><sup>−/−</sup> mouse model showed a decreased level of NR2A, NR2B, GluA2 and HOMER [<xref ref-type="bibr" rid="RSOB180265C108">108</xref>]. However, other mouse models of <italic>Shank3</italic> also show related biochemical alteration (<xref ref-type="table" rid="RSOB180265TB1">table 1</xref>). Based on the studies above, it is evident that the SHANK family of proteins have diverse roles in cellular signalling at different brain regions. In conclusion, the SHANK family of proteins differentially regulate synaptic function by modulating different receptor subunit expression, and, thus, regulate neuronal function, learning and memory, and behaviour.</p>
</sec>
<sec id="s5d4">
<label>5.4.4.</label>
<title>The critical period of plasticity</title>
<p>An <italic>in vivo</italic> study has shown that loss of <italic>Shank3</italic> led to impairment in the ability of visual cortical circuit recovery following sensory input deprivation [<xref ref-type="bibr" rid="RSOB180265C316">316</xref>]. Also, the homeostatic plasticity of neuronal circuits was disrupted in the <italic>Shank3</italic> KO model, which hints towards perturbation of the critical period in <italic>Shank3</italic> mutation [<xref ref-type="bibr" rid="RSOB180265C316">316</xref>]. However, using a conditional knockin mouse model, Mei <italic>et al.</italic> [<xref ref-type="bibr" rid="RSOB180265C317">317</xref>] showed re-expression of SHANK3 in adulthood restored spine density and synaptic functions in the striatum. Repetitive grooming and impaired social interaction were improved, whereas no improvement was seen in anxiety-like behaviour and motor behaviour [<xref ref-type="bibr" rid="RSOB180265C317">317</xref>]. From these studies, we can speculate that there was no major effect of <italic>Shank3</italic> perturbation on the critical period of development. However, another possibility could be delayed closure of the critical period, which may persist until adulthood in the <italic>Shank3</italic> KO, but this is unclear. This may explain the partial rescue of behavioural phenotypes observed after restoring <italic>Shank3</italic> expression in adulthood.</p>
</sec>
</sec>
<sec id="s5e">
<label>5.5.</label>
<title>Neuroligins</title>
<p>For almost two decades, it has been known that, to hold a particular synapse together for communications between neurons to occur, there are synaptic adhesion molecules such as NEUROLIGINS present in the post-synapse [<xref ref-type="bibr" rid="RSOB180265C318">318</xref>,<xref ref-type="bibr" rid="RSOB180265C319">319</xref>], and NEUREXINS, present in the pre-synapses, are known to hold a particular synapse together [<xref ref-type="bibr" rid="RSOB180265C320">320</xref>–<xref ref-type="bibr" rid="RSOB180265C322">322</xref>]. Mutations in <italic>NEUREXIN</italic> and <italic>NEUROLIGIN</italic> genes increase the likeliness of affecting synapse formation, as well as function [<xref ref-type="bibr" rid="RSOB180265C318">318</xref>,<xref ref-type="bibr" rid="RSOB180265C319">319</xref>,<xref ref-type="bibr" rid="RSOB180265C323">323</xref>,<xref ref-type="bibr" rid="RSOB180265C324">324</xref>]. <italic>NRXN1, NRXN2</italic> and <italic>NRXN3</italic>, in mammals encode for NEUREXINS, α-NEUREXIN and β-NEUREXIN, depending on their promoters [<xref ref-type="bibr" rid="RSOB180265C320">320</xref>,<xref ref-type="bibr" rid="RSOB180265C321">321</xref>]. NEUROLIGINS generally interact with β-NEUREXIN isoforms [<xref ref-type="bibr" rid="RSOB180265C318">318</xref>]. NEUROLIGINS, on the other hand, are encoded by five genes, <italic>NLGN1, NLGN2, NLGN3, NLGN4</italic> and <italic>NLGN4Y</italic>, in humans [<xref ref-type="bibr" rid="RSOB180265C318">318</xref>,<xref ref-type="bibr" rid="RSOB180265C319">319</xref>,<xref ref-type="bibr" rid="RSOB180265C325">325</xref>,<xref ref-type="bibr" rid="RSOB180265C326">326</xref>]. Based on immunostaining and biochemical analysis, subcellular localization of NLGN1 was found to be present at the excitatory synapses, and the expression level is low at birth but increases during post-natal days 1–8 and remains relatively high in later stages of development in mouse [<xref ref-type="bibr" rid="RSOB180265C323">323</xref>]. NLGN2 and NLGN4 were shown to be expressed in inhibitory synapses [<xref ref-type="bibr" rid="RSOB180265C327">327</xref>,<xref ref-type="bibr" rid="RSOB180265C328">328</xref>], whereas NLGN3 was expressed in both excitatory as well as inhibitory synapses [<xref ref-type="bibr" rid="RSOB180265C329">329</xref>]. With the help of different binding partners, such as PSD-95 [<xref ref-type="bibr" rid="RSOB180265C330">330</xref>], MAGUK [<xref ref-type="bibr" rid="RSOB180265C331">331</xref>] and GluN1 [<xref ref-type="bibr" rid="RSOB180265C332">332</xref>] at excitatory synapses and GEPHYRIN [<xref ref-type="bibr" rid="RSOB180265C242">242</xref>,<xref ref-type="bibr" rid="RSOB180265C327">327</xref>] and COLLYBISTIN [<xref ref-type="bibr" rid="RSOB180265C333">333</xref>,<xref ref-type="bibr" rid="RSOB180265C334">334</xref>] at inhibitory synapses, all NEUROLIGINS are required to maintain synapse number/density and to regulate maturation and differentiation of synapses.</p>
<p>NEUROLIGINS were recognized to induce the formation of functional synapses in early 2000. These studies, using non-neuronal cells expressing NEUROLIGIN, revealed that NLGN1 and NLGN2 alone could trigger the formation of pre-synaptic structures such as clustering of synaptic vesicles in the axon terminals of central nervous system (CNS) neurons [<xref ref-type="bibr" rid="RSOB180265C335">335</xref>]. The role of NEUROLIGINS was further validated by dissecting functional characteristics, such as NMDAR-mediated excitatory postsynaptic currents and NMDAR-dependent LTP, which are a cellular correlate of learning and memory [<xref ref-type="bibr" rid="RSOB180265C336">336</xref>,<xref ref-type="bibr" rid="RSOB180265C337">337</xref>]. This study suggests a vital role of NEUROLIGINS in learning and memory. Moreover, Varoqueaux <italic>et al.</italic> [<xref ref-type="bibr" rid="RSOB180265C338">338</xref>] have shown that the <italic>Neuroligin</italic> mouse model dies after birth due to a reduced neuronal network activity and reduced glutamatergic and GABAergic synapse formation/function resulting in respiratory failure [<xref ref-type="bibr" rid="RSOB180265C338">338</xref>], suggesting the importance of NEUROLIGINS not only in synapse formation and maturation but also in neuronal function. <italic>In vitro</italic> electrophysiological studies have shown altered mIPSC amplitude as well as frequency, suggesting a reduced number of functional GABA receptors at the post-synapse resulting in altered E/I. Furthermore, decreased excitatory and inhibitory synapses were observed in the downregulation of NLGN1 and NLGN2 [<xref ref-type="bibr" rid="RSOB180265C339">339</xref>]. The introduction of exogenous NLGN increased both mEPSCs and mIPSCs indicates an increase in excitatory and inhibitory synaptic function (increased number of functional AMPAR and GABAR in the post-synapse, respectively) [<xref ref-type="bibr" rid="RSOB180265C340">340</xref>], implying the critical role of NEUROLIGINS in maintaining E/I balance.</p>
<p>Clinically, <italic>NLGN1</italic> genetic variants are associated with disorders, such as ASDs [<xref ref-type="bibr" rid="RSOB180265C341">341</xref>,<xref ref-type="bibr" rid="RSOB180265C342">342</xref>], Alzheimer's disease (AD) [<xref ref-type="bibr" rid="RSOB180265C343">343</xref>] and post-traumatic stress disorder (PTSD) [<xref ref-type="bibr" rid="RSOB180265C344">344</xref>]. Genome sequence studies in humans have shown dysfunction in <italic>NLGN2</italic> to be associated with ASD and schizophrenia. Studies were done by assessing the developmental history of a patient with a rare missense mutation, R215H, which revealed that the patient had psychotic symptoms such as self-laughing and talking, auditory hallucinations and delusions. However, the patient's sibling was a carrier of this mutation, suggesting that the R215H mutation is inheritable and had incomplete penetrance [<xref ref-type="bibr" rid="RSOB180265C345">345</xref>,<xref ref-type="bibr" rid="RSOB180265C346">346</xref>].</p>
<sec id="s5e1">
<label>5.5.1.</label>
<title>Behavioural alterations</title>
<p>Impaired spatial working memory by using the Morris water maze in either loss of <italic>Nlgn1</italic> or overexpression of <italic>Nlgn1</italic> was observed, which further implies the constitutive requirement of <italic>Nlgn1</italic> for learning and memory [<xref ref-type="bibr" rid="RSOB180265C347">347</xref>,<xref ref-type="bibr" rid="RSOB180265C348">348</xref>]. Conditional KO of <italic>Nlgn1</italic> in the CA1 region of the hippocampus in new-born (P0) or P21 resulted in impaired NMDAR-type and L-type Ca<sup>2+</sup> channel-dependent LTP, further validating the loss of spatial working memory [<xref ref-type="bibr" rid="RSOB180265C349">349</xref>]. <italic>Nlgn1</italic> KO mice created by targeted deletion of exon sequences covering the translational start site 380 bp of the 5′ coding sequence of NLGN1 and by homologous recombination in embryonic stem cells exhibited increased repetitive behaviour such as grooming, impaired social interaction and altered pain sensation [<xref ref-type="bibr" rid="RSOB180265C347">347</xref>].</p>
<p>Overexpression of <italic>Nlgn2</italic> in transgenic mice had displayed diverse behavioural deficits such as reduced lifespan, limb clasping, offspring viability, repetitive behaviour, anxiety and impaired social interactions [<xref ref-type="bibr" rid="RSOB180265C350">350</xref>]. Based on the inhibitory avoidance (IA) behaviour paradigm, widely used for studying fear memories, Ye <italic>et al.</italic> [<xref ref-type="bibr" rid="RSOB180265C351">351</xref>] had found increased expression of NLGN1 and NLGN2 in quantitative immunoblot analyses after training of rats for IA. This altered expression of NLGN1 and NLGN2 suggests a role for both <italic>Nlgn1</italic> and <italic>Nlgn2</italic> in memory consolidation [<xref ref-type="bibr" rid="RSOB180265C351">351</xref>]. Further studies were performed to understand the role of <italic>Nlgn2</italic> in memory formation and behaviour. Overexpression of <italic>Nlgn2</italic> in the hippocampus had shown an increase in adult neurogenesis but decreased performance in the water maze task, suggesting an impaired working memory [<xref ref-type="bibr" rid="RSOB180265C352">352</xref>]. <italic>Nlgn2</italic> KO mice showed reduced anxiety, increased impulsivity in the elevated plus maze and reduced fear conditioning with an increased ratio of evoked E/I synaptic currents [<xref ref-type="bibr" rid="RSOB180265C353">353</xref>,<xref ref-type="bibr" rid="RSOB180265C354">354</xref>]. These reports proved the importance of <italic>Nlgn2</italic> in diverse behavioural functions by regulating inhibitory synapse function and plasticity in the mPFC, which is essential for anxiety and fear memory. In addition, <italic>Nlgn2</italic> KO mice exhibited an irregular breathing pattern, suggesting its role in regulating lung and heart functions [<xref ref-type="bibr" rid="RSOB180265C338">338</xref>].</p>
<p>As discussed in the earlier section regarding the significant role of <italic>Nlgn4</italic> KO in synaptic function, other studies have shown perturbations in general behavioural patterns, such as visible platform training in the Morris water maze (for vision), buried food finding (for olfaction), sucrose preference (taste), startle response (hearing), prepulse inhibition (sensorimotor gating), rotarod (locomotor activity and balance), hole board (exploratory behaviour), object preference, open field, hidden platform training in the Morris water maze, cued and contextual fear conditioning, and reversal training in the Morris water maze but lacked seizure propensity. These studies demonstrate a selective deficit in social interaction in <italic>Nlgn4</italic> KO as seen in patients with ASDs [<xref ref-type="bibr" rid="RSOB180265C109">109</xref>,<xref ref-type="bibr" rid="RSOB180265C355">355</xref>,<xref ref-type="bibr" rid="RSOB180265C356">356</xref>].</p>
</sec>
<sec id="s5e2">
<label>5.5.2.</label>
<title>Synaptic function and morphology</title>
<p>A transgenic mouse model of <italic>Nlgn1</italic> overexpression led to an increase in excitatory dendritic spine and synapse number, E/I ratio and synaptic transmission in the hippocampus. Additionally, overexpression or downregulation of <italic>Nlgn1</italic> has been shown to have impaired long-term potentiation (LTP), suggesting importance for <italic>Nlgn1</italic> in learning and memory [<xref ref-type="bibr" rid="RSOB180265C348">348</xref>,<xref ref-type="bibr" rid="RSOB180265C357">357</xref>]. Moreover, studies from <italic>Caenorhabditis elegans</italic> lacking <italic>nrxn-1 <italic>or</italic> nlgn-1</italic> have been shown to mediate retrograde synaptic signalling that inhibits neurotransmitter release at neuromuscular junctions, which might affect the activity of neurons in response to stimuli [<xref ref-type="bibr" rid="RSOB180265C358">358</xref>]. <italic>Nlgn1</italic> KO mice made by targeted deletion (exon sequences covering the translational start site 380 bp of the 5′ coding sequence of <italic>Nlgn1</italic>) by homologous recombination in embryonic stem cells showed no change in PPRs, and basal synaptic transmission but altered LTP and AMPA/NMDA [<xref ref-type="bibr" rid="RSOB180265C347">347</xref>]. These studies from different mouse models show that <italic>Nlgn1</italic> is necessary for AMPAR dynamics and, thus, the alteration would impair learning and memory.</p>
<p>E/I imbalance is one of the significant characteristic features of ID and ASDs that causes various physiological and behavioural deficits. In fact, in <italic>Nlgn2</italic> transgenic mice, the E/I ratio was found to be decreased in the PFC along with the increased frequency of miniature inhibitory synaptic currents, which suggests an inclination towards potentiation of inhibitory synapses and, thereby, shifting towards altered inhibition [<xref ref-type="bibr" rid="RSOB180265C350">350</xref>]. <italic>Nlgn2</italic> knockdown was associated with abolished GABAergic function from excitation to inhibition switch in cortical neurons based on Ca<sup>2+</sup> imaging studies that show a gradual decrease of GABAR-evoked Ca<sup>2+</sup> response in developing neurons along with the decreased frequency of mIPSC and mEPSC, suggesting a reduction in excitatory and inhibitory receptors. However, overexpression of KCC2, the potassium-chloride co-transporter, partially rescued synaptic currents, suggesting a role of NLGN2 in excitatory as well as inhibitory synaptic function [<xref ref-type="bibr" rid="RSOB180265C359">359</xref>].</p>
<p>Along with these earlier studies, another study has reported that <italic>Nlgn2</italic> KO mice have developmental delays such as delayed eye-opening period, vocalization in pups and reduced body length in these <italic>Nlgn2</italic> KO mice [<xref ref-type="bibr" rid="RSOB180265C360">360</xref>]. Furthermore, these mice displayed diminished inhibitory synaptic transmission with no change in synapse number in the ventrolateral medulla [<xref ref-type="bibr" rid="RSOB180265C333">333</xref>]. These studies suggest that <italic>Nlgn2</italic> is an essential constituent of inhibitory synapses and necessary for the formation, maintenance and function of inhibitory neurons.</p>
<p>To further study the role of <italic>Nlgn3</italic> mutations in synaptic function and neuronal development <italic>in vivo,</italic> lentiviral-mediated knockdown of <italic>Nlgn3</italic> in the CA1 region of the hippocampus at P0 and P21 was performed, and excitatory basal synaptic transmission was unaffected [<xref ref-type="bibr" rid="RSOB180265C361">361</xref>]. On the contrary, a primary neuronal culture study has shown that overexpression of <italic>Nlgn3</italic> increased inhibitory postsynaptic currents (IPSCs), suggesting an increase in expression of GABAergic currents [<xref ref-type="bibr" rid="RSOB180265C362">362</xref>]. Patch clamp recordings from the hippocampus, somatosensory cortex and cerebellum of <italic>Nlgn3</italic> KO mice have revealed increased mIPSC (increased number of functional GABA receptors) and decreased mEPSC (decreased number of functional AMPA receptors) in the hippocampus, suggesting an increase in inhibitory activity as the number of functional GABARs was higher when compared with excitatory activity. Additionally, decreased mEPSC and impaired mGluR-mediated LTD in the cerebellum was also observed, which suggests a differential function of <italic>Nlgn3</italic> in different regions of the brain [<xref ref-type="bibr" rid="RSOB180265C110">110</xref>,<xref ref-type="bibr" rid="RSOB180265C363">363</xref>].</p>
<p>An <italic>Nlgn3,</italic> wherein R451C was overexpressed, increase in mIPSC frequency (increase in the number of functional GABARs) was associated with altered GABA release probability, concomitant with an increase in giant depolarizing potential (GDP), a neuronal network-related activity mediated by GABAR [<xref ref-type="bibr" rid="RSOB180265C111">111</xref>]. These studies further validate the importance of <italic>Nlgn3</italic> in network-based activities in immature neurons. Since GABAR-mediated network activity, as well as GABAergic synaptic transmission, was impaired in R451C, it is essential to understand whether the effects observed were a global GABAR-mediated phenomenon or any specific GABAergic cell types involved in it. Using a paired whole-cell patch clamp between one PV expressing basket cells and either spiny neurons/pyramidal neurons, IPSCs measured from PV neurons displayed impaired amplitude and frequency in the hippocampus as well as in the barrel cortex in <italic>Nlgn3</italic> R451C knockin mice [<xref ref-type="bibr" rid="RSOB180265C112">112</xref>,<xref ref-type="bibr" rid="RSOB180265C113">113</xref>]. In addition, these studies found that the IPSC was reduced, leading to an altered E/I ratio in D1-medium spiny neurons (D1-MSN) in R451C mutant mice [<xref ref-type="bibr" rid="RSOB180265C114">114</xref>]. These studies show that the NLGN3 mutation has a stronger effect on PV cells comparatively, and is vital for D1-MSN-mediated synaptic transmission.</p>
<p>Moreover, the same knockin mouse model of <italic>Nlgn3</italic>, R451C, showed increased dendritic complexity and branching in stratum radiatum. These mice also showed increased excitatory basal synaptic transmission, LTP, NMDA/AMPA and mEPSC in the CA1 region of the hippocampus, suggesting, unlike KO models of <italic>Nlgn3,</italic> R451C function majorly affects glutamatergic synapse [<xref ref-type="bibr" rid="RSOB180265C110">110</xref>]. In contrast to previous studies, another mouse model of <italic>Nlgn3</italic>, R704C, displayed a decreased AMPAR-mediated synaptic response, rendering the NMADR- or GABAR-mediated response unaltered. Additionally, NMDAR-mediated LTP was associated with reduced EPSC frequency and increased NMDA/AMPA ratio in cultured hippocampal neurons, suggesting that an R704 mutation affects differently the inhibitory as well as excitatory synapses [<xref ref-type="bibr" rid="RSOB180265C115">115</xref>]. Overall, different mutant mouse models of <italic>Nlgn3</italic> depict region- and synapse-specific function. Therefore, specificity in neuronal types and synapses may help <italic>Nlgn3</italic> to execute different functions efficiently in various parts of the brain.</p>
<p><italic>Nlgn4</italic> is another essential gene that plays a significant role in synapse formation, development and function. To further understand the role of <italic>Nlgn4</italic> in neuronal function, Jamain and group [<xref ref-type="bibr" rid="RSOB180265C355">355</xref>] have demonstrated reduced ultrasonic vocalizations in <italic>Nlgn4</italic> KO males. The <italic>Nlgn4</italic> KO is the result of chimeric non-functional protein. It contains a small fraction of the esterase domain that cannot bind to <italic>Nrxn</italic> upon contact with a female in oestrous cycle, suggesting a lack of ability to attract the opposite gender despite being fertile. A magnetic resonance imaging volumetric study demonstrated a reduction in total brain volume, particularly in the cerebellum and brainstem [<xref ref-type="bibr" rid="RSOB180265C355">355</xref>]. <italic>Nlgn4</italic> KO showed a reduced decay in glycinergic mIPSC, impaired inhibition, altered firing and decreased β-wave amplitude in retinal cells, demonstrating that <italic>Nlgn4</italic> localizes to glycinergic post-synapses and plays an essential role in encoding stimuli in the retinal network [<xref ref-type="bibr" rid="RSOB180265C328">328</xref>]. The <italic>Nlgn4</italic> R87 W mutation abolished NLGN4-induced synapse formation and function, particularly in modulating synaptic strength [<xref ref-type="bibr" rid="RSOB180265C364">364</xref>]. An important hallmark of several NDDs, such as ID/ASDs, is impaired synapse formation and function. As <italic>NLGN4</italic> is implicated in ASDs (reviewed extensively in [<xref ref-type="bibr" rid="RSOB180265C356">356</xref>]), a point mutation in <italic>Nlgn4</italic> causes ID/ASDs through the loss of function. A study identified a frameshift de novo mutation, 1186insT in <italic>NLGN4,</italic> in two siblings with ASD and Asperger syndrome in a Swedish family, and that linked <italic>NLGN3</italic> and <italic>NLGN4</italic> to ASDs. Another Swedish family of two siblings with ASD and Asperger syndrome were identified with a C to T transition in <italic>NLGN3.</italic> This mutation had led to changes in highly conserved arginine to cysteine (R451C), an integral part of the esterase domain that is necessary for interaction with <italic>NRXNs</italic> [<xref ref-type="bibr" rid="RSOB180265C365">365</xref>]. Therefore, these studies have demonstrated that mutations in different <italic>Nlgn</italic> genes affect the basic synaptic transmission, which can have lasting implications for the pathophysiology in ID/ASDs.</p>
</sec>
<sec id="s5e3">
<label>5.5.3.</label>
<title>Biochemical pathways</title>
<p>NEUREXIN and NEUROLIGIN contain an intracellular PDZ-binding domain that mediates interactions with synaptic scaffolding proteins, such as calcium/calmodulin-dependent serine protein kinase (CASK) [<xref ref-type="bibr" rid="RSOB180265C366">366</xref>], and Munc18 interacting protein; lin10/X11 [<xref ref-type="bibr" rid="RSOB180265C367">367</xref>] (for NEUREXINS) and PSD95 (for NEUROLIGINS) [<xref ref-type="bibr" rid="RSOB180265C330">330</xref>]. The synaptic function of NEUROLIGIN depends on <italic>cis</italic> clustering of NEUROLIGIN molecules, which requires a crucial integral esterase like ectodomain that can interact with NEUREXIN and execute synaptic functions [<xref ref-type="bibr" rid="RSOB180265C368">368</xref>]. PSD-95, a critical scaffolding protein interacting with NEUROLIGIN, recruits different synaptic protein/receptors like NMDAR, which activate the downstream signalling necessary for learning and memory. It also recruits specific adaptor proteins such as GKAP [<xref ref-type="bibr" rid="RSOB180265C369">369</xref>] that, in turn, interacts with SHANK3 [<xref ref-type="bibr" rid="RSOB180265C356">356</xref>,<xref ref-type="bibr" rid="RSOB180265C369">369</xref>]. This interaction is necessary for normal synaptic functions and is indirectly driven by different synaptic partners. Sequence homology studies have revealed that NLGN1, NLGN3 and NLGN4 were similar, unlike NLGN2, which is predominantly expressed in inhibitory synapses [<xref ref-type="bibr" rid="RSOB180265C318">318</xref>,<xref ref-type="bibr" rid="RSOB180265C319">319</xref>]. NLGN2 was shown to stabilize inhibitory synapses with the help of scaffolding protein GEPHYRIN, which interacts with an <italic>α</italic>2 subunit of GABARs [<xref ref-type="bibr" rid="RSOB180265C370">370</xref>,<xref ref-type="bibr" rid="RSOB180265C371">371</xref>] and helps in the maintenance and function of GABAergic synapses. Overall, NLGN4 is considered as one of the primary receptors involved in learning and memory formation, along with evolutionary conserved other NLGNs.</p>
</sec>
<sec id="s5e4">
<label>5.5.4.</label>
<title>The critical period of plasticity</title>
<p>During brain development, NLGN1, NLGN2, NLGN3 and NLGN4 expression increases from embryonic to post-natal days before reaching a plateau around three weeks in the mouse hippocampus [<xref ref-type="bibr" rid="RSOB180265C355">355</xref>]. This study suggests that NLGNs have a precise developmental window of expression and, thus, could be considered as one of the determinants of a critical period of development in the brain, which could have implications in ID/ASDs [<xref ref-type="bibr" rid="RSOB180265C356">356</xref>]. To further corroborate NLGNs in the critical period of development, monocular and binocular deprivations (MD, BD) in mice were performed. Increased spatial acuity by measuring visually evoked potentials was observed in young adult R451C <italic>Nlgn3</italic> mutant mice. Immunohistochemical analysis revealed an increased number of puncta of GAD65. This increase suggests an alteration in the number of GABAergic interneurons, thereby resulting in elevated inhibition that led to decreased E/I, and, thus, increased acuity in mutant mice. R451C also showed permanent loss of acuity on prolonged MD as WT, but the relative loss was more for the mutant mice, suggesting a longer window for plasticity. This alteration observed in MD might lead to the abnormal opening of a critical period of plasticity and impaired local circuit connections [<xref ref-type="bibr" rid="RSOB180265C355">355</xref>]. Studies have further tried to dissect the mechanism of NEUROLIGIN functions in synapse development and neuronal functions using different animal models such as KO, knockin and transgenic mice.</p>
</sec>
</sec>
</sec>
<sec id="s6">
<label>6.</label>
<title>Metaplasticity</title>
<p>Metaplasticity is a term which refers to the higher order of synaptic plasticity, i.e. plasticity of the synaptic plasticity [<xref ref-type="bibr" rid="RSOB180265C372">372</xref>]. It includes processes that lead to physiological and biochemical changes, altering the neuron's ability to induce and maintain synaptic plasticity [<xref ref-type="bibr" rid="RSOB180265C373">373</xref>]. Different mechanisms have been proposed to explain metaplasticity depending on the location and the type of synapse or receptors of interest [<xref ref-type="bibr" rid="RSOB180265C373">373</xref>]. To date, there are no reports stating the direct involvement of metaplasticity in any gene mutations implicated in ID or ASDs. However, it has been proposed that synaptic defects and memory deficits associated with ID and ASDs may be due to an inability to undergo metaplasticity during various developmental stages [<xref ref-type="bibr" rid="RSOB180265C374">374</xref>]. It has also been demonstrated that hippocampal metaplasticity is required for the formation of temporal associative memories [<xref ref-type="bibr" rid="RSOB180265C375">375</xref>]. Although studies done to investigate the effect of metaplasticity in animal models are limited, owing to its role in the maintenance of LTP and LTD it may be crucial for learning and memory impairments in ID.</p>
</sec>
<sec id="s7">
<label>7.</label>
<title>Glial cells in intellectual disability</title>
<p>Other than neuronal cells, the brain consists of non-neuronal cells called glia. The three main types of glia are—oligodendrocytes (responsible for axonal myelination), microglia (responsible for immunity-related functions) and astrocytes (responsible for maintaining homeostasis in the brain) [<xref ref-type="bibr" rid="RSOB180265C376">376</xref>].</p>
<sec id="s7a">
<label>7.1.</label>
<title>Astrocytes</title>
<p>Astrocytes are star-shaped cells initially only known to provide neuronal support. However, research over the past few decades has increasingly revealed the importance of astrocytes, and their multifaceted role in the brain [<xref ref-type="bibr" rid="RSOB180265C20">20</xref>,<xref ref-type="bibr" rid="RSOB180265C377">377</xref>,<xref ref-type="bibr" rid="RSOB180265C378">378</xref>]. Astrocytes regulate post-natal neurogenesis [<xref ref-type="bibr" rid="RSOB180265C379">379</xref>,<xref ref-type="bibr" rid="RSOB180265C380">380</xref>] and maintain homeostasis of many factors such as ions, neurotransmitters, water and extracellular matrix [<xref ref-type="bibr" rid="RSOB180265C381">381</xref>–<xref ref-type="bibr" rid="RSOB180265C384">384</xref>]. They regulate many aspects of the blood–brain barrier [<xref ref-type="bibr" rid="RSOB180265C385">385</xref>,<xref ref-type="bibr" rid="RSOB180265C386">386</xref>] and glucose metabolism (supply and storage) in the brain [<xref ref-type="bibr" rid="RSOB180265C387">387</xref>,<xref ref-type="bibr" rid="RSOB180265C388">388</xref>]. They protect against damaging factors such as pathogens, reactive oxygen species and excitotoxicity [<xref ref-type="bibr" rid="RSOB180265C389">389</xref>–<xref ref-type="bibr" rid="RSOB180265C391">391</xref>]. Most importantly, astrocytes wrap around synapses and finely regulate all aspects of synaptic dynamics such as formation, maturation, plasticity and even elimination [<xref ref-type="bibr" rid="RSOB180265C378">378</xref>,<xref ref-type="bibr" rid="RSOB180265C392">392</xref>–<xref ref-type="bibr" rid="RSOB180265C395">395</xref>].</p>
<p>Proteins of many genes implicated in ASDs and ID are expressed in astrocytes. <italic>Fmr1</italic> is one such gene that encodes FMRP. In astrocytes, FMRP is expressed during early and mid-post-natal developmental stages, indicating its probable role in brain development and fragile X pathology [<xref ref-type="bibr" rid="RSOB180265C396">396</xref>,<xref ref-type="bibr" rid="RSOB180265C397">397</xref>]. Indeed, studies have shown that <italic>Fmr1</italic>-KO astrocytes were able to induce pathogenic delayed maturation and synaptic protein expression in WT neurons. Vice versa, WT astrocytes can rescue abnormal spinal and dendritic phenotype in <italic>Fmr1-</italic>KO neurons [<xref ref-type="bibr" rid="RSOB180265C398">398</xref>,<xref ref-type="bibr" rid="RSOB180265C399">399</xref>]. Astrocyte-specific knockdown of <italic>Fmr1</italic> led to increased spine density in cortical neurons and can be rescued by restoring astrocytic FMRP levels [<xref ref-type="bibr" rid="RSOB180265C21">21</xref>]. A study on MECP2 has also been shown to be expressed in astrocytes, and similar co-culture studies demonstrate astroglia contribution to disease pathology [<xref ref-type="bibr" rid="RSOB180265C400">400</xref>,<xref ref-type="bibr" rid="RSOB180265C401">401</xref>]. Other than these proteins, only NEUROLIGINS are expressed in astrocytes, where they contribute to the formation of astrocyte morphology and neuronal synapses [<xref ref-type="bibr" rid="RSOB180265C402">402</xref>]. Disease-related studies for <italic>Neuroligins</italic>, <italic>Shank</italic> and <italic>Syngap1</italic> remain to be carried out.</p>
</sec>
<sec id="s7b">
<label>7.2.</label>
<title>Microglia and oligodendrocytes</title>
<p>Microglia are the resident macrophages of the brain. They are of mesodermal origin and migrate into the brain during development [<xref ref-type="bibr" rid="RSOB180265C376">376</xref>,<xref ref-type="bibr" rid="RSOB180265C403">403</xref>]. Other than immune surveillance, microglia help in synaptic pruning (through complement-mediated phagocytosis or TREM2 signalling), clearance of apoptotic neural debris during development and synaptic plasticity (through secreted factors) [<xref ref-type="bibr" rid="RSOB180265C404">404</xref>,<xref ref-type="bibr" rid="RSOB180265C405">405</xref>]. On the other hand, oligodendrocytes originate from neural tissue and differentiate from oligodendrocyte precursor cells. They differentiate soon after neuronal migration and start wrapping neuronal axons with lipid-rich myelin, providing insulation and dividing the axon into multiple domains. The altered activity helps in regulation of the propagating action potentials and, in turn, neuronal circuit properties [<xref ref-type="bibr" rid="RSOB180265C406">406</xref>]. Oligodendrocytes also provide metabolic support and maintain ion homeostasis of the axon [<xref ref-type="bibr" rid="RSOB180265C407">407</xref>,<xref ref-type="bibr" rid="RSOB180265C408">408</xref>]. Not many studies have been performed on the relationship between genes implicated in ID/ASDs and microglia/oligodendrocytes. However, FMRP has been demonstrated to express in both cell types [<xref ref-type="bibr" rid="RSOB180265C397">397</xref>]. Further studies regarding how these mutations (implicated in ID and ASDs) affect microglia and oligodendrocytes, and how this, in turn, contributes to the pathophysiology of these disorders remains an open and exciting topic for investigation.</p>
</sec>
</sec>
<sec id="s8">
<label>8.</label>
<title>Current and upcoming therapeutic options targeting synaptic abnormalities</title>
<p>A therapeutic intervention targeting the underlying causes of ID and ASDs is not yet available in the clinic, but preclinical trials are going on in many laboratories. Drugs are, nevertheless, used to provide symptomatic relief from anxiety, epilepsy, depression, and cognitive and social dysfunctions in ID/ASDs. Response to already existing treatment options is known to be variable and is reported to have some side effects owing to their off-target interactions [<xref ref-type="bibr" rid="RSOB180265C29">29</xref>,<xref ref-type="bibr" rid="RSOB180265C30">30</xref>]. Coadministration of different medications with irrational prescription and use was another concern that affects people with ID/ASDs. More often than not, polypharmacy is a common practice and may lead to adverse drug reactions [<xref ref-type="bibr" rid="RSOB180265C31">31</xref>,<xref ref-type="bibr" rid="RSOB180265C32">32</xref>].</p>
<p>Although some of the currently followed strategies have prolonged the life of patients, their quality of life has not improved substantially [<xref ref-type="bibr" rid="RSOB180265C33">33</xref>]. Hence, there is a need to search for a new therapeutic intervention which can provide a cure, or at least alleviate the symptoms better than the existing therapeutic strategies for patients with ASDs and ID.</p>
<p>Different mutations, as discussed earlier, and drugs targeting these had undergone rigorous testing in preclinical trials on different mouse models. These have provided insights into the underlying mechanisms associated with the efficacy of these drugs for the treatment of ID/ASDs. Some of these approaches are summarized in <xref ref-type="table" rid="RSOB180265TB2">table 2</xref>. However, their translational success is yet to be validated in clinical trials.
<table-wrap id="RSOB180265TB2" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Upcoming therapeutic approaches for the treatment of ID. This includes drugs which have shown some promise in the preclinical studies for the treatment of ID. HMG-Co-A, 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead valign="bottom"><tr><th align="left" colspan="1" rowspan="1">s.no.</th><th align="left" colspan="1" rowspan="1">drug</th><th align="left" colspan="1" rowspan="1">known mechanism of action</th><th align="left" colspan="1" rowspan="1">structure</th><th align="left" colspan="1" rowspan="1">approval status</th><th align="left" colspan="1" rowspan="1">target in ID</th><th align="left" colspan="1" rowspan="1">references</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">lovastatin</td><td colspan="1" rowspan="1">statins (HMG-Co-A inhibitor)</td><td colspan="1" rowspan="1"><inline-graphic xlink:href="rsob-9-180265-i1.jpg"></inline-graphic></td><td colspan="1" rowspan="1">approved for hypercholesterolaemia</td><td colspan="1" rowspan="1">FMRP and SYNGAP1-mediated RAS-ERK1/2 activation</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C32">32</xref>,<xref ref-type="bibr" rid="RSOB180265C34">34</xref>]</td></tr><tr><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">rapamycin</td><td colspan="1" rowspan="1">mTOR inhibitor</td><td colspan="1" rowspan="1"><inline-graphic xlink:href="rsob-9-180265-i2.jpg"></inline-graphic></td><td colspan="1" rowspan="1">approved as an immunomodulator</td><td colspan="1" rowspan="1">the modulator of SYNGAP1-mediated mTOR signalling</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C33">33</xref>]</td></tr><tr><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">ganaxolone</td><td colspan="1" rowspan="1">the positive allosteric modulator of GABA<sub>A</sub> receptors</td><td colspan="1" rowspan="1"><inline-graphic xlink:href="rsob-9-180265-i3.jpg"></inline-graphic></td><td colspan="1" rowspan="1">phase 3 clinical trial for CDKL5 deficiency disorder</td><td colspan="1" rowspan="1">the positive modulator of FMRP-mediated GABA<sub>A</sub> receptor expression</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C30">30</xref>]</td></tr><tr><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">valproate</td><td colspan="1" rowspan="1">inhibitor of GABA transaminase and that of voltage-gated Na<sup>+</sup> channels</td><td colspan="1" rowspan="1"><inline-graphic xlink:href="rsob-9-180265-i4.jpg"></inline-graphic></td><td colspan="1" rowspan="1">approved for mania and epilepsy</td><td colspan="1" rowspan="1">rescues from the SHANK-3 overexpression-mediated manic-like behaviour</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C35">35</xref>]</td></tr><tr><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">oxytocin</td><td colspan="1" rowspan="1">peptide hormone which plays a role in milk ejection</td><td colspan="1" rowspan="1">Cys – Tyr – Ile – Gln – Asn – Cys – Pro – Leu – Gly – NH<sub>2</sub></td><td colspan="1" rowspan="1">approved for improvement or facilitation of uterine contractions during birth</td><td colspan="1" rowspan="1">reverses the behavioural deficits in <italic>Shank-3</italic>-deficient mice</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C30">30</xref>]</td></tr><tr><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">D-cycloserine</td><td colspan="1" rowspan="1">an antibiotic which is an inhibitor of the bacterial cell wall synthesis</td><td colspan="1" rowspan="1"><inline-graphic xlink:href="rsob-9-180265-i5.jpg"></inline-graphic></td><td colspan="1" rowspan="1">approved antibiotic for the treatment of tuberculosis</td><td colspan="1" rowspan="1">reverses the repetitive and stereotyped grooming behavioural deficits in Neuroligin 1 knockout mice</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="RSOB180265C36">36</xref>]</td></tr></tbody></table></table-wrap></p>
</sec>
<sec id="s9">
<label>9.</label>
<title>Conclusion</title>
<p>ID and ASDs are prevalent NDDs that have proven to be complicated and challenging in several aspects. Since they often present with a highly variable and overlapping spectrum of symptoms and syndromes, defining a distinct set of diagnostic criteria has been difficult for clinicians and scientists. However, studies in mouse models of monogenic causes of ID and ASDs have proved to be immensely helpful in the construction of the pathophysiology of these disorders, through a bottom-up approach. These studies have demonstrated that ID/ASDs with diverse causal origins have intersecting aetiologies that might be responsible for the observed shared phenotypes. Opposing cellular phenotypes observed in these disorders highlight the importance and need for balanced and timely developmental processes at all systemic levels.</p>
<p>Further studies have employed these aspects for the development of genetic and pharmacological therapeutic strategies (creation of mouse models with counteracting mutations to re-establish balance and the testing of drugs targeting common neurological pathways). However, only a fraction have been uncovered in the understanding of these disorders, and require further studies for improved diagnosis, treatment and prognosis. As highlighted in this review, there are several areas which remain unexplored and could play an essential role in the pathophysiology of ID/ASDs. Additionally, the role of non-neuronal cells such as astrocytes, oligodendrocytes and microglia have also not been studied in detail concerning mutations in ID/ASDs. The augmented critical period is another characteristic modality altered in many forms of ID/ASDs. The study of precise mechanisms for a better understanding of this phase of development could be useful for rescue during the later period of life. Because the diagnosis is delayed during a critical period of development, reversing neuronal connections becomes difficult, which is one of the significant questions lingering in the minds of neuroscientists. Preclinical studies in this regard can warrant some useful clues for the translational success of small molecules being tested for efficacy in ID/ASDs. However, many drugs still fail in clinical trials even after ameliorating disease pathology in the preclinical mouse models. Poor experimental design with inadequate sample size could be one of the reasons for failure at the later stages.</p>
<p>Another critical point is the variability in the intrinsic metabolic and biochemical pathways among different animal strains and species that lead to changes in drug pharmacokinetics and pharmacodynamics across systems. These factors influence how a potential therapeutic candidate molecule can be metabolized by the animal model, and how this is different in human beings. One viable alternative to overcome the above issues is to use patient-derived IPSCs, which have been considered as a model in the last decade or so. However, to acquire an all-round understanding of ID/ASDs, it is crucial to study <italic>in vivo,</italic> i.e. animal models in combination with patient-derived IPSCs. Such a combinatorial study can fulfil the existing gap in our knowledge about ID/ASDs and show the way for future therapeutic strategies.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="d35e146">
<caption>
<title>Reviewer comments</title>
</caption>
<media mime-subtype="pdf" mimetype="application" xlink:href="rsob180265_review_history.pdf"></media>
</supplementary-material>
</sec>
</body>
<back>
<sec id="s10">
<title>Data accessibility</title>
<p>This article does not contain any additional data.</p>
</sec>
<sec id="s11">
<title>Authors' contribution</title>
<p>V.V., A.P., A.A.V. and B.V. contributed equally to this review. V.V. wrote the sections related to NEUROLIGINS and the critical period of development; A.P. wrote the sections related to MECP2 and SHANK mutation, A.A.V. wrote the sections related to the FMRP, aetiology, contribution of non-neuronal cells and conclusion part of the review. B.V. wrote the sections pertaining to the introduction, SYNGAP1, animal models of ID, metaplasticity and therapeutic approaches. All authors contributed equally to the figures and tables. J.P.C. edited the manuscript. All the authors provided the conceptual idea for the review.</p>
</sec>
<sec id="s12" sec-type="COI-statement">
<title>Competing interests</title>
<p>All authors declare no conflict of interest.</p>
</sec>
<sec id="s13">
<title>Funding</title>
<p>The work was supported by grants to J.P.C. by DST-SERB (SERB/JC/4518), DBT-JNCASR (LSRET-JNC/JC/4531) and intramural funding from the Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="RSOB180265C1">
<label>1</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azevedo</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Carvalho</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Grinberg</surname><given-names>LT</given-names></name>, <name name-style="western"><surname>Farfel</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Ferretti</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Leite</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Filho</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Lent</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Herculano-Houzel</surname><given-names>S</given-names></name></person-group>
<year>2009</year>
<article-title>Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain</article-title>. <source/>J. Comp. Neurol.
<volume>513</volume>, <fpage>532</fpage>–<lpage>541</lpage>. (<pub-id pub-id-type="doi">10.1002/cne.21974</pub-id>)<pub-id pub-id-type="pmid">19226510</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C2">
<label>2</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carninci</surname><given-names>P</given-names></name><etal>et al.</etal></person-group>
<year>2005</year>
<article-title>The transcriptional landscape of the mammalian genome</article-title>. <source/>Science
<volume>309</volume>, <fpage>1559</fpage>–<lpage>1563</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1112014</pub-id>)<pub-id pub-id-type="pmid">16141072</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C3">
<label>3</label>
<mixed-citation publication-type="book"><collab>American Psychiatric Association</collab>. <year>2013</year>
<source/>Diagnostic and statistical manual of mental disorders; DSM-V. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychiatric Association</publisher-name>.</mixed-citation>
</ref>
<ref id="RSOB180265C4">
<label>4</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoo</surname><given-names>H</given-names></name></person-group>
<year>2015</year>
<article-title>Genetics of autism spectrum disorder: current status and possible clinical applications</article-title>. <source/>Exp. Neurobiol.
<volume>24</volume>, <fpage>257</fpage>–<lpage>272</lpage>. (<pub-id pub-id-type="doi">10.5607/en.2015.24.4.257</pub-id>)<pub-id pub-id-type="pmid">26713075</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C5">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kohane</surname><given-names>IS</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>The co-morbidity burden of children and young adults with autism spectrum disorders</article-title>. <source/>PLoS ONE
<volume>7</volume>, <fpage>e33224</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pone.0033224</pub-id>)<pub-id pub-id-type="pmid">22511918</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C6">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rapoport</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chavez</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Greenstein</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Addington</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gogtay</surname><given-names>N</given-names></name></person-group>
<year>2009</year>
<article-title>Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited</article-title>. <source/>J. Am. Acad. Child Adolesc. Psychiatry
<volume>48</volume>, <fpage>10</fpage>–<lpage>18</lpage>. (<pub-id pub-id-type="doi">10.1097/CHI.0b013e31818b1c63</pub-id>)<pub-id pub-id-type="pmid">19218893</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C7">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsiao</surname><given-names>EY</given-names></name>, <name name-style="western"><surname>McBride</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Chow</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mazmanian</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Patterson</surname><given-names>PH</given-names></name></person-group>
<year>2012</year>
<article-title>Modeling an autism risk factor in mice leads to permanent immune dysregulation</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>109</volume>, <fpage>12 776</fpage>–<lpage>12 781</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1202556109</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C8">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schieve</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Boulet</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Visser</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Rice</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Braun</surname><given-names>KVN</given-names></name>, <name name-style="western"><surname>Boyle</surname><given-names>CA</given-names></name></person-group>
<year>2012</year>
<article-title>Concurrent medical conditions and health care use and needs among children with learning and behavioral developmental disabilities, National Health Interview Survey, 2006–2010</article-title>. <source/>Res. Dev. Disabil.
<volume>33</volume>, <fpage>467</fpage>–<lpage>476</lpage>. (<pub-id pub-id-type="doi">10.1016/j.ridd.2011.10.008</pub-id>)<pub-id pub-id-type="pmid">22119694</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C9">
<label>9</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiler</surname><given-names>IJ</given-names></name><etal>et al.</etal></person-group>
<year>1997</year>
<article-title>Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>94</volume>, <fpage>5395</fpage>–<lpage>5400</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.94.10.5395</pub-id>)<pub-id pub-id-type="pmid">9144248</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C10">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Liao</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Lau</surname><given-names>L-F</given-names></name>, <name name-style="western"><surname>Huganir</surname><given-names>RL</given-names></name></person-group>
<year>1998</year>
<article-title>SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family</article-title>. <source/>Neuron
<volume>20</volume>, <fpage>683</fpage>–<lpage>691</lpage>. (<pub-id pub-id-type="doi">10.1016/S0896-6273(00)81008-9</pub-id>)<pub-id pub-id-type="pmid">9581761</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C11">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamdan</surname><given-names>FF</given-names></name><etal>et al.</etal></person-group>
<year>2011</year>
<article-title>Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability</article-title>. <source/>Am. J. Hum. Genet.
<volume>88</volume>, <fpage>306</fpage>–<lpage>316</lpage>. (<pub-id pub-id-type="doi">10.1016/j.ajhg.2011.02.001</pub-id>)<pub-id pub-id-type="pmid">21376300</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C12">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gomot</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2003</year>
<article-title>MECP2 gene mutations in non-syndromic X-linked mental retardation: phenotype–genotype correlation</article-title>. <source/>Am. J. Med. Genet. A
<volume>123</volume>, <fpage>129</fpage>–<lpage>139</lpage>. (<pub-id pub-id-type="doi">10.1002/ajmg.a.20247</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C13">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christensen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Grønborg</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Sørensen</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Schendel</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Parner</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>Pedersen</surname><given-names>LH</given-names></name>, <name name-style="western"><surname>Vestergaard</surname><given-names>M</given-names></name></person-group>
<year>2013</year>
<article-title>Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism</article-title>. <source/>JAMA
<volume>309</volume>, <fpage>1696</fpage>–<lpage>1703</lpage>. (<pub-id pub-id-type="doi">10.1001/jama.2013.2270</pub-id>)<pub-id pub-id-type="pmid">23613074</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C14">
<label>14</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mukherjee</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Layton</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yacoub</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Turk</surname><given-names>J</given-names></name></person-group>
<year>2011</year>
<article-title>Autism and autistic traits in people exposed to heavy prenatal alcohol: data from a clinical series of 21 individuals and nested case control study</article-title>. <source/>Adv. Ment. Health Intellect. Disabil
<volume>5</volume>, <fpage>42</fpage>–<lpage>49</lpage>. (<pub-id pub-id-type="doi">10.5042/amhid.2011.0015</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C15">
<label>15</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gorini</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Muratori</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Morales</surname><given-names>MA</given-names></name></person-group>
<year>2014</year>
<article-title>The role of heavy metal pollution in neurobehavioral disorders: a focus on autism</article-title>. <source/>Rev. J. Autism Dev. Disord.
<volume>1</volume>, <fpage>354</fpage>–<lpage>372</lpage>. (<pub-id pub-id-type="doi">10.1007/s40489-014-0028-3</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C16">
<label>16</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawicka</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Regulska-Ilow</surname><given-names>B</given-names></name></person-group>
<year>2013</year>
<article-title>How nutritional status, diet and dietary supplements can affect autism. A review</article-title>. <source/>Roczniki Państwowego Zakładu Higieny
<volume>64</volume>, <fpage>1</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">23789306</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C17">
<label>17</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deth</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Muratore</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Benzecry</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Power-Charnitsky</surname><given-names>V-A</given-names></name>, <name name-style="western"><surname>Waly</surname><given-names>M</given-names></name></person-group>
<year>2008</year>
<article-title>How environmental and genetic factors combine to cause autism: a redox/methylation hypothesis</article-title>. <source/>Neurotoxicology
<volume>29</volume>, <fpage>190</fpage>–<lpage>201</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuro.2007.09.010</pub-id>)<pub-id pub-id-type="pmid">18031821</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C18">
<label>18</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barnes</surname><given-names>SA</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>Convergence of hippocampal pathophysiology in Syngap+/− and Fmr1−/y mice</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>15 073</fpage>–<lpage>15 081</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1087-15.2015</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C19">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aceti</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>Syngap1 haploinsufficiency damages a postnatal critical period of pyramidal cell structural maturation linked to cortical circuit assembly</article-title>. <source/>Biol. Psychiatry
<volume>77</volume>, <fpage>805</fpage>–<lpage>815</lpage>. (<pub-id pub-id-type="doi">10.1016/j.biopsych.2014.08.001</pub-id>)<pub-id pub-id-type="pmid">25444158</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C20">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clarke</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Barres</surname><given-names>BA</given-names></name></person-group>
<year>2013</year>
<article-title>Emerging roles of astrocytes in neural circuit development</article-title>. <source/>Nat. Rev. Neurosci.
<volume>14</volume>, <fpage>311</fpage>–<lpage>321</lpage>. (<pub-id pub-id-type="doi">10.1038/nrn3484</pub-id>)<pub-id pub-id-type="pmid">23595014</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C21">
<label>21</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Higashimori</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Schin</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Chiang</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Morel</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Shoneye</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name></person-group>
<year>2016</year>
<article-title>Selective deletion of astroglial FMRP dysregulates glutamate transporter GLT1 and contributes to fragile X syndrome phenotypes <italic>in vivo</italic></article-title>. <source/>J. Neurosci.
<volume>36</volume>, <fpage>7079</fpage>–<lpage>7094</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1069-16.2016</pub-id>)<pub-id pub-id-type="pmid">27383586</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C22">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van der Staay</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Arndt</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Nordquist</surname><given-names>RE</given-names></name></person-group>
<year>2009</year>
<article-title>Evaluation of animal models of neurobehavioral disorders</article-title>. <source/>Behav. Brain Funct.
<volume>5</volume>, <fpage>11</fpage> (<pub-id pub-id-type="doi">10.1186/1744-9081-5-11</pub-id>)<pub-id pub-id-type="pmid">19243583</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C23">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bitta</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kariuki</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Abubakar</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Newton</surname><given-names>CR</given-names></name></person-group>
<year>2017</year>
<article-title>Burden of neurodevelopmental disorders in low and middle-income countries: a systematic review and meta-analysis</article-title>. <source/>Wellcome Open Res.
<volume>2</volume>, <fpage>121</fpage> (<pub-id pub-id-type="doi">10.12688/wellcomeopenres.13540.3</pub-id>)<pub-id pub-id-type="pmid">29881784</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C24">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maulik</surname><given-names>PK</given-names></name>, <name name-style="western"><surname>Mascarenhas</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Mathers</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Dua</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Saxena</surname><given-names>S</given-names></name></person-group>
<year>2011</year>
<article-title>Prevalence of intellectual disability: a meta-analysis of population-based studies</article-title>. <source/>Res. Dev. Disabil.
<volume>32</volume>, <fpage>419</fpage>–<lpage>436</lpage>. (<pub-id pub-id-type="doi">10.1016/j.ridd.2010.12.018</pub-id>)<pub-id pub-id-type="pmid">21236634</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C25">
<label>25</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boyle</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Boulet</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Schieve</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Blumberg</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Yeargin-Allsopp</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Visser</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kogan</surname><given-names>MD</given-names></name></person-group>
<year>2011</year>
<article-title>Trends in the prevalence of developmental disabilities in US children, 1997–2008</article-title>. <source/>Pediatrics.
<volume>127</volume>, <fpage>1034</fpage>–<lpage>1042</lpage>. (<pub-id pub-id-type="doi">10.1542/peds.2010-2989</pub-id>)<pub-id pub-id-type="pmid">21606152</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C26">
<label>26</label>
<mixed-citation publication-type="other"><collab>World Health Organization. Autism spectrum disorders</collab>. <year>2017</year>
<comment>[cited 2018 8th December]. See <uri xlink:href="https://www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders">https://www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders</uri></comment></mixed-citation>
</ref>
<ref id="RSOB180265C27">
<label>27</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pushpakom</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>
<year>2018</year>
<article-title>Drug repurposing: progress, challenges and recommendations</article-title>. <source/>Nat. Rev. Drug Discov.
<volume>18</volume>, <fpage>41</fpage>–<lpage>58</lpage>. (<pub-id pub-id-type="doi">10.1038/nrd.2018.168</pub-id>)<pub-id pub-id-type="pmid">30310233</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C28">
<label>28</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zoghbi</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Bear</surname><given-names>MF</given-names></name></person-group>
<year>2012</year>
<article-title>Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities</article-title>. <source/>Cold Spring Harb. Perspect. Biol.
<volume>4</volume>, <fpage>a009886</fpage> (<pub-id pub-id-type="doi">10.1101/cshperspect.a009886</pub-id>)<pub-id pub-id-type="pmid">22258914</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C29">
<label>29</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moog</surname><given-names>U</given-names></name></person-group>
<year>2005</year>
<article-title>The outcome of diagnostic studies on the etiology of mental retardation: considerations on the classification of the causes</article-title>. <source/>Am. J. Med. Genet. A
<volume>137</volume>, <fpage>228</fpage>–<lpage>231</lpage>. (<pub-id pub-id-type="doi">10.1002/ajmg.a.30841</pub-id>)<pub-id pub-id-type="pmid">16086396</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C30">
<label>30</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ellison</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Rosenfeld</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Shaffer</surname><given-names>LG</given-names></name></person-group>
<year>2013</year>
<article-title>Genetic basis of intellectual disability</article-title>. <source/>Annu. Rev. Med.
<volume>64</volume>, <fpage>441</fpage>–<lpage>450</lpage>. (<pub-id pub-id-type="doi">10.1146/annurev-med-042711-140053</pub-id>)<pub-id pub-id-type="pmid">23020879</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C31">
<label>31</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Srivastava</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Schwartz</surname><given-names>CE</given-names></name></person-group>
<year>2014</year>
<article-title>Intellectual disability and autism spectrum disorders: causal genes and molecular mechanisms</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>46</volume>(<issue>Pt 2</issue>), <fpage>161</fpage>–<lpage>174</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neubiorev.2014.02.015</pub-id>)<pub-id pub-id-type="pmid">24709068</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C32">
<label>32</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Srour</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shevell</surname><given-names>M</given-names></name></person-group>
<year>2014</year>
<article-title>Genetics and the investigation of developmental delay/intellectual disability</article-title>. <source/>Arch. Dis. Child.
<volume>99</volume>, <fpage>386</fpage>–<lpage>389</lpage>. (<pub-id pub-id-type="doi">10.1136/archdischild-2013-304063</pub-id>)<pub-id pub-id-type="pmid">24344174</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C33">
<label>33</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katz</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lazcano-Ponce</surname><given-names>E</given-names></name></person-group>
<year>2008</year>
<article-title>Intellectual disability: definition, etiological factors, classification, diagnosis, treatment and prognosis</article-title>. <source/>Salud Publica Mex.
<volume>50</volume>(<issue>Suppl. 2</issue>), <fpage>s132</fpage>–<lpage>s141</lpage>.<pub-id pub-id-type="pmid">18470340</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C34">
<label>34</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reichenberg</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>Discontinuity in the genetic and environmental causes of the intellectual disability spectrum</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>113</volume>, <fpage>1098</fpage>–<lpage>1103</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1508093112</pub-id>)<pub-id pub-id-type="pmid">26711998</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C35">
<label>35</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vissers</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Gilissen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Veltman</surname><given-names>JA</given-names></name></person-group>
<year>2016</year>
<article-title>Genetic studies in intellectual disability and related disorders</article-title>. <source/>Nat. Rev. Genet.
<volume>17</volume>, <fpage>9</fpage>–<lpage>18</lpage>. (<pub-id pub-id-type="doi">10.1038/nrg3999</pub-id>)<pub-id pub-id-type="pmid">26503795</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C36">
<label>36</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pinto</surname><given-names>D</given-names></name><etal>et al.</etal></person-group>
<year>2010</year>
<article-title>Functional impact of global rare copy number variation in autism spectrum disorders</article-title>. <source/>Nature
<volume>466</volume>, <fpage>368</fpage>–<lpage>372</lpage>. (<pub-id pub-id-type="doi">10.1038/nature09146</pub-id>)<pub-id pub-id-type="pmid">20531469</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C37">
<label>37</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaufman</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ayub</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Vincent</surname><given-names>JB</given-names></name></person-group>
<year>2010</year>
<article-title>The genetic basis of non-syndromic intellectual disability: a review</article-title>. <source/>J. Neurodev. Disord.
<volume>2</volume>, <fpage>182</fpage>–<lpage>209</lpage>. (<pub-id pub-id-type="doi">10.1007/s11689-010-9055-2</pub-id>)<pub-id pub-id-type="pmid">21124998</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C38">
<label>38</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chelly</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mandel</surname><given-names>JL</given-names></name></person-group>
<year>2001</year>
<article-title>Monogenic causes of X-linked mental retardation</article-title>. <source/>Nat. Rev. Genet.
<volume>2</volume>, <fpage>669</fpage>–<lpage>680</lpage>. (<pub-id pub-id-type="doi">10.1038/35088558</pub-id>)<pub-id pub-id-type="pmid">11533716</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C39">
<label>39</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bliss</surname><given-names>TV</given-names></name>, <name name-style="western"><surname>Collingridge</surname><given-names>GL</given-names></name></person-group>
<year>1993</year>
<article-title>A synaptic model of memory: long-term potentiation in the hippocampus</article-title>. <source/>Nature
<volume>361</volume>, <fpage>31</fpage>–<lpage>39</lpage>. (<pub-id pub-id-type="doi">10.1038/361031a0</pub-id>)<pub-id pub-id-type="pmid">8421494</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C40">
<label>40</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levitt</surname><given-names>P</given-names></name></person-group>
<year>2003</year>
<article-title>Structural and functional maturation of the developing primate brain</article-title>. <source/>J. Pediatr.
<volume>143</volume>, <fpage>S35</fpage>–<lpage>S45</lpage>. (<pub-id pub-id-type="doi">10.1067/S0022-3476(03)00400-1</pub-id>)<pub-id pub-id-type="pmid">14597912</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C41">
<label>41</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiesel</surname><given-names>TN</given-names></name>, <name name-style="western"><surname>Hubel</surname><given-names>DH</given-names></name></person-group>
<year>1963</year>
<article-title>Single-cell responses in striate cortex of kittens deprived of vision in one eye</article-title>. <source/>J. Neurophysiol.
<volume>26</volume>, <fpage>1003</fpage>–<lpage>1017</lpage>. (<pub-id pub-id-type="doi">10.1152/jn.1963.26.6.1003</pub-id>)<pub-id pub-id-type="pmid">14084161</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C42">
<label>42</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stiles</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jernigan</surname><given-names>TL</given-names></name></person-group>
<year>2010</year>
<article-title>The basics of brain development</article-title>. <source/>Neuropsychol. Rev.
<volume>20</volume>, <fpage>327</fpage>–<lpage>348</lpage>. (<pub-id pub-id-type="doi">10.1007/s11065-010-9148-4</pub-id>)<pub-id pub-id-type="pmid">21042938</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C43">
<label>43</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hensch</surname><given-names>TK</given-names></name></person-group>
<year>2005</year>
<article-title>Critical period plasticity in local cortical circuits</article-title>. <source/>Nat. Rev. Neurosci.
<volume>6</volume>, <fpage>877</fpage>–<lpage>888</lpage>. (<pub-id pub-id-type="doi">10.1038/nrn1787</pub-id>)<pub-id pub-id-type="pmid">16261181</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C44">
<label>44</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hensch</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Bilimoria</surname><given-names>PM</given-names></name></person-group>
<year>2012</year>
<article-title>Re-opening windows: manipulating critical periods for brain development</article-title>. <source/>Cerebrum
<volume>2012</volume>, <fpage>11</fpage>.<pub-id pub-id-type="pmid">23447797</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C45">
<label>45</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hubel</surname><given-names>DH</given-names></name></person-group>
<year>1957</year>
<article-title>Tungsten microelectrode for recording from single units</article-title>. <source/>Science
<volume>125</volume>, <fpage>549</fpage>–<lpage>550</lpage>. (<pub-id pub-id-type="doi">10.1126/science.125.3247.549</pub-id>)<pub-id pub-id-type="pmid">17793797</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C46">
<label>46</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hubel</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Wiesel</surname><given-names>TN</given-names></name></person-group>
<year>1968</year>
<article-title>Receptive fields and functional architecture of monkey striate cortex</article-title>. <source/>J. Physiol.
<volume>195</volume>, <fpage>215</fpage>–<lpage>243</lpage>. (<pub-id pub-id-type="doi">10.1113/jphysiol.1968.sp008455</pub-id>)<pub-id pub-id-type="pmid">4966457</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C47">
<label>47</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hubel</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Wiesel</surname><given-names>TN</given-names></name></person-group>
<year>1970</year>
<article-title>The period of susceptibility to the physiological effects of unilateral eye closure in kittens</article-title>. <source/>J. Physiol.
<volume>206</volume>, <fpage>419</fpage>–<lpage>436</lpage>. (<pub-id pub-id-type="doi">10.1113/jphysiol.1970.sp009022</pub-id>)<pub-id pub-id-type="pmid">5498493</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C48">
<label>48</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hubel</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Wiesel</surname><given-names>TN</given-names></name></person-group>
<year>1962</year>
<article-title>Receptive fields, binocular interaction and functional architecture in the cat's visual cortex</article-title>. <source/>J. Physiol.
<volume>160</volume>, <fpage>106</fpage>–<lpage>154</lpage>. (<pub-id pub-id-type="doi">10.1113/jphysiol.1962.sp006837</pub-id>)<pub-id pub-id-type="pmid">14449617</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C49">
<label>49</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horton</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Hocking</surname><given-names>DR</given-names></name></person-group>
<year>1997</year>
<article-title>Timing of the critical period for plasticity of ocular dominance columns in macaque striate cortex</article-title>. <source/>J. Neurosci.
<volume>17</volume>, <fpage>3684</fpage>–<lpage>3709</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-10-03684.1997</pub-id>)<pub-id pub-id-type="pmid">9133391</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C50">
<label>50</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Trachtenberg</surname><given-names>JT</given-names></name></person-group>
<year>2007</year>
<article-title>Experience-dependent binocular competition in the visual cortex begins at eye opening</article-title>. <source/>Nat. Neurosci.
<volume>10</volume>, <fpage>370</fpage>–<lpage>375</lpage>. (<pub-id pub-id-type="doi">10.1038/nn1844</pub-id>)<pub-id pub-id-type="pmid">17293862</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C51">
<label>51</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crowley</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Katz</surname><given-names>LC</given-names></name></person-group>
<year>2000</year>
<article-title>Early development of ocular dominance columns</article-title>. <source/>Science
<volume>290</volume>, <fpage>1321</fpage>–<lpage>1324</lpage>. (<pub-id pub-id-type="doi">10.1126/science.290.5495.1321</pub-id>)<pub-id pub-id-type="pmid">11082053</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C52">
<label>52</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faguet</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Maranhao</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Trachtenberg</surname><given-names>JT</given-names></name></person-group>
<year>2009</year>
<article-title>Ipsilateral eye cortical maps are uniquely sensitive to binocular plasticity</article-title>. <source/>J. Neurophysiol.
<volume>101</volume>, <fpage>855</fpage>–<lpage>861</lpage>. (<pub-id pub-id-type="doi">10.1152/jn.90893.2008</pub-id>)<pub-id pub-id-type="pmid">19052109</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C53">
<label>53</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Espinosa</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Stryker</surname><given-names>MP</given-names></name></person-group>
<year>2012</year>
<article-title>Development and plasticity of the primary visual cortex</article-title>. <source/>Neuron
<volume>75</volume>, <fpage>230</fpage>–<lpage>249</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2012.06.009</pub-id>)<pub-id pub-id-type="pmid">22841309</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C54">
<label>54</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erzurumlu</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Gaspar</surname><given-names>P</given-names></name></person-group>
<year>2012</year>
<article-title>Development and critical period plasticity of the barrel cortex</article-title>. <source/>Eur. J. Neurosci.
<volume>35</volume>, <fpage>1540</fpage>–<lpage>1553</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1460-9568.2012.08075.x</pub-id>)<pub-id pub-id-type="pmid">22607000</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C55">
<label>55</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lendvai</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Stern</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Svoboda</surname><given-names>K</given-names></name></person-group>
<year>2000</year>
<article-title>Experience-dependent plasticity of dendritic spines in the developing rat barrel cortex <italic>in vivo</italic></article-title>. <source/>Nature
<volume>404</volume>, <fpage>876</fpage>–<lpage>881</lpage>. (<pub-id pub-id-type="doi">10.1038/35009107</pub-id>)<pub-id pub-id-type="pmid">10786794</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C56">
<label>56</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maravall</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Petersen</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Fairhall</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Arabzadeh</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Diamond</surname><given-names>ME</given-names></name></person-group>
<year>2007</year>
<article-title>Shifts in coding properties and maintenance of information transmission during adaptation in barrel cortex</article-title>. <source/>PLoS Biol.
<volume>5</volume>, <fpage>e19</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pbio.0050019</pub-id>)<pub-id pub-id-type="pmid">17253902</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C57">
<label>57</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shoykhet</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Land</surname><given-names>PW</given-names></name>, <name name-style="western"><surname>Simons</surname><given-names>DJ</given-names></name></person-group>
<year>2005</year>
<article-title>Whisker trimming begun at birth or on postnatal day 12 affects excitatory and inhibitory receptive fields of layer IV barrel neurons</article-title>. <source/>J. Neurophysiol.
<volume>94</volume>, <fpage>3987</fpage>–<lpage>3995</lpage>. (<pub-id pub-id-type="doi">10.1152/jn.00569.2005</pub-id>)<pub-id pub-id-type="pmid">16093330</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C58">
<label>58</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cull-Candy</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Brickley</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Farrant</surname><given-names>M</given-names></name></person-group>
<year>2001</year>
<article-title>NMDA receptor subunits: diversity, development and disease</article-title>. <source/>Curr. Opin Neurobiol.
<volume>11</volume>, <fpage>327</fpage>–<lpage>335</lpage>. (<pub-id pub-id-type="doi">10.1016/S0959-4388(00)00215-4</pub-id>)<pub-id pub-id-type="pmid">11399431</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C59">
<label>59</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Livingston</surname><given-names>FS</given-names></name>, <name name-style="western"><surname>Mooney</surname><given-names>R</given-names></name></person-group>
<year>1997</year>
<article-title>Development of intrinsic and synaptic properties in a forebrain nucleus essential to avian song learning</article-title>. <source/>J. Neurosci.
<volume>17</volume>, <fpage>8997</fpage>–<lpage>9009</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-23-08997.1997</pub-id>)<pub-id pub-id-type="pmid">9364047</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C60">
<label>60</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flint</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Maisch</surname><given-names>US</given-names></name>, <name name-style="western"><surname>Weishaupt</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Kriegstein</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Monyer</surname><given-names>H</given-names></name></person-group>
<year>1997</year>
<article-title>NR2A subunit expression shortens NMDA receptor synaptic currents in developing neocortex</article-title>. <source/>J. Neurosci.
<volume>17</volume>, <fpage>2469</fpage>–<lpage>2476</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-07-02469.1997</pub-id>)<pub-id pub-id-type="pmid">9065507</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C61">
<label>61</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roberts</surname><given-names>EB</given-names></name>, <name name-style="western"><surname>Ramoa</surname><given-names>AS</given-names></name></person-group>
<year>1999</year>
<article-title>Enhanced NR2A subunit expression and decreased NMDA receptor decay time at the onset of ocular dominance plasticity in the ferret</article-title>. <source/>J. Neurophysiol.
<volume>81</volume>, <fpage>2587</fpage>–<lpage>2591</lpage>. (<pub-id pub-id-type="doi">10.1152/jn.1999.81.5.2587</pub-id>)<pub-id pub-id-type="pmid">10322092</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C62">
<label>62</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carmignoto</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Vicini</surname><given-names>S</given-names></name></person-group>
<year>1992</year>
<article-title>Activity-dependent decrease in NMDA receptor responses during development of the visual cortex</article-title>. <source/>Science
<volume>258</volume>, <fpage>1007</fpage>–<lpage>1011</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1279803</pub-id>)<pub-id pub-id-type="pmid">1279803</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C63">
<label>63</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crair</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Malenka</surname><given-names>RC</given-names></name></person-group>
<year>1995</year>
<article-title>A critical period for long-term potentiation at thalamocortical synapses</article-title>. <source/>Nature
<volume>375</volume>, <fpage>325</fpage>–<lpage>328</lpage>. (<pub-id pub-id-type="doi">10.1038/375325a0</pub-id>)<pub-id pub-id-type="pmid">7753197</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C64">
<label>64</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Man</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ju</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Trimble</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>MacDonald</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>YT</given-names></name></person-group>
<year>2001</year>
<article-title>Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons</article-title>. <source/>Neuron
<volume>29</volume>, <fpage>243</fpage>–<lpage>254</lpage>. (<pub-id pub-id-type="doi">10.1016/S0896-6273(01)00194-5</pub-id>)<pub-id pub-id-type="pmid">11182095</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C65">
<label>65</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agmon</surname><given-names>A</given-names></name>, <name name-style="western"><surname>O'Dowd</surname><given-names>DK</given-names></name></person-group>
<year>1992</year>
<article-title>NMDA receptor-mediated currents are prominent in the thalamocortical synaptic response before maturation of inhibition</article-title>. <source/>J. Neurophysiol.
<volume>68</volume>, <fpage>345</fpage>–<lpage>349</lpage>. (<pub-id pub-id-type="doi">10.1152/jn.1992.68.1.345</pub-id>)<pub-id pub-id-type="pmid">1381421</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C66">
<label>66</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ben-Ari</surname><given-names>Y</given-names></name></person-group>
<year>2014</year>
<article-title>The GABA excitatory/inhibitory developmental sequence: a personal journey</article-title>. <source/>Neuroscience
<volume>279</volume>, <fpage>187</fpage>–<lpage>219</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuroscience.2014.08.001</pub-id>)<pub-id pub-id-type="pmid">25168736</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C67">
<label>67</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fagiolini</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hensch</surname><given-names>TK</given-names></name></person-group>
<year>2000</year>
<article-title>Inhibitory threshold for critical-period activation in primary visual cortex</article-title>. <source/>Nature
<volume>404</volume>, <fpage>183</fpage>–<lpage>186</lpage>. (<pub-id pub-id-type="doi">10.1038/35004582</pub-id>)<pub-id pub-id-type="pmid">10724170</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C68">
<label>68</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sipila</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Huttu</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yamada</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Afzalov</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Voipio</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Blaesse</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kaila</surname><given-names>K</given-names></name></person-group>
<year>2009</year>
<article-title>Compensatory enhancement of intrinsic spiking upon NKCC1 disruption in neonatal hippocampus</article-title>. <source/>J. Neurosci.
<volume>29</volume>, <fpage>6982</fpage>–<lpage>6988</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0443-09.2009</pub-id>)<pub-id pub-id-type="pmid">19474325</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C69">
<label>69</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hubner</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Hermans-Borgmeyer</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Meyer</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ballanyi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Jentsch</surname><given-names>TJ</given-names></name></person-group>
<year>2001</year>
<article-title>Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition</article-title>. <source/>Neuron
<volume>30</volume>, <fpage>515</fpage>–<lpage>524</lpage>. (<pub-id pub-id-type="doi">10.1016/S0896-6273(01)00297-5</pub-id>)<pub-id pub-id-type="pmid">11395011</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C70">
<label>70</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baroncelli</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Braschi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Spolidoro</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Begenisic</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Maffei</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sale</surname><given-names>A</given-names></name></person-group>
<year>2011</year>
<article-title>Brain plasticity and disease: a matter of inhibition</article-title>. <source/>Neural Plast.
<volume>2011</volume>, <fpage>286073</fpage> (<pub-id pub-id-type="doi">10.1155/2011/286073</pub-id>)<pub-id pub-id-type="pmid">21766040</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C71">
<label>71</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bavelier</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Levi</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Dan</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hensch</surname><given-names>TK</given-names></name></person-group>
<year>2010</year>
<article-title>Removing brakes on adult brain plasticity: from molecular to behavioral interventions</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>14 964</fpage>–<lpage>14 971</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4812-10.2010</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C72">
<label>72</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hensch</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Fagiolini</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mataga</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Stryker</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Baekkeskov</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kash</surname><given-names>SF</given-names></name></person-group>
<year>1998</year>
<article-title>Local GABA circuit control of experience-dependent plasticity in developing visual cortex</article-title>. <source/>Science
<volume>282</volume>, <fpage>1504</fpage>–<lpage>1508</lpage>. (<pub-id pub-id-type="doi">10.1126/science.282.5393.1504</pub-id>)<pub-id pub-id-type="pmid">9822384</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C73">
<label>73</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanover</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>ZJ</given-names></name>, <name name-style="western"><surname>Tonegawa</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Stryker</surname><given-names>MP</given-names></name></person-group>
<year>1999</year>
<article-title>Brain-derived neurotrophic factor overexpression induces precocious critical period in mouse visual cortex</article-title>. <source/>J. Neurosci.
<volume>19</volume>, <fpage>RC40</fpage> (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-22-j0003.1999</pub-id>)<pub-id pub-id-type="pmid">10559430</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C74">
<label>74</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanold</surname><given-names>PO</given-names></name></person-group>
<year>2009</year>
<article-title>Subplate neurons: crucial regulators of cortical development and plasticity</article-title>. <source/>Front. Neuroanat.
<volume>3</volume>, <fpage>16</fpage> (<pub-id pub-id-type="doi">10.3389/neuro.05.016.2009</pub-id>)<pub-id pub-id-type="pmid">19738926</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C75">
<label>75</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Southwell</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Froemke</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Alvarez-Buylla</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Stryker</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Gandhi</surname><given-names>SP</given-names></name></person-group>
<year>2010</year>
<article-title>Cortical plasticity induced by inhibitory neuron transplantation</article-title>. <source/>Science
<volume>327</volume>, <fpage>1145</fpage>–<lpage>1148</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1183962</pub-id>)<pub-id pub-id-type="pmid">20185728</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C76">
<label>76</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toyoizumi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Miyamoto</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yazaki-Sugiyama</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Atapour</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hensch</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>KD</given-names></name></person-group>
<year>2013</year>
<article-title>A theory of the transition to critical period plasticity: inhibition selectively suppresses spontaneous activity</article-title>. <source/>Neuron
<volume>80</volume>, <fpage>51</fpage>–<lpage>63</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2013.07.022</pub-id>)<pub-id pub-id-type="pmid">24094102</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C77">
<label>77</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>ZJ</given-names></name>, <name name-style="western"><surname>Kirkwood</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pizzorusso</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Porciatti</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Morales</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bear</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Maffei</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tonegawa</surname><given-names>S</given-names></name></person-group>
<year>1999</year>
<article-title>BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex</article-title>. <source/>Cell
<volume>98</volume>, <fpage>739</fpage>–<lpage>755</lpage>. (<pub-id pub-id-type="doi">10.1016/S0092-8674(00)81509-3</pub-id>)<pub-id pub-id-type="pmid">10499792</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C78">
<label>78</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andersen</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Winter</surname><given-names>LM</given-names></name></person-group>
<year>2017</year>
<article-title>Animal models in biological and biomedical research-experimental and ethical concerns</article-title>. <source/>An. Acad. Bras. Cienc.
<volume>91</volume>(<issue>Suppl. 1</issue>), <fpage>e20170238</fpage> (<pub-id pub-id-type="doi">10.1590/0001-3765201720170238</pub-id>)<pub-id pub-id-type="pmid">28876358</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C79">
<label>79</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erickson</surname><given-names>CA</given-names></name><etal>et al</etal></person-group>
<year>2017</year>
<article-title>Fragile X targeted pharmacotherapy: lessons learned and future directions</article-title>. <source/>J. Neurodev. Disord.
<volume>9</volume>, <fpage>7</fpage> (<pub-id pub-id-type="doi">10.1186/s11689-017-9186-9</pub-id>)<pub-id pub-id-type="pmid">28616096</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C80">
<label>80</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Orban</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Chui</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Marth</surname><given-names>JD</given-names></name></person-group>
<year>1992</year>
<article-title>Tissue-and site-specific DNA recombination in transgenic mice</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>89</volume>, <fpage>6861</fpage>–<lpage>6865</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.89.15.6861</pub-id>)<pub-id pub-id-type="pmid">1495975</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C81">
<label>81</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doetschman</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Azhar</surname><given-names>M</given-names></name></person-group>
<year>2012</year>
<article-title>Cardiac-specific inducible and conditional gene targeting in mice</article-title>. <source/>Circ. Res.
<volume>110</volume>, <fpage>1498</fpage>–<lpage>1512</lpage>. (<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.112.265066</pub-id>)<pub-id pub-id-type="pmid">22628574</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C82">
<label>82</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeyabalan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Clement</surname><given-names>JP</given-names></name></person-group>
<year>2016</year>
<article-title>SYNGAP1: mind the gap</article-title>. <source/>Front. Cell. Neurosci.
<volume>10</volume>, <fpage>32</fpage> (<pub-id pub-id-type="doi">10.3389/fncel.2016.00032</pub-id>)<pub-id pub-id-type="pmid">26912996</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C83">
<label>83</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scorza</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Cavalheiro</surname><given-names>EA</given-names></name></person-group>
<year>2011</year>
<article-title>Animal models of intellectual disability: towards a translational approach</article-title>. <source/>Clinics
<volume>66</volume>, <fpage>55</fpage>–<lpage>63</lpage>. (<pub-id pub-id-type="doi">10.1590/S1807-59322011001300007</pub-id>)<pub-id pub-id-type="pmid">21779723</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C84">
<label>84</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ogden</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Ozkan</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Rumbaugh</surname><given-names>G</given-names></name></person-group>
<year>2016</year>
<article-title>Prioritizing the development of mouse models for childhood brain disorders</article-title>. <source/>Neuropharmacology
<volume>100</volume>, <fpage>2</fpage>–<lpage>16</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuropharm.2015.07.029</pub-id>)<pub-id pub-id-type="pmid">26231830</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C85">
<label>85</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Hamilton</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Reish</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Sweatt</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Rumbaugh</surname><given-names>G</given-names></name></person-group>
<year>2009</year>
<article-title>Reduced expression of the NMDA receptor-interacting protein SynGAP causes behavioral abnormalities that model symptoms of schizophrenia</article-title>. <source/>Neuropsychopharmacology
<volume>34</volume>, <fpage>1659</fpage>–<lpage>1672</lpage>. (<pub-id pub-id-type="doi">10.1038/npp.2008.223</pub-id>)<pub-id pub-id-type="pmid">19145222</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C86">
<label>86</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>H-K</given-names></name>, <name name-style="western"><surname>Takamiya</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Huganir</surname><given-names>RL</given-names></name></person-group>
<year>2003</year>
<article-title>The role of synaptic GTPase-activating protein in neuronal development and synaptic plasticity</article-title>. <source/>J. Neurosci.
<volume>23</volume>, <fpage>1119</fpage>–<lpage>1124</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-04-01119.2003</pub-id>)<pub-id pub-id-type="pmid">12598599</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C87">
<label>87</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vazquez</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>H-J</given-names></name>, <name name-style="western"><surname>Sokolova</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Knuesel</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>MB</given-names></name></person-group>
<year>2004</year>
<article-title>SynGAP regulates spine formation</article-title>. <source/>J. Neurosci.
<volume>24</volume>, <fpage>8862</fpage>–<lpage>8872</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3213-04.2004</pub-id>)<pub-id pub-id-type="pmid">15470153</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C88">
<label>88</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clement</surname><given-names>JP</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses</article-title>. <source/>Cell
<volume>151</volume>, <fpage>709</fpage>–<lpage>723</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2012.08.045</pub-id>)<pub-id pub-id-type="pmid">23141534</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C89">
<label>89</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oostra</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bakker</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Reyniers</surname><given-names>E</given-names></name></person-group>
<year>1994</year>
<article-title>FMR1 knockout mice: a model to study fragile X mental retardation</article-title>. <source/>Am. J. Hum. Genet.
<volume>55</volume>, <fpage>23</fpage>–<lpage>33</lpage>.</mixed-citation>
</ref>
<ref id="RSOB180265C90">
<label>90</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dahlhaus</surname><given-names>R</given-names></name></person-group>
<year>2018</year>
<article-title>Of men and mice: modeling the fragile X syndrome</article-title>. <source/>Front. Mol. Neurosci.
<volume>11</volume>, <fpage>41</fpage> (<pub-id pub-id-type="doi">10.3389/fnmol.2018.00041</pub-id>)<pub-id pub-id-type="pmid">29599705</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C91">
<label>91</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mientjes</surname><given-names>E</given-names></name><etal>et al.</etal></person-group>
<year>2006</year>
<article-title>The generation of a conditional Fmr1 knock out mouse model to study Fmrp function <italic>in vivo</italic></article-title>. <source/>Neurobiol. Dis.
<volume>21</volume>, <fpage>549</fpage>–<lpage>555</lpage>. (<pub-id pub-id-type="doi">10.1016/j.nbd.2005.08.019</pub-id>)<pub-id pub-id-type="pmid">16257225</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C92">
<label>92</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaudissard</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ginger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Premoli</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Memo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Frick</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pietropaolo</surname><given-names>S</given-names></name></person-group>
<year>2017</year>
<article-title>Behavioral abnormalities in the Fmr1-KO2 mouse model of fragile X syndrome: the relevance of early life phases</article-title>. <source/>Autism Res.
<volume>10</volume>, <fpage>1584</fpage>–<lpage>1596</lpage>. (<pub-id pub-id-type="doi">10.1002/aur.1814</pub-id>)<pub-id pub-id-type="pmid">28590057</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C93">
<label>93</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wijetunge</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Angibaud</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Frick</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kind</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Nägerl</surname><given-names>UV</given-names></name></person-group>
<year>2014</year>
<article-title>Stimulated emission depletion (STED) microscopy reveals nanoscale defects in the developmental trajectory of dendritic spine morphogenesis in a mouse model of fragile X syndrome</article-title>. <source/>J. Neurosci.
<volume>34</volume>, <fpage>6405</fpage>–<lpage>6412</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5302-13.2014</pub-id>)<pub-id pub-id-type="pmid">24790210</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C94">
<label>94</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koekkoek</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>
<year>2005</year>
<article-title>Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in fragile X syndrome</article-title>. <source/>Neuron.
<volume>47</volume>, <fpage>339</fpage>–<lpage>352</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2005.07.005</pub-id>)<pub-id pub-id-type="pmid">16055059</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C95">
<label>95</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>W</given-names></name><etal>et al.</etal></person-group>
<year>2011</year>
<article-title>Ablation of Fmrp in adult neural stem cells disrupts hippocampus-dependent learning</article-title>. <source/>Nat. Med.
<volume>17</volume>, <fpage>559</fpage>–<lpage>565</lpage>. (<pub-id pub-id-type="doi">10.1038/nm.2336</pub-id>)<pub-id pub-id-type="pmid">21516088</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C96">
<label>96</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El-Khoury</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Panayotis</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Matagne</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Ghata</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Villard</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>J-C</given-names></name></person-group>
<year>2014</year>
<article-title>GABA and glutamate pathways are spatially and developmentally affected in the brain of Mecp2-deficient mice</article-title>. <source/>PLoS ONE
<volume>9</volume>, <fpage>e92169</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pone.0092169</pub-id>)<pub-id pub-id-type="pmid">24667344</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C97">
<label>97</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blue</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Kaufmann</surname><given-names>WE</given-names></name>, <name name-style="western"><surname>Bressler</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Eyring</surname><given-names>C</given-names></name>, <name name-style="western"><surname>O'Driscoll</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Naidu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Johnston</surname><given-names>MV</given-names></name></person-group>
<year>2011</year>
<article-title>Temporal and regional alterations in NMDA receptor expression in Mecp2-null mice</article-title>. <source/>Anat. Rec.
<volume>294</volume>, <fpage>1624</fpage>–<lpage>1634</lpage>. (<pub-id pub-id-type="doi">10.1002/ar.21380</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C98">
<label>98</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guy</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hendrich</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Holmes</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Bird</surname><given-names>A</given-names></name></person-group>
<year>2001</year>
<article-title>A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome</article-title>. <source/>Nat. Genet.
<volume>27</volume>, <fpage>322</fpage>–<lpage>326</lpage>. (<pub-id pub-id-type="doi">10.1038/85899</pub-id>)<pub-id pub-id-type="pmid">11242117</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C99">
<label>99</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krishnan</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>B-S</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Maffei</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>ZJ</given-names></name></person-group>
<year>2015</year>
<article-title>MeCP2 regulates the timing of critical period plasticity that shapes functional connectivity in primary visual cortex</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>112</volume>, <fpage>E4782</fpage>–<lpage>E4791</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1506499112</pub-id>)<pub-id pub-id-type="pmid">26261347</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C100">
<label>100</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abdala</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Dutschmann</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bissonnette</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Paton</surname><given-names>JF</given-names></name></person-group>
<year>2010</year>
<article-title>Correction of respiratory disorders in a mouse model of Rett syndrome</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>107</volume>, <fpage>18 208</fpage>–<lpage>18 213</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1012104107</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C101">
<label>101</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carouge</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Host</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Aunis</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Zwiller</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Anglard</surname><given-names>P</given-names></name></person-group>
<year>2010</year>
<article-title>CDKL5 is a brain MeCP2 target gene regulated by DNA methylation</article-title>. <source/>Neurobiol. Dis.
<volume>38</volume>, <fpage>414</fpage>–<lpage>424</lpage>. (<pub-id pub-id-type="doi">10.1016/j.nbd.2010.02.014</pub-id>)<pub-id pub-id-type="pmid">20211261</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C102">
<label>102</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singleton</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Gonzales</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>KN</given-names></name>, <name name-style="western"><surname>Yasui</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Schroeder</surname><given-names>DI</given-names></name>, <name name-style="western"><surname>Dunaway</surname><given-names>K</given-names></name>, <name name-style="western"><surname>LaSalle</surname><given-names>JM</given-names></name></person-group>
<year>2011</year>
<article-title>MeCP2 is required for global heterochromatic and nucleolar changes during activity-dependent neuronal maturation</article-title>. <source/>Neurobiol. Dis.
<volume>43</volume>, <fpage>190</fpage>–<lpage>200</lpage>. (<pub-id pub-id-type="doi">10.1016/j.nbd.2011.03.011</pub-id>)<pub-id pub-id-type="pmid">21420494</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C103">
<label>103</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Samaco</surname><given-names>RC</given-names></name><etal>et al.</etal></person-group>
<year>2009</year>
<article-title>Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>106</volume>, <fpage>21 966</fpage>–<lpage>21 971</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0912257106</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C104">
<label>104</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luikenhuis</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Giacometti</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Beard</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Jaenisch</surname><given-names>R</given-names></name></person-group>
<year>2004</year>
<article-title>Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>101</volume>, <fpage>6033</fpage>–<lpage>6038</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0401626101</pub-id>)<pub-id pub-id-type="pmid">15069197</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C105">
<label>105</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lawson-Yuen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>ZI</given-names></name>, <name name-style="western"><surname>Tsai</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Basu</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Picker</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Coyle</surname><given-names>JT</given-names></name></person-group>
<year>2007</year>
<article-title>Ube3a mRNA and protein expression are not decreased in Mecp2R168X mutant mice</article-title>. <source/>Brain Res.
<volume>1180</volume>, <fpage>1</fpage>–<lpage>6</lpage>. (<pub-id pub-id-type="doi">10.1016/j.brainres.2007.08.039</pub-id>)<pub-id pub-id-type="pmid">17936729</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C106">
<label>106</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><etal>et al.</etal></person-group>
<year>2011</year>
<article-title>Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3</article-title>. <source/>Hum. Mol. Genet.
<volume>20</volume>, <fpage>3093</fpage>–<lpage>3108</lpage>. (<pub-id pub-id-type="doi">10.1093/hmg/ddr212</pub-id>)<pub-id pub-id-type="pmid">21558424</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C107">
<label>107</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bozdagi</surname><given-names>O</given-names></name><etal>et al.</etal></person-group>
<year>2010</year>
<article-title>Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication</article-title>. <source/>Mol. Autism
<volume>1</volume>, <fpage>15</fpage> (<pub-id pub-id-type="doi">10.1186/2040-2392-1-15</pub-id>)<pub-id pub-id-type="pmid">21167025</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C108">
<label>108</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peca</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Feliciano</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ting</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Wells</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Venkatraman</surname><given-names>TN</given-names></name>, <name name-style="western"><surname>Lascola</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>G</given-names></name></person-group>
<year>2011</year>
<article-title>Shank3 mutant mice display autistic-like behaviours and striatal dysfunction</article-title>. <source/>Nature
<volume>472</volume>, <fpage>437</fpage>–<lpage>442</lpage>. (<pub-id pub-id-type="doi">10.1038/nature09965</pub-id>)<pub-id pub-id-type="pmid">21423165</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C109">
<label>109</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabuchi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Blundell</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Etherton</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Hammer</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Powell</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name></person-group>
<year>2007</year>
<article-title>A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice</article-title>. <source/>Science
<volume>318</volume>, <fpage>71</fpage>–<lpage>76</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1146221</pub-id>)<pub-id pub-id-type="pmid">17823315</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C110">
<label>110</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Etherton</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Foldy</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tabuchi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Shamloo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Malenka</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name></person-group>
<year>2011</year>
<article-title>Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>108</volume>, <fpage>13 764</fpage>–<lpage>13 769</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1111093108</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C111">
<label>111</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pizzarelli</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Cherubini</surname><given-names>E</given-names></name></person-group>
<year>2013</year>
<article-title>Developmental regulation of GABAergic signalling in the hippocampus of neuroligin 3 R451C knock-in mice: an animal model of autism</article-title>. <source/>Front. Cell. Neurosci.
<volume>7</volume>, <fpage>85</fpage> (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/0.3389/fncel.2013.00085">doi:0.3389/fncel.2013.00085</ext-link>)<pub-id pub-id-type="pmid">23761734</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C112">
<label>112</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cellot</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Cherubini</surname><given-names>E</given-names></name></person-group>
<year>2014</year>
<article-title>Reduced inhibitory gate in the barrel cortex of Neuroligin3R451C knock-in mice, an animal model of autism spectrum disorders</article-title>. <source/>Physiol Rep.
<volume>2</volume>, <fpage>e12077</fpage> (<pub-id pub-id-type="doi">10.14814/phy2.12077</pub-id>)<pub-id pub-id-type="pmid">25347860</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C113">
<label>113</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Foldy</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Malenka</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name></person-group>
<year>2013</year>
<article-title>Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling</article-title>. <source/>Neuron
<volume>78</volume>, <fpage>498</fpage>–<lpage>509</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2013.02.036</pub-id>)<pub-id pub-id-type="pmid">23583622</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C114">
<label>114</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rothwell</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Fuccillo</surname><given-names>MV</given-names></name>, <name name-style="western"><surname>Maxeiner</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hayton</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Gokce</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>BK</given-names></name>, <name name-style="western"><surname>Fowler</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Malenka</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name></person-group>
<year>2014</year>
<article-title>Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors</article-title>. <source/>Cell
<volume>158</volume>, <fpage>198</fpage>–<lpage>212</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2014.04.045</pub-id>)<pub-id pub-id-type="pmid">24995986</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C115">
<label>115</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Etherton</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Tabuchi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ko</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name></person-group>
<year>2011</year>
<article-title>An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus</article-title>. <source/>EMBO J.
<volume>30</volume>, <fpage>2908</fpage>–<lpage>2919</lpage>. (<pub-id pub-id-type="doi">10.1038/emboj.2011.182</pub-id>)<pub-id pub-id-type="pmid">21642956</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C116">
<label>116</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>H-J</given-names></name>, <name name-style="western"><surname>Rojas-Soto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Oguni</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>MB</given-names></name></person-group>
<year>1998</year>
<article-title>A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II</article-title>. <source/>Neuron
<volume>20</volume>, <fpage>895</fpage>–<lpage>904</lpage>. (<pub-id pub-id-type="doi">10.1016/S0896-6273(00)80471-7</pub-id>)<pub-id pub-id-type="pmid">9620694</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C117">
<label>117</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McMahon</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>SynGAP isoforms exert opposing effects on synaptic strength</article-title>. <source/>Nat. Commun.
<volume>3</volume>, <fpage>900</fpage> (<pub-id pub-id-type="doi">10.1038/ncomms1900</pub-id>)<pub-id pub-id-type="pmid">22692543</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C118">
<label>118</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parker</surname><given-names>MJ</given-names></name><etal>et al</etal></person-group>
<year>2015</year>
<article-title>De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability</article-title>. <source/>Am. J. Med. Genet. A
<volume>167</volume>, <fpage>2231</fpage>–<lpage>2237</lpage>. (<pub-id pub-id-type="doi">10.1002/ajmg.a.37189</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C119">
<label>119</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ozkan</surname><given-names>ED</given-names></name><etal>et al.</etal></person-group>
<year>2014</year>
<article-title>Reduced cognition in Syngap1 mutants is caused by isolated damage within developing forebrain excitatory neurons</article-title>. <source/>Neuron
<volume>82</volume>, <fpage>1317</fpage>–<lpage>1333</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2014.05.015</pub-id>)<pub-id pub-id-type="pmid">24945774</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C120">
<label>120</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muhia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Willadt</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yee</surname><given-names>BK</given-names></name>, <name name-style="western"><surname>Feldon</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Paterna</surname><given-names>J-C</given-names></name>, <name name-style="western"><surname>Schwendener</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Vogt</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Knuesel</surname><given-names>I</given-names></name></person-group>
<year>2012</year>
<article-title>Molecular and behavioral changes associated with adult hippocampus-specific SynGAP1 knockout</article-title>. <source/>Learn. Mem.
<volume>19</volume>, <fpage>268</fpage>–<lpage>281</lpage>. (<pub-id pub-id-type="doi">10.1101/lm.026351.112</pub-id>)<pub-id pub-id-type="pmid">22700469</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C121">
<label>121</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muhia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yee</surname><given-names>BK</given-names></name>, <name name-style="western"><surname>Feldon</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Markopoulos</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Knuesel</surname><given-names>I</given-names></name></person-group>
<year>2010</year>
<article-title>Disruption of hippocampus-regulated behavioural and cognitive processes by heterozygous constitutive deletion of SynGAP</article-title>. <source/>Eur. J. Neurosci.
<volume>31</volume>, <fpage>529</fpage>–<lpage>543</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1460-9568.2010.07079.x</pub-id>)<pub-id pub-id-type="pmid">20105235</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C122">
<label>122</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kilinc</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Creson</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Rojas</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Aceti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ellegood</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Vaissiere</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Lerch</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Rumbaugh</surname><given-names>G</given-names></name></person-group>
<year>2018</year>
<article-title>Species-conserved SYNGAP1 phenotypes associated with neurodevelopmental disorders</article-title>. <source/>Mol. Cell. Neurosci.
<volume>91</volume>, <fpage>140</fpage>–<lpage>150</lpage>. (<pub-id pub-id-type="doi">10.1016/j.mcn.2018.03.008</pub-id>)<pub-id pub-id-type="pmid">29580901</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C123">
<label>123</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamdan</surname><given-names>FF</given-names></name><etal>et al.</etal></person-group>
<year>2009</year>
<article-title>Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation</article-title>. <source/>N. Engl. J. Med.
<volume>360</volume>, <fpage>599</fpage>–<lpage>605</lpage>. (<pub-id pub-id-type="doi">10.1056/NEJMoa0805392</pub-id>)<pub-id pub-id-type="pmid">19196676</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C124">
<label>124</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mignot</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy</article-title>. <source/>J. Med. Genet.
<volume>53</volume>, <fpage>511</fpage>–<lpage>522</lpage>. (<pub-id pub-id-type="doi">10.1136/jmedgenet-2015-103451</pub-id>)<pub-id pub-id-type="pmid">26989088</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C125">
<label>125</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berryer</surname><given-names>MH</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>Decrease of SYNGAP1 in GABAergic cells impairs inhibitory synapse connectivity, synaptic inhibition and cognitive function</article-title>. <source/>Nat. Commun.
<volume>7</volume>, <fpage>13340</fpage> (<pub-id pub-id-type="doi">10.1038/ncomms13340</pub-id>)<pub-id pub-id-type="pmid">27827368</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C126">
<label>126</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michaelson</surname><given-names>SD</given-names></name><etal>et al</etal></person-group>
<year>2018</year>
<article-title>SYNGAP1 heterozygosity disrupts sensory processing by reducing touch-related activity within somatosensory cortex circuits</article-title>. <source/>Nat. Neurosci.
<volume>21</volume>, <fpage>1</fpage>–<lpage>13</lpage>. (<pub-id pub-id-type="doi">10.1038/s41593-018-0268-0</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C127">
<label>127</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kimura</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Akahira-Azuma</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Harada</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Enomoto</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Tsurusaki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kurosawa</surname><given-names>K</given-names></name></person-group>
<year>2018</year>
<article-title>Novel SYNGAP1 variant in a patient with intellectual disability and distinctive dysmorphisms</article-title>. <source/>Congenit. Anom.
<volume>58</volume>, <fpage>188</fpage>–<lpage>190</lpage>. (<pub-id pub-id-type="doi">10.1111/cga.12273</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C128">
<label>128</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berryer</surname><given-names>MH</given-names></name><etal>et al.</etal></person-group>
<year>2013</year>
<article-title>Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency</article-title>. <source/>Hum. Mutat.
<volume>34</volume>, <fpage>385</fpage>–<lpage>394</lpage>. (<pub-id pub-id-type="doi">10.1002/humu.22248</pub-id>)<pub-id pub-id-type="pmid">23161826</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C129">
<label>129</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Writzl</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Knegt</surname><given-names>AC</given-names></name></person-group>
<year>2013</year>
<article-title>6p21.3 microdeletion involving the SYNGAP1 gene in a patient with intellectual disability, seizures, and severe speech impairment</article-title>. <source/>Am. J. Med. Genet. A
<volume>161</volume>, <fpage>1682</fpage>–<lpage>1685</lpage>. (<pub-id pub-id-type="doi">10.1002/ajmg.a.35930</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C130">
<label>130</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Stülpnagel</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Funke</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Haberl</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hörtnagel</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Jüngling</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Weber</surname><given-names>YG</given-names></name>, <name name-style="western"><surname>Staudt</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kluger</surname><given-names>G</given-names></name></person-group>
<year>2015</year>
<article-title>SYNGAP1 mutation in focal and generalized epilepsy: a literature overview and a case report with special aspects of the EEG</article-title>. <source/>Neuropediatrics
<volume>46</volume>, <fpage>287</fpage>–<lpage>291</lpage>. (<pub-id pub-id-type="doi">10.1055/s-0035-1554098</pub-id>)<pub-id pub-id-type="pmid">26110312</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C131">
<label>131</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lo-Castro</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Curatolo</surname><given-names>P</given-names></name></person-group>
<year>2014</year>
<article-title>Epilepsy associated with autism and attention deficit hyperactivity disorder: is there a genetic link?</article-title>
<source/>Brain Dev.
<volume>36</volume>, <fpage>185</fpage>–<lpage>193</lpage>. (<pub-id pub-id-type="doi">10.1016/j.braindev.2013.04.013</pub-id>)<pub-id pub-id-type="pmid">23726375</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C132">
<label>132</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prchalova</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Havlovicova</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sterbova</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Stranecky</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Hancarova</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sedlacek</surname><given-names>Z</given-names></name></person-group>
<year>2017</year>
<article-title>Analysis of 31-year-old patient with SYNGAP1 gene defect points to importance of variants in broader splice regions and reveals developmental trajectory of SYNGAP1-associated phenotype: case report</article-title>. <source/>BMC Med. Genet.
<volume>18</volume>, <fpage>62</fpage> (<pub-id pub-id-type="doi">10.1186/s12881-017-0425-4</pub-id>)<pub-id pub-id-type="pmid">28576131</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C133">
<label>133</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dyment</surname><given-names>D</given-names></name><etal>et al.</etal></person-group>
<year>2015</year>
<article-title>Whole-exome sequencing broadens the phenotypic spectrum of rare pediatric epilepsy: a retrospective study</article-title>. <source/>Clin. Genet.
<volume>88</volume>, <fpage>34</fpage>–<lpage>40</lpage>. (<pub-id pub-id-type="doi">10.1111/cge.12464</pub-id>)<pub-id pub-id-type="pmid">25046240</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C134">
<label>134</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knuesel</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Elliott</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Mansuy</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>MB</given-names></name></person-group>
<year>2005</year>
<article-title>A role for synGAP in regulating neuronal apoptosis</article-title>. <source/>Eur. J. Neurosci.
<volume>21</volume>, <fpage>611</fpage>–<lpage>621</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1460-9568.2005.03908.x</pub-id>)<pub-id pub-id-type="pmid">15733080</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C135">
<label>135</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carlisle</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Manzerra</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Marcora</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>MB</given-names></name></person-group>
<year>2008</year>
<article-title>SynGAP regulates steady-state and activity-dependent phosphorylation of cofilin</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>13 673</fpage>–<lpage>13 683</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4695-08.2008</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C136">
<label>136</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clement</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Ozkan</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Aceti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Rumbaugh</surname><given-names>G</given-names></name></person-group>
<year>2013</year>
<article-title>SYNGAP1 links the maturation rate of excitatory synapses to the duration of critical-period synaptic plasticity</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>10 447</fpage>–<lpage>10 452</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0765-13.2013</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C137">
<label>137</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheng</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>SH</given-names></name></person-group>
<year>2001</year>
<article-title>AMPA receptor trafficking and the control of synaptic transmission</article-title>. <source/>Cell
<volume>105</volume>, <fpage>825</fpage>–<lpage>828</lpage>. (<pub-id pub-id-type="doi">10.1016/S0092-8674(01)00406-8</pub-id>)<pub-id pub-id-type="pmid">11439178</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C138">
<label>138</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Komiyama</surname><given-names>NH</given-names></name><etal>et al.</etal></person-group>
<year>2002</year>
<article-title>SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor</article-title>. <source/>J. Neurosci.
<volume>22</volume>, <fpage>9721</fpage>–<lpage>9732</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-22-09721.2002</pub-id>)<pub-id pub-id-type="pmid">12427827</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C139">
<label>139</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Norris</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Korol</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>TC</given-names></name></person-group>
<year>1996</year>
<article-title>Increased susceptibility to induction of long-term depression and long-term potentiation reversal during aging</article-title>. <source/>J. Neurosci.
<volume>16</volume>, <fpage>5382</fpage>–<lpage>5392</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-17-05382.1996</pub-id>)<pub-id pub-id-type="pmid">8757251</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C140">
<label>140</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oh</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Manzerra</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>MB</given-names></name></person-group>
<year>2004</year>
<article-title>Regulation of the neuron-specific Ras GTPase activating protein, synGAP, by Ca2+/calmodulin-dependent protein kinase II</article-title>. <source/>J. Biol. Chem.
<volume>279</volume>, <fpage>17 980</fpage>–<lpage>17 988</lpage>.</mixed-citation>
</ref>
<ref id="RSOB180265C141">
<label>141</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rumbaugh</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Huganir</surname><given-names>RL</given-names></name></person-group>
<year>2006</year>
<article-title>SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>103</volume>, <fpage>4344</fpage>–<lpage>4351</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0600084103</pub-id>)<pub-id pub-id-type="pmid">16537406</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C142">
<label>142</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trachtenberg</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Knott</surname><given-names>GW</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Sanes</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Welker</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Svoboda</surname><given-names>K</given-names></name></person-group>
<year>2002</year>
<article-title>Long-term <italic>in vivo</italic> imaging of experience-dependent synaptic plasticity in adult cortex</article-title>. <source/>Nature
<volume>420</volume>, <fpage>788</fpage>–<lpage>794</lpage>. (<pub-id pub-id-type="doi">10.1038/nature01273</pub-id>)<pub-id pub-id-type="pmid">12490942</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C143">
<label>143</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rousseau</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Rouillard</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Morel</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Khandjian</surname><given-names>EW</given-names></name>, <name name-style="western"><surname>Morgan</surname><given-names>K</given-names></name></person-group>
<year>1995</year>
<article-title>Prevalence of carriers of premutation-size alleles of the FMRI gene—and implications for the population genetics of the fragile X syndrome</article-title>. <source/>Am. J. Hum. Genet.
<volume>57</volume>, <fpage>1006</fpage>–<lpage>1018</lpage>.<pub-id pub-id-type="pmid">7485149</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C144">
<label>144</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hersh</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Saul</surname><given-names>RA</given-names></name>, <collab>Committee on Genetics</collab></person-group>
<year>2011</year>
<article-title>Health supervision for children with fragile X syndrome</article-title>. <source/>Pediatrics
<volume>127</volume>, <fpage>994</fpage>–<lpage>1006</lpage>. (<pub-id pub-id-type="doi">10.1542/peds.2010-3500</pub-id>)<pub-id pub-id-type="pmid">21518720</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C145">
<label>145</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Bell</surname><given-names>J</given-names></name></person-group>
<year>1943</year>
<article-title>A pedigree of mental defect showing sex-linkage</article-title>. <source/>J. Neurol. Psychiatry
<volume>6</volume>, <fpage>154</fpage>–<lpage>157</lpage>. (<pub-id pub-id-type="doi">10.1136/jnnp.6.3-4.154</pub-id>)<pub-id pub-id-type="pmid">21611430</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C146">
<label>146</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wijetunge</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Chattarji</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wyllie</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Kind</surname><given-names>PC</given-names></name></person-group>
<year>2013</year>
<article-title>Fragile X syndrome: from targets to treatments</article-title>. <source/>Neuropharmacology
<volume>68</volume>, <fpage>83</fpage>–<lpage>96</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuropharm.2012.11.028</pub-id>)<pub-id pub-id-type="pmid">23257237</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C147">
<label>147</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sherman</surname><given-names>SL</given-names></name><etal>et al.</etal></person-group>
<year>1985</year>
<article-title>Further segregation analysis of the fragile X syndrome with special reference to transmitting males</article-title>. <source/>Hum. Genet.
<volume>69</volume>, <fpage>289</fpage>–<lpage>299</lpage>. (<pub-id pub-id-type="doi">10.1007/BF00291644</pub-id>)<pub-id pub-id-type="pmid">3838733</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C148">
<label>148</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verkerk</surname><given-names>AJ</given-names></name><etal>et al.</etal></person-group>
<year>1991</year>
<article-title>Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome</article-title>. <source/>Cell
<volume>65</volume>, <fpage>905</fpage>–<lpage>914</lpage>. (<pub-id pub-id-type="doi">10.1016/0092-8674(91)90397-h</pub-id>)<pub-id pub-id-type="pmid">1710175</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C149">
<label>149</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sutcliffe</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Pieretti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Caskey</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Saxe</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name></person-group>
<year>1992</year>
<article-title>DNA methylation represses FMR-1 transcription in fragile X syndrome</article-title>. <source/>Hum. Mol. Genet.
<volume>1</volume>, <fpage>397</fpage>–<lpage>400</lpage>. (<pub-id pub-id-type="doi">10.1093/hmg/1.6.397</pub-id>)<pub-id pub-id-type="pmid">1301913</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C150">
<label>150</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>YH</given-names></name><etal>et al.</etal></person-group>
<year>1991</year>
<article-title>Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox</article-title>. <source/>Cell
<volume>67</volume>, <fpage>1047</fpage>–<lpage>1058</lpage>. (<pub-id pub-id-type="doi">10.1016/0092-8674(91)90283-5</pub-id>)<pub-id pub-id-type="pmid">1760838</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C151">
<label>151</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McMurray</surname><given-names>CT</given-names></name></person-group>
<year>2010</year>
<article-title>Mechanisms of trinucleotide repeat instability during human development</article-title>. <source/>Nat. Rev. Genet.
<volume>11</volume>, <fpage>786</fpage>–<lpage>799</lpage>. (<pub-id pub-id-type="doi">10.1038/nrg2828</pub-id>)<pub-id pub-id-type="pmid">20953213</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C152">
<label>152</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hartenstine</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Goodman</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Petruska</surname><given-names>J</given-names></name></person-group>
<year>2000</year>
<article-title>Base stacking and even/odd behavior of hairpin loops in DNA triplet repeat slippage and expansion with DNA polymerase</article-title>. <source/>J. Biol. Chem.
<volume>275</volume>, <fpage>18 382</fpage>–<lpage>18 390</lpage>. (<pub-id pub-id-type="doi">10.1074/jbc.275.24.18382</pub-id>)<pub-id pub-id-type="pmid">10617580</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C153">
<label>153</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oberle</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Rousseau</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Heitz</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kretz</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Devys</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hanauer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Boue</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bertheas</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Mandel</surname><given-names>JL</given-names></name></person-group>
<year>1991</year>
<article-title>Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome</article-title>. <source/>Science
<volume>252</volume>, <fpage>1097</fpage>–<lpage>1102</lpage>. (<pub-id pub-id-type="doi">10.2307/2876286</pub-id>)<pub-id pub-id-type="pmid">2031184</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C154">
<label>154</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coffee</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Reines</surname><given-names>D</given-names></name></person-group>
<year>1999</year>
<article-title>Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells</article-title>. <source/>Nat. Genet.
<volume>22</volume>, <fpage>98</fpage>–<lpage>101</lpage>. (<pub-id pub-id-type="doi">10.1038/8807</pub-id>)<pub-id pub-id-type="pmid">10319871</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C155">
<label>155</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coffee</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ceman</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Reines</surname><given-names>D</given-names></name></person-group>
<year>2002</year>
<article-title>Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile X syndrome</article-title>. <source/>Am. J. Hum. Genet.
<volume>71</volume>, <fpage>923</fpage>–<lpage>932</lpage>. (<pub-id pub-id-type="doi">10.1086/342931</pub-id>)<pub-id pub-id-type="pmid">12232854</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C156">
<label>156</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pieretti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>FP</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Oostra</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Caskey</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>DL</given-names></name></person-group>
<year>1991</year>
<article-title>Absence of expression of the FMR-1 gene in fragile X syndrome</article-title>. <source/>Cell
<volume>66</volume>, <fpage>817</fpage>–<lpage>822</lpage>. (<pub-id pub-id-type="doi">10.1016/0092-8674(91)90125-i</pub-id>)<pub-id pub-id-type="pmid">1878973</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C157">
<label>157</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sutherland</surname><given-names>GR</given-names></name></person-group>
<year>1977</year>
<article-title>Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium</article-title>. <source/>Science
<volume>197</volume>, <fpage>265</fpage>–<lpage>266</lpage>. (<pub-id pub-id-type="doi">10.2307/1744517</pub-id>)<pub-id pub-id-type="pmid">877551</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C158">
<label>158</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heitz</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Devys</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Imbert</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Kretz</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Mandel</surname><given-names>JL</given-names></name></person-group>
<year>1992</year>
<article-title>Inheritance of the fragile X syndrome: size of the fragile X premutation is a major determinant of the transition to full mutation</article-title>. <source/>J. Med. Genet.
<volume>29</volume>, <fpage>794</fpage>–<lpage>801</lpage>. (<pub-id pub-id-type="doi">10.1136/jmg.29.11.794</pub-id>)<pub-id pub-id-type="pmid">1453430</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C159">
<label>159</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jacquemont</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>
<year>2004</year>
<article-title>Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population</article-title>. <source/>JAMA
<volume>291</volume>, <fpage>460</fpage>–<lpage>469</lpage>. (<pub-id pub-id-type="doi">10.1001/jama.291.4.460</pub-id>)<pub-id pub-id-type="pmid">14747503</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C160">
<label>160</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tassone</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Hagerman</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Garcia-Arocena</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Khandjian</surname><given-names>EW</given-names></name>, <name name-style="western"><surname>Greco</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Hagerman</surname><given-names>PJ</given-names></name></person-group>
<year>2004</year>
<article-title>Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome</article-title>. <source/>J. Med. Genet.
<volume>41</volume>, <fpage>e43</fpage> (<pub-id pub-id-type="doi">10.1136/jmg.2003.012518</pub-id>)<pub-id pub-id-type="pmid">15060119</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C161">
<label>161</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santoro</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Bray</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name></person-group>
<year>2012</year>
<article-title>Molecular mechanisms of fragile X syndrome: a twenty-year perspective</article-title>. <source/>Annu. Rev. Pathol.
<volume>7</volume>, <fpage>219</fpage>–<lpage>245</lpage>. (<pub-id pub-id-type="doi">10.1146/annurev-pathol-011811-132457</pub-id>)<pub-id pub-id-type="pmid">22017584</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C162">
<label>162</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sherman</surname><given-names>SL</given-names></name></person-group>
<year>2000</year>
<article-title>Premature ovarian failure in the fragile X syndrome</article-title>. <source/>Am. J. Med. Genet.
<volume>97</volume>, <fpage>189</fpage>–<lpage>194</lpage>. (<pub-id pub-id-type="doi">10.1002/1096-8628(200023)97:3&lt;189::AID-AJMG1036&gt;3.0.CO;2-J</pub-id>)<pub-id pub-id-type="pmid">11449487</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C163">
<label>163</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hagerman</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Hagerman</surname><given-names>PJ</given-names></name></person-group>
<year>2002</year>
<article-title>The fragile X premutation: into the phenotypic fold</article-title>. <source/>Curr. Opin Genet. Dev.
<volume>12</volume>, <fpage>278</fpage>–<lpage>283</lpage>. (<pub-id pub-id-type="doi">10.1016/s0959-437x(02)00299-x</pub-id>)<pub-id pub-id-type="pmid">12076670</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C164">
<label>164</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hagerman</surname><given-names>RJ</given-names></name><etal>et al.</etal></person-group>
<year>2009</year>
<article-title>Advances in the treatment of fragile X syndrome</article-title>. <source/>Pediatrics
<volume>123</volume>, <fpage>378</fpage>–<lpage>390</lpage>. (<pub-id pub-id-type="doi">10.1542/peds.2008-0317</pub-id>)<pub-id pub-id-type="pmid">19117905</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C165">
<label>165</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hagerman</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Amiri</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Cronister</surname><given-names>A</given-names></name></person-group>
<year>1991</year>
<article-title>Fragile X checklist</article-title>. <source/>Am. J. Med. Genet.
<volume>38</volume>, <fpage>283</fpage>–<lpage>287</lpage>. (<pub-id pub-id-type="doi">10.1002/ajmg.1320380223</pub-id>)<pub-id pub-id-type="pmid">2018072</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C166">
<label>166</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bakker</surname><given-names>CE</given-names></name><etal>et al.</etal></person-group>
<year>1994</year>
<article-title>Fmr1 knockout mice: a model to study fragile X mental retardation</article-title>. <source/>Cell
<volume>78</volume>, <fpage>23</fpage>–<lpage>33</lpage>. (<pub-id pub-id-type="doi">10.1016/0092-8674(94)90569-x</pub-id>)<pub-id pub-id-type="pmid">8033209</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C167">
<label>167</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lubs</surname><given-names>HA</given-names></name></person-group>
<year>1969</year>
<article-title>A marker X chromosome</article-title>. <source/>Am. J. Hum. Genet.
<volume>21</volume>, <fpage>231</fpage>–<lpage>244</lpage>.<pub-id pub-id-type="pmid">5794013</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C168">
<label>168</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lubs</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Watson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Breg</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lujan</surname><given-names>E</given-names></name></person-group>
<year>1984</year>
<article-title>Restudy of the original marker X family</article-title>. <source/>Am. J. Med. Genet.
<volume>17</volume>, <fpage>133</fpage>–<lpage>144</lpage>. (<pub-id pub-id-type="doi">10.1002/ajmg.1320170108</pub-id>)<pub-id pub-id-type="pmid">6711592</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C169">
<label>169</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cantu</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Scaglia</surname><given-names>HE</given-names></name>, <name name-style="western"><surname>Medina</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gonzalez-Diddi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Morato</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Moreno</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Perez-Palacios</surname><given-names>G</given-names></name></person-group>
<year>1976</year>
<article-title>Inherited congenital normofunctional testicular hyperplasia and mental deficiency</article-title>. <source/>Hum. Genet.
<volume>33</volume>, <fpage>23</fpage>–<lpage>33</lpage>. (<pub-id pub-id-type="doi">10.1007/bf00447283</pub-id>)<pub-id pub-id-type="pmid">939556</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C170">
<label>170</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mattei</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Mattei</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Aumeras</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Auger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Giraud</surname><given-names>F</given-names></name></person-group>
<year>1981</year>
<article-title>X-linked mental retardation with the fragile X. A study of 15 families</article-title>. <source/>Hum. Genet.
<volume>59</volume>, <fpage>281</fpage>–<lpage>289</lpage>. (<pub-id pub-id-type="doi">10.1007/bf00295459</pub-id>)<pub-id pub-id-type="pmid">7333582</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C171">
<label>171</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davids</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Hagerman</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Eilert</surname><given-names>RE</given-names></name></person-group>
<year>1990</year>
<article-title>Orthopaedic aspects of fragile-X syndrome</article-title>. <source/>J. Bone Joint Surg. Am.
<volume>72</volume>, <fpage>889</fpage>–<lpage>896</lpage>. (<pub-id pub-id-type="doi">10.2106/00004623-199072060-00015</pub-id>)<pub-id pub-id-type="pmid">2195034</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C172">
<label>172</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paradee</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Melikian</surname><given-names>HE</given-names></name>, <name name-style="western"><surname>Rasmussen</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Kenneson</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Conn</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name></person-group>
<year>1999</year>
<article-title>Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function</article-title>. <source/>Neuroscience
<volume>94</volume>, <fpage>185</fpage>–<lpage>192</lpage>. (<pub-id pub-id-type="doi">10.1016/s0306-4522(99)00285-7</pub-id>)<pub-id pub-id-type="pmid">10613508</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C173">
<label>173</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Sethna</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H</given-names></name></person-group>
<year>2014</year>
<article-title>Behavioral analysis of male and female Fmr1 knockout mice on C57BL/6 background</article-title>. <source/>Behav. Brain Res.
<volume>271</volume>, <fpage>72</fpage>–<lpage>78</lpage>. (<pub-id pub-id-type="doi">10.1016/j.bbr.2014.05.046</pub-id>)<pub-id pub-id-type="pmid">24886775</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C174">
<label>174</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Toyoda</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ko</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Zhuo</surname><given-names>M</given-names></name></person-group>
<year>2005</year>
<article-title>Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome</article-title>. <source/>J. Neurosci.
<volume>25</volume>, <fpage>7385</fpage>–<lpage>7392</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1520-05.2005</pub-id>)<pub-id pub-id-type="pmid">16093389</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C175">
<label>175</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dobkin</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rabe</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dumas</surname><given-names>R</given-names></name>, <name name-style="western"><surname>El Idrissi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Haubenstock</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>WT</given-names></name></person-group>
<year>2000</year>
<article-title>Fmr1 knockout mouse has a distinctive strain-specific learning impairment</article-title>. <source/>Neuroscience
<volume>100</volume>, <fpage>423</fpage>–<lpage>429</lpage>. (<pub-id pub-id-type="doi">10.1016/s0306-4522(00)00292-x</pub-id>)<pub-id pub-id-type="pmid">11008180</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C176">
<label>176</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Dam</surname><given-names>D</given-names></name>, <name name-style="western"><surname>D'Hooge</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hauben</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Reyniers</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gantois</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Bakker</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Oostra</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Kooy</surname><given-names>RF</given-names></name>, <name name-style="western"><surname>De Deyn</surname><given-names>PP</given-names></name></person-group>
<year>2000</year>
<article-title>Spatial learning, contextual fear conditioning and conditioned emotional response in Fmr1 knockout mice</article-title>. <source/>Behav. Brain Res.
<volume>117</volume>, <fpage>127</fpage>–<lpage>136</lpage>. (<pub-id pub-id-type="doi">10.1016/s0166-4328(00)00296-5</pub-id>)<pub-id pub-id-type="pmid">11099766</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C177">
<label>177</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kooy</surname><given-names>RF</given-names></name><etal>et al.</etal></person-group>
<year>1996</year>
<article-title>Transgenic mouse model for the fragile X syndrome</article-title>. <source/>Am. J. Med. Genet.
<volume>64</volume>, <fpage>241</fpage>–<lpage>245</lpage>. (<pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19960809)64:2&lt;241::AID-AJMG1&gt;3.0.CO;2-X</pub-id>)<pub-id pub-id-type="pmid">8844056</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C178">
<label>178</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ventura</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Pascucci</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Catania</surname><given-names>MV</given-names></name>, <name name-style="western"><surname>Musumeci</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Puglisi-Allegra</surname><given-names>S</given-names></name></person-group>
<year>2004</year>
<article-title>Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex</article-title>. <source/>Behav. Pharmacol.
<volume>15</volume>, <fpage>A28</fpage> (<pub-id pub-id-type="doi">10.1097/00008877-200409000-00107</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C179">
<label>179</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>King</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Jope</surname><given-names>RS</given-names></name></person-group>
<year>2013</year>
<article-title>Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome</article-title>. <source/>Genes Brain Behav.
<volume>12</volume>, <fpage>723</fpage>–<lpage>731</lpage>. (<pub-id pub-id-type="doi">10.1111/gbb.12071</pub-id>)<pub-id pub-id-type="pmid">23941202</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C180">
<label>180</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veeraragavan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bui</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Perkins</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Yuva-Paylor</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Carpenter</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Paylor</surname><given-names>R</given-names></name></person-group>
<year>2011</year>
<article-title>Modulation of behavioral phenotypes by a muscarinic M1 antagonist in a mouse model of fragile X syndrome</article-title>. <source/>Psychopharmacology (Berl.)
<volume>217</volume>, <fpage>143</fpage>–<lpage>151</lpage>. (<pub-id pub-id-type="doi">10.1007/s00213-011-2276-6</pub-id>)<pub-id pub-id-type="pmid">21487657</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C181">
<label>181</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michalon</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sidorov</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ballard</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Ozmen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Spooren</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Wettstein</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Jaeschke</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Bear</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Lindemann</surname><given-names>L</given-names></name></person-group>
<year>2012</year>
<article-title>Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice</article-title>. <source/>Neuron
<volume>74</volume>, <fpage>49</fpage>–<lpage>56</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2012.03.009</pub-id>)<pub-id pub-id-type="pmid">22500629</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C182">
<label>182</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dolen</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Osterweil</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Rao</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>GB</given-names></name>, <name name-style="western"><surname>Auerbach</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Chattarji</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bear</surname><given-names>MF</given-names></name></person-group>
<year>2007</year>
<article-title>Correction of fragile X syndrome in mice</article-title>. <source/>Neuron
<volume>56</volume>, <fpage>955</fpage>–<lpage>962</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2007.12.001</pub-id>)<pub-id pub-id-type="pmid">18093519</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C183">
<label>183</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peier</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>McIlwain</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Kenneson</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Paylor</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>DL</given-names></name></person-group>
<year>2000</year>
<article-title>(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features</article-title>. <source/>Hum. Mol. Genet.
<volume>9</volume>, <fpage>1145</fpage>–<lpage>1159</lpage>. (<pub-id pub-id-type="doi">10.1093/hmg/9.8.1145</pub-id>)<pub-id pub-id-type="pmid">10767339</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C184">
<label>184</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spencer</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Alekseyenko</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Serysheva</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Yuva-Paylor</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Paylor</surname><given-names>R</given-names></name></person-group>
<year>2005</year>
<article-title>Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome</article-title>. <source/>Genes Brain Behav.
<volume>4</volume>, <fpage>420</fpage>–<lpage>430</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1601-183X.2005.00123.x</pub-id>)<pub-id pub-id-type="pmid">16176388</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C185">
<label>185</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mineur</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Sluyter</surname><given-names>F</given-names></name>, <name name-style="western"><surname>de Wit</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Oostra</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Crusio</surname><given-names>WE</given-names></name></person-group>
<year>2002</year>
<article-title>Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse</article-title>. <source/>Hippocampus
<volume>12</volume>, <fpage>39</fpage>–<lpage>46</lpage>. (<pub-id pub-id-type="doi">10.1002/hipo.10005</pub-id>)<pub-id pub-id-type="pmid">11918286</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C186">
<label>186</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McNaughton</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Moon</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Strawderman</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Maclean</surname><given-names>KN</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Strupp</surname><given-names>BJ</given-names></name></person-group>
<year>2008</year>
<article-title>Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome</article-title>. <source/>Behav. Neurosci.
<volume>122</volume>, <fpage>293</fpage>–<lpage>300</lpage>. (<pub-id pub-id-type="doi">10.1037/0735-7044.122.2.293</pub-id>)<pub-id pub-id-type="pmid">18410169</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C187">
<label>187</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dahlhaus</surname><given-names>R</given-names></name>, <name name-style="western"><surname>El-Husseini</surname><given-names>A</given-names></name></person-group>
<year>2010</year>
<article-title>Altered neuroligin expression is involved in social deficits in a mouse model of the fragile X syndrome</article-title>. <source/>Behav. Brain Res.
<volume>208</volume>, <fpage>96</fpage>–<lpage>105</lpage>. (<pub-id pub-id-type="doi">10.1016/j.bbr.2009.11.019</pub-id>)<pub-id pub-id-type="pmid">19932134</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C188">
<label>188</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rotschafer</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Trujillo</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Dansie</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Ethell</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Razak</surname><given-names>KA</given-names></name></person-group>
<year>2012</year>
<article-title>Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of fragile X syndrome</article-title>. <source/>Brain Res.
<volume>1439</volume>, <fpage>7</fpage>–<lpage>14</lpage>. (<pub-id pub-id-type="doi">10.1016/j.brainres.2011.12.041</pub-id>)<pub-id pub-id-type="pmid">22265702</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C189">
<label>189</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roy</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Watkins</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Heck</surname><given-names>D</given-names></name></person-group>
<year>2012</year>
<article-title>Comprehensive analysis of ultrasonic vocalizations in a mouse model of fragile X syndrome reveals limited, call type specific deficits</article-title>. <source/>PLoS ONE
<volume>7</volume>, <fpage>e44816</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pone.0044816</pub-id>)<pub-id pub-id-type="pmid">22984567</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C190">
<label>190</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Musumeci</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Ferri</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Elia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Colognola</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Bergonzi</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Tassinari</surname><given-names>CA</given-names></name></person-group>
<year>1991</year>
<article-title>Epilepsy and fragile X syndrome: a follow-up study</article-title>. <source/>Am. J. Med. Genet.
<volume>38</volume>, <fpage>511</fpage>–<lpage>513</lpage>. (<pub-id pub-id-type="doi">10.1002/ajmg.1320380276</pub-id>)<pub-id pub-id-type="pmid">2018098</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C191">
<label>191</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Musumeci</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Bosco</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Calabrese</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Bakker</surname><given-names>C</given-names></name>, <name name-style="western"><surname>De Sarro</surname><given-names>GB</given-names></name>, <name name-style="western"><surname>Elia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ferri</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Oostra</surname><given-names>BA</given-names></name></person-group>
<year>2000</year>
<article-title>Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome</article-title>. <source/>Epilepsia
<volume>41</volume>, <fpage>19</fpage>–<lpage>23</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1528-1157.2000.tb01499.x</pub-id>)<pub-id pub-id-type="pmid">10643918</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C192">
<label>192</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paylor</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Yuva-Paylor</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Spencer</surname><given-names>CM</given-names></name></person-group>
<year>2008</year>
<article-title>Reversal of sensorimotor gating abnormalities in Fmr1 knockout mice carrying a human Fmr1 transgene</article-title>. <source/>Behav. Neurosci.
<volume>122</volume>, <fpage>1371</fpage>–<lpage>1377</lpage>. (<pub-id pub-id-type="doi">10.1037/a0013047</pub-id>)<pub-id pub-id-type="pmid">19045956</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C193">
<label>193</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pietropaolo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Guilleminot</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>B</given-names></name>, <name name-style="western"><surname>D'Amato</surname><given-names>FR</given-names></name>, <name name-style="western"><surname>Crusio</surname><given-names>WE</given-names></name></person-group>
<year>2011</year>
<article-title>Genetic-background modulation of core and variable autistic-like symptoms in Fmr1 knock-out mice</article-title>. <source/>PLoS ONE
<volume>6</volume>, <fpage>e17073</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pone.0017073</pub-id>)<pub-id pub-id-type="pmid">21364941</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C194">
<label>194</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spencer</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Alekseyenko</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Hamilton</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Serysheva</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Yuva-Paylor</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Paylor</surname><given-names>R</given-names></name></person-group>
<year>2011</year>
<article-title>Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses</article-title>. <source/>Autism Res.
<volume>4</volume>, <fpage>40</fpage>–<lpage>56</lpage>. (<pub-id pub-id-type="doi">10.1002/aur.168</pub-id>)<pub-id pub-id-type="pmid">21268289</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C195">
<label>195</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kazdoba</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Leach</surname><given-names>PT</given-names></name>, <name name-style="western"><surname>Silverman</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Crawley</surname><given-names>JN</given-names></name></person-group>
<year>2014</year>
<article-title>Modeling fragile X syndrome in the Fmr1 knockout mouse</article-title>. <source/>Intractable Rare Dis. Res.
<volume>3</volume>, <fpage>118</fpage>–<lpage>133</lpage>. (<pub-id pub-id-type="doi">10.5582/irdr.2014.01024</pub-id>)<pub-id pub-id-type="pmid">25606362</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C196">
<label>196</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Melancia</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Trezza</surname><given-names>V</given-names></name></person-group>
<year>2018</year>
<article-title>Modelling fragile X syndrome in the laboratory setting: a behavioral perspective</article-title>. <source/>Behav. Brain Res.
<volume>350</volume>, <fpage>149</fpage>–<lpage>163</lpage>. (<pub-id pub-id-type="doi">10.1016/j.bbr.2018.04.042</pub-id>)<pub-id pub-id-type="pmid">29704597</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C197">
<label>197</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alvarez</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Sabatini</surname><given-names>BL</given-names></name></person-group>
<year>2007</year>
<article-title>Anatomical and physiological plasticity of dendritic spines</article-title>. <source/>Annu. Rev. Neurosci.
<volume>30</volume>, <fpage>79</fpage>–<lpage>97</lpage>. (<pub-id pub-id-type="doi">10.1146/annurev.neuro.30.051606.094222</pub-id>)<pub-id pub-id-type="pmid">17280523</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C198">
<label>198</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zuo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gan</surname><given-names>WB</given-names></name></person-group>
<year>2005</year>
<article-title>Development of long-term dendritic spine stability in diverse regions of cerebral cortex</article-title>. <source/>Neuron
<volume>46</volume>, <fpage>181</fpage>–<lpage>189</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2005.04.001</pub-id>)<pub-id pub-id-type="pmid">15848798</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C199">
<label>199</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roberts</surname><given-names>TF</given-names></name>, <name name-style="western"><surname>Tschida</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Mooney</surname><given-names>R</given-names></name></person-group>
<year>2010</year>
<article-title>Rapid spine stabilization and synaptic enhancement at the onset of behavioural learning</article-title>. <source/>Nature
<volume>463</volume>, <fpage>948</fpage>–<lpage>952</lpage>. (<pub-id pub-id-type="doi">10.1038/nature08759</pub-id>)<pub-id pub-id-type="pmid">20164928</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C200">
<label>200</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rudelli</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>WT</given-names></name>, <name name-style="western"><surname>Wisniewski</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Jenkins</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Laure-Kamionowska</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Connell</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Wisniewski</surname><given-names>HM</given-names></name></person-group>
<year>1985</year>
<article-title>Adult fragile X syndrome. Clinico-neuropathologic findings</article-title>. <source/>Acta Neuropathol.
<volume>67</volume>, <fpage>289</fpage>–<lpage>295</lpage>. (<pub-id pub-id-type="doi">10.1007/BF00687814</pub-id>)<pub-id pub-id-type="pmid">4050344</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C201">
<label>201</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Irwin</surname><given-names>SA</given-names></name><etal>et al.</etal></person-group>
<year>2001</year>
<article-title>Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination</article-title>. <source/>Am. J. Med. Genet.
<volume>98</volume>, <fpage>161</fpage>–<lpage>167</lpage>. (<pub-id pub-id-type="doi">10.1002/1096-8628(20010115)98:2&lt;161::aid-ajmg1025&gt;3.0.co;2-b</pub-id>)<pub-id pub-id-type="pmid">11223852</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C202">
<label>202</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grossman</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Aldridge</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Weiler</surname><given-names>IJ</given-names></name>, <name name-style="western"><surname>Greenough</surname><given-names>WT</given-names></name></person-group>
<year>2006</year>
<article-title>Local protein synthesis and spine morphogenesis: fragile X syndrome and beyond</article-title>. <source/>J. Neurosci.
<volume>26</volume>, <fpage>7151</fpage>–<lpage>7155</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1790-06.2006</pub-id>)<pub-id pub-id-type="pmid">16822971</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C203">
<label>203</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Comery</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Willems</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Oostra</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Irwin</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Weiler</surname><given-names>IJ</given-names></name>, <name name-style="western"><surname>Greenough</surname><given-names>WT</given-names></name></person-group>
<year>1997</year>
<article-title>Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>94</volume>, <fpage>5401</fpage>–<lpage>5404</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.94.10.5401</pub-id>)<pub-id pub-id-type="pmid">9144249</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C204">
<label>204</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galvez</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gopal</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Greenough</surname><given-names>WT</given-names></name></person-group>
<year>2003</year>
<article-title>Somatosensory cortical barrel dendritic abnormalities in a mouse model of the fragile X mental retardation syndrome</article-title>. <source/>Brain Res.
<volume>971</volume>, <fpage>83</fpage>–<lpage>89</lpage>. (<pub-id pub-id-type="doi">10.1016/s0006-8993(03)02363-1</pub-id>)<pub-id pub-id-type="pmid">12691840</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C205">
<label>205</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cruz-Martin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Crespo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Portera-Cailliau</surname><given-names>C</given-names></name></person-group>
<year>2010</year>
<article-title>Delayed stabilization of dendritic spines in fragile X mice</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>7793</fpage>–<lpage>7803</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0577-10.2010</pub-id>)<pub-id pub-id-type="pmid">20534828</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C206">
<label>206</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Aldridge</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Greenough</surname><given-names>WT</given-names></name>, <name name-style="western"><surname>Gan</surname><given-names>WB</given-names></name></person-group>
<year>2010</year>
<article-title>Dendritic spine instability and insensitivity to modulation by sensory experience in a mouse model of fragile X syndrome</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>107</volume>, <fpage>17 768</fpage>–<lpage>17 773</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1012496107</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C207">
<label>207</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antar</surname><given-names>LN</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Carroll</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Bassell</surname><given-names>GJ</given-names></name></person-group>
<year>2006</year>
<article-title>Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses</article-title>. <source/>Mol. Cell. Neurosci.
<volume>32</volume>, <fpage>37</fpage>–<lpage>48</lpage>. (<pub-id pub-id-type="doi">10.1016/j.mcn.2006.02.001</pub-id>)<pub-id pub-id-type="pmid">16631377</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C208">
<label>208</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huber</surname><given-names>K</given-names></name></person-group>
<year>2007</year>
<article-title>Fragile X syndrome: molecular mechanisms of cognitive dysfunction</article-title>. <source/>Am. J. Psychiatry.
<volume>164</volume>, <fpage>556</fpage> (<pub-id pub-id-type="doi">10.1176/ajp.2007.164.4.556</pub-id>)<pub-id pub-id-type="pmid">17403966</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C209">
<label>209</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pfeiffer</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Huber</surname><given-names>KM</given-names></name></person-group>
<year>2007</year>
<article-title>Fragile X mental retardation protein induces synapse loss through acute postsynaptic translational regulation</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>3120</fpage>–<lpage>3130</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0054-07.2007</pub-id>)<pub-id pub-id-type="pmid">17376973</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C210">
<label>210</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braun</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Segal</surname><given-names>M</given-names></name></person-group>
<year>2000</year>
<article-title>FMRP involvement in formation of synapses among cultured hippocampal neurons</article-title>. <source/>Cereb. Cortex.
<volume>10</volume>, <fpage>1045</fpage>–<lpage>1052</lpage>. (<pub-id pub-id-type="doi">10.1093/cercor/10.10.1045</pub-id>)<pub-id pub-id-type="pmid">11007555</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C211">
<label>211</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pilpel</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kolleker</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Berberich</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ginger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Frick</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mientjes</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Oostra</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Seeburg</surname><given-names>PH</given-names></name></person-group>
<year>2009</year>
<article-title>Synaptic ionotropic glutamate receptors and plasticity are developmentally altered in the CA1 field of Fmr1 knockout mice</article-title>. <source/>J. Physiol.
<volume>587</volume>, <fpage>787</fpage>–<lpage>804</lpage>. (<pub-id pub-id-type="doi">10.1113/jphysiol.2008.160929</pub-id>)<pub-id pub-id-type="pmid">19103683</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C212">
<label>212</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huber</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Kayser</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Bear</surname><given-names>MF</given-names></name></person-group>
<year>2000</year>
<article-title>Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression</article-title>. <source/>Science
<volume>288</volume>, <fpage>1254</fpage>–<lpage>1257</lpage>. (<pub-id pub-id-type="doi">10.1126/science.288.5469.1254</pub-id>)<pub-id pub-id-type="pmid">10818003</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C213">
<label>213</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huber</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Gallagher</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Bear</surname><given-names>MF</given-names></name></person-group>
<year>2002</year>
<article-title>Altered synaptic plasticity in a mouse model of fragile X mental retardation</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>99</volume>, <fpage>7746</fpage>–<lpage>7750</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.122205699</pub-id>)<pub-id pub-id-type="pmid">12032354</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C214">
<label>214</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>YY</given-names></name>, <name name-style="western"><surname>Kandel</surname><given-names>ER</given-names></name></person-group>
<year>2005</year>
<article-title>Theta frequency stimulation induces a local form of late phase LTP in the CA1 region of the hippocampus</article-title>. <source/>Learn. Mem.
<volume>12</volume>, <fpage>587</fpage>–<lpage>593</lpage>. (<pub-id pub-id-type="doi">10.1101/lm.98905</pub-id>)<pub-id pub-id-type="pmid">16287724</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C215">
<label>215</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>YY</given-names></name>, <name name-style="western"><surname>Kandel</surname><given-names>ER</given-names></name></person-group>
<year>2005</year>
<article-title>Theta frequency stimulation up-regulates the synaptic strength of the pathway from CA1 to subiculum region of hippocampus</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>102</volume>, <fpage>232</fpage>–<lpage>237</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0408368102</pub-id>)<pub-id pub-id-type="pmid">15623558</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C216">
<label>216</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Mercaldo</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zhuo</surname><given-names>M</given-names></name></person-group>
<year>2009</year>
<article-title>Fragile X mental retardation protein is required for chemically-induced long-term potentiation of the hippocampus in adult mice</article-title>. <source/>J. Neurochem.
<volume>111</volume>, <fpage>635</fpage>–<lpage>646</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06314.x</pub-id>)<pub-id pub-id-type="pmid">19659572</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C217">
<label>217</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Qin</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Bochorishvili</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>van Aelst</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>JJ</given-names></name></person-group>
<year>2008</year>
<article-title>Ras signaling mechanisms underlying impaired GluR1-dependent plasticity associated with fragile X syndrome</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>7847</fpage>–<lpage>7862</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1496-08.2008</pub-id>)<pub-id pub-id-type="pmid">18667617</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C218">
<label>218</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lauterborn</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Rex</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Kramar</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>LY</given-names></name>, <name name-style="western"><surname>Pandyarajan</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Lynch</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Gall</surname><given-names>CM</given-names></name></person-group>
<year>2007</year>
<article-title>Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>10 685</fpage>–<lpage>10 694</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2624-07.2007</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C219">
<label>219</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soden</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L</given-names></name></person-group>
<year>2010</year>
<article-title>Fragile X protein FMRP is required for homeostatic plasticity and regulation of synaptic strength by retinoic acid</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>16 910</fpage>–<lpage>16 921</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3660-10.2010</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C220">
<label>220</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><etal>et al.</etal></person-group>
<year>2018</year>
<article-title>The fragile X mutation impairs homeostatic plasticity in human neurons by blocking synaptic retinoic acid signaling</article-title>. <source/>Sci. Transl. Med.
<volume>10</volume>, <fpage>eaar4338</fpage> (<pub-id pub-id-type="doi">10.1126/scitranslmed.aar4338</pub-id>)<pub-id pub-id-type="pmid">30068571</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C221">
<label>221</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><etal>et al.</etal></person-group>
<year>2008</year>
<article-title>FMRP acts as a key messenger for dopamine modulation in the forebrain</article-title>. <source/>Neuron
<volume>59</volume>, <fpage>634</fpage>–<lpage>647</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2008.06.027</pub-id>)<pub-id pub-id-type="pmid">18760699</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C222">
<label>222</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Qi</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>H</given-names></name></person-group>
<year>2018</year>
<article-title>Impaired GABA neural circuits are critical for fragile X syndrome</article-title>. <source/>Neural Plast.
<volume>2018</volume>, <fpage>8423420</fpage> (<pub-id pub-id-type="doi">10.1155/2018/8423420</pub-id>)<pub-id pub-id-type="pmid">30402088</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C223">
<label>223</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Centonze</surname><given-names>D</given-names></name><etal>et al.</etal></person-group>
<year>2008</year>
<article-title>Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome</article-title>. <source/>Biol. Psychiatry.
<volume>63</volume>, <fpage>963</fpage>–<lpage>973</lpage>. (<pub-id pub-id-type="doi">10.1016/j.biopsych.2007.09.008</pub-id>)<pub-id pub-id-type="pmid">18028882</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C224">
<label>224</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gibson</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Bartley</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Hays</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Huber</surname><given-names>KM</given-names></name></person-group>
<year>2008</year>
<article-title>Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome</article-title>. <source/>J. Neurophysiol.
<volume>100</volume>, <fpage>2615</fpage>–<lpage>2626</lpage>. (<pub-id pub-id-type="doi">10.1152/jn.90752.2008</pub-id>)<pub-id pub-id-type="pmid">18784272</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C225">
<label>225</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Curia</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Papouin</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Seguela</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Avoli</surname><given-names>M</given-names></name></person-group>
<year>2009</year>
<article-title>Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome</article-title>. <source/>Cereb. Cortex.
<volume>19</volume>, <fpage>1515</fpage>–<lpage>1520</lpage>. (<pub-id pub-id-type="doi">10.1093/cercor/bhn159</pub-id>)<pub-id pub-id-type="pmid">18787232</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C226">
<label>226</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tyzio</surname><given-names>R</given-names></name><etal>et al.</etal></person-group>
<year>2014</year>
<article-title>Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring</article-title>. <source/>Science
<volume>343</volume>, <fpage>675</fpage>–<lpage>679</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1247190</pub-id>)<pub-id pub-id-type="pmid">24503856</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C227">
<label>227</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Contractor</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Klyachko</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Portera-Cailliau</surname><given-names>C</given-names></name></person-group>
<year>2015</year>
<article-title>Altered neuronal and circuit excitability in fragile X syndrome</article-title>. <source/>Neuron
<volume>87</volume>, <fpage>699</fpage>–<lpage>715</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2015.06.017</pub-id>)<pub-id pub-id-type="pmid">26291156</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C228">
<label>228</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doll</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Vita</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Broadie</surname><given-names>K</given-names></name></person-group>
<year>2017</year>
<article-title>Fragile X mental retardation protein requirements in activity-dependent critical period neural circuit refinement</article-title>. <source/>Curr. Biol.
<volume>27</volume>, <fpage>2318</fpage>–<lpage>2330 e2313</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cub.2017.06.046</pub-id>)<pub-id pub-id-type="pmid">28756946</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C229">
<label>229</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gibboni</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kirkhart</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bao</surname><given-names>S</given-names></name></person-group>
<year>2013</year>
<article-title>Impaired critical period plasticity in primary auditory cortex of fragile X model mice</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>15 686</fpage>–<lpage>15 692</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3246-12.2013</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C230">
<label>230</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Devys</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Lutz</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Rouyer</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Bellocq</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Mandel</surname><given-names>JL</given-names></name></person-group>
<year>1993</year>
<article-title>The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation</article-title>. <source/>Nat. Genet.
<volume>4</volume>, <fpage>335</fpage>–<lpage>340</lpage>. (<pub-id pub-id-type="doi">10.1038/ng0893-335</pub-id>)<pub-id pub-id-type="pmid">8401578</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C231">
<label>231</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ashley</surname><given-names>CT</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Wilkinson</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Reines</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name></person-group>
<year>1993</year>
<article-title>FMR1 protein: conserved RNP family domains and selective RNA binding</article-title>. <source/>Science
<volume>262</volume>, <fpage>563</fpage>–<lpage>566</lpage>. (<pub-id pub-id-type="doi">10.1126/science.7692601</pub-id>)<pub-id pub-id-type="pmid">7692601</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C232">
<label>232</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siomi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Siomi</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Nussbaum</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Dreyfuss</surname><given-names>G</given-names></name></person-group>
<year>1993</year>
<article-title>The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein</article-title>. <source/>Cell
<volume>74</volume>, <fpage>291</fpage>–<lpage>298</lpage>. (<pub-id pub-id-type="doi">10.1016/0092-8674(93)90420-u</pub-id>)<pub-id pub-id-type="pmid">7688265</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C233">
<label>233</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khandjian</surname><given-names>EW</given-names></name>, <name name-style="western"><surname>Corbin</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Woerly</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rousseau</surname><given-names>F</given-names></name></person-group>
<year>1996</year>
<article-title>The fragile X mental retardation protein is associated with ribosomes</article-title>. <source/>Nat. Genet.
<volume>12</volume>, <fpage>91</fpage>–<lpage>93</lpage>. (<pub-id pub-id-type="doi">10.1038/ng0196-91</pub-id>)<pub-id pub-id-type="pmid">8528261</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C234">
<label>234</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Darnell</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Jensen</surname><given-names>KB</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Darnell</surname><given-names>RB</given-names></name></person-group>
<year>2001</year>
<article-title>Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function</article-title>. <source/>Cell
<volume>107</volume>, <fpage>489</fpage>–<lpage>499</lpage>. (<pub-id pub-id-type="doi">10.1016/S0092-8674(01)00566-9</pub-id>)<pub-id pub-id-type="pmid">11719189</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C235">
<label>235</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Darnell</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Fraser</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Mostovetsky</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Stefani</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Eddy</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Darnell</surname><given-names>RB</given-names></name></person-group>
<year>2005</year>
<article-title>Kissing complex RNAs mediate interaction between the fragile-X mental retardation protein KH2 domain and brain polyribosomes</article-title>. <source/>Genes Dev.
<volume>19</volume>, <fpage>903</fpage>–<lpage>918</lpage>. (<pub-id pub-id-type="doi">10.1101/gad.1276805</pub-id>)<pub-id pub-id-type="pmid">15805463</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C236">
<label>236</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schaeffer</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bardoni</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Mandel</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Ehresmann</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ehresmann</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Moine</surname><given-names>H</given-names></name></person-group>
<year>2001</year>
<article-title>The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif</article-title>. <source/>EMBO J.
<volume>20</volume>, <fpage>4803</fpage>–<lpage>4813</lpage>. (<pub-id pub-id-type="doi">10.1093/emboj/20.17.4803</pub-id>)<pub-id pub-id-type="pmid">11532944</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C237">
<label>237</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Darnell</surname><given-names>JC</given-names></name><etal>et al.</etal></person-group>
<year>2011</year>
<article-title>FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism</article-title>. <source/>Cell
<volume>146</volume>, <fpage>247</fpage>–<lpage>261</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2011.06.013</pub-id>)<pub-id pub-id-type="pmid">21784246</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C238">
<label>238</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Napoli</surname><given-names>I</given-names></name><etal>et al.</etal></person-group>
<year>2008</year>
<article-title>The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP</article-title>. <source/>Cell
<volume>134</volume>, <fpage>1042</fpage>–<lpage>1054</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2008.07.031</pub-id>)<pub-id pub-id-type="pmid">18805096</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C239">
<label>239</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caudy</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Myers</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hannon</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Hammond</surname><given-names>SM</given-names></name></person-group>
<year>2002</year>
<article-title>Fragile X-related protein and VIG associate with the RNA interference machinery</article-title>. <source/>Genes Dev.
<volume>16</volume>, <fpage>2491</fpage>–<lpage>2496</lpage>. (<pub-id pub-id-type="doi">10.1101/gad.1025202</pub-id>)<pub-id pub-id-type="pmid">12368260</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C240">
<label>240</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ishizuka</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Siomi</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Siomi</surname><given-names>H</given-names></name></person-group>
<year>2002</year>
<article-title>A drosophila fragile X protein interacts with components of RNAi and ribosomal proteins</article-title>. <source/>Genes Dev.
<volume>16</volume>, <fpage>2497</fpage>–<lpage>2508</lpage>. (<pub-id pub-id-type="doi">10.1101/gad.1022002</pub-id>)<pub-id pub-id-type="pmid">12368261</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C241">
<label>241</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plante</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Davidovic</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ouellet</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Gobeil</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Tremblay</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Khandjian</surname><given-names>EW</given-names></name>, <name name-style="western"><surname>Provost</surname><given-names>P</given-names></name></person-group>
<year>2006</year>
<article-title>Dicer-derived microRNAs are utilized by the fragile X mental retardation protein for assembly on target RNAs</article-title>. <source/>J. Biomed. Biotechnol.
<volume>2006</volume>, <fpage>64347</fpage> (<pub-id pub-id-type="doi">10.1155/JBB/2006/64347</pub-id>)<pub-id pub-id-type="pmid">17057366</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C242">
<label>242</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graf</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>SX</given-names></name>, <name name-style="western"><surname>Linhoff</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Craig</surname><given-names>AM</given-names></name></person-group>
<year>2004</year>
<article-title>Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins</article-title>. <source/>Cell
<volume>119</volume>, <fpage>1013</fpage>–<lpage>1026</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2004.11.035</pub-id>)<pub-id pub-id-type="pmid">15620359</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C243">
<label>243</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eberhart</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Malter</surname><given-names>HE</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name></person-group>
<year>1996</year>
<article-title>The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals</article-title>. <source/>Hum. Mol. Genet.
<volume>5</volume>, <fpage>1083</fpage>–<lpage>1091</lpage>. (<pub-id pub-id-type="doi">10.1093/hmg/5.8.1083</pub-id>)<pub-id pub-id-type="pmid">8842725</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C244">
<label>244</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bramham</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Wells</surname><given-names>DG</given-names></name></person-group>
<year>2007</year>
<article-title>Dendritic mRNA: transport, translation and function</article-title>. <source/>Nat. Rev. Neurosci.
<volume>8</volume>, <fpage>776</fpage>–<lpage>789</lpage>. (<pub-id pub-id-type="doi">10.1038/nrn2150</pub-id>)<pub-id pub-id-type="pmid">17848965</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C245">
<label>245</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maurer-Stroh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dickens</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Hughes-Davies</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Kouzarides</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Eisenhaber</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ponting</surname><given-names>CP</given-names></name></person-group>
<year>2003</year>
<article-title>The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains</article-title>. <source/>Trends Biochem. Sci.
<volume>28</volume>, <fpage>69</fpage>–<lpage>74</lpage>. (<pub-id pub-id-type="doi">10.1016/S0968-0004(03)00004-5</pub-id>)<pub-id pub-id-type="pmid">12575993</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C246">
<label>246</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adams-Cioaba</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Bian</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Amaya</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Lam</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wasney</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Vedadi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Min</surname><given-names>J</given-names></name></person-group>
<year>2010</year>
<article-title>Structural studies of the tandem Tudor domains of fragile X mental retardation related proteins FXR1 and FXR2</article-title>. <source/>PLoS ONE
<volume>5</volume>, <fpage>e13559</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pone.0013559</pub-id>)<pub-id pub-id-type="pmid">21072162</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C247">
<label>247</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bassell</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name></person-group>
<year>2008</year>
<article-title>Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function</article-title>. <source/>Neuron
<volume>60</volume>, <fpage>201</fpage>–<lpage>214</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2008.10.004</pub-id>)<pub-id pub-id-type="pmid">18957214</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C248">
<label>248</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ceman</surname><given-names>S</given-names></name>, <name name-style="western"><surname>O'Donnell</surname><given-names>WT</given-names></name>, <name name-style="western"><surname>Reed</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Patton</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pohl</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name></person-group>
<year>2003</year>
<article-title>Phosphorylation influences the translation state of FMRP-associated polyribosomes</article-title>. <source/>Hum. Mol. Genet.
<volume>12</volume>, <fpage>3295</fpage>–<lpage>3305</lpage>. (<pub-id pub-id-type="doi">10.1093/hmg/ddg350</pub-id>)<pub-id pub-id-type="pmid">14570712</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C249">
<label>249</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muddashetty</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Nalavadi</surname><given-names>VC</given-names></name>, <name name-style="western"><surname>Gross</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Laur</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Bassell</surname><given-names>GJ</given-names></name></person-group>
<year>2011</year>
<article-title>Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling</article-title>. <source/>Mol. Cell.
<volume>42</volume>, <fpage>673</fpage>–<lpage>688</lpage>. (<pub-id pub-id-type="doi">10.1016/j.molcel.2011.05.006</pub-id>)<pub-id pub-id-type="pmid">21658607</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C250">
<label>250</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Narayanan</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Nalavadi</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Nakamoto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pallas</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Ceman</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bassell</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name></person-group>
<year>2007</year>
<article-title>FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>14 349</fpage>–<lpage>14 357</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2969-07.2007</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C251">
<label>251</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheever</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ceman</surname><given-names>S</given-names></name></person-group>
<year>2009</year>
<article-title>Phosphorylation of FMRP inhibits association with dicer</article-title>. <source/>RNA
<volume>15</volume>, <fpage>362</fpage>–<lpage>366</lpage>. (<pub-id pub-id-type="doi">10.1261/rna.1500809</pub-id>)<pub-id pub-id-type="pmid">19155329</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C252">
<label>252</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakamoto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nalavadi</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Epstein</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Narayanan</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Bassell</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name></person-group>
<year>2007</year>
<article-title>Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>104</volume>, <fpage>15 537</fpage>–<lpage>15 542</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0707484104</pub-id>)<pub-id pub-id-type="pmid">17182746</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C253">
<label>253</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Narayanan</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Nalavadi</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Nakamoto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Ceman</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bassell</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name></person-group>
<year>2008</year>
<article-title>S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade</article-title>. <source/>J. Biol. Chem.
<volume>283</volume>, <fpage>18 478</fpage>–<lpage>18 482</lpage>. (<pub-id pub-id-type="doi">10.1074/jbc.C800055200</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C254">
<label>254</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hoeffer</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Takayasu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Miyawaki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>McBride</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Klann</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Zukin</surname><given-names>RS</given-names></name></person-group>
<year>2010</year>
<article-title>Dysregulation of mTOR signaling in fragile X syndrome</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>694</fpage>–<lpage>702</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3696-09.2010</pub-id>)<pub-id pub-id-type="pmid">20071534</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C255">
<label>255</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bear</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Huber</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>ST</given-names></name></person-group>
<year>2004</year>
<article-title>The mGluR theory of fragile X mental retardation</article-title>. <source/>Trends Neurosci.
<volume>27</volume>, <fpage>370</fpage>–<lpage>377</lpage>. (<pub-id pub-id-type="doi">10.1016/j.tins.2004.04.009</pub-id>)<pub-id pub-id-type="pmid">15219735</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C256">
<label>256</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harlow</surname><given-names>EG</given-names></name>, <name name-style="western"><surname>Till</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Russell</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Wijetunge</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Kind</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Contractor</surname><given-names>A</given-names></name></person-group>
<year>2010</year>
<article-title>Critical period plasticity is disrupted in the barrel cortex of FMR1 knockout mice</article-title>. <source/>Neuron
<volume>65</volume>, <fpage>385</fpage>–<lpage>398</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2010.01.024</pub-id>)<pub-id pub-id-type="pmid">20159451</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C257">
<label>257</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nimchinsky</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Oberlander</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Svoboda</surname><given-names>K</given-names></name></person-group>
<year>2001</year>
<article-title>Abnormal development of dendritic spines in FMR1 knock-out mice</article-title>. <source/>J. Neurosci.
<volume>21</volume>, <fpage>5139</fpage>–<lpage>5146</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-14-05139.2001</pub-id>)<pub-id pub-id-type="pmid">11438589</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C258">
<label>258</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galvez</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Greenough</surname><given-names>WT</given-names></name></person-group>
<year>2005</year>
<article-title>Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome</article-title>. <source/>Am. J. Med. Genet. A
<volume>135</volume>, <fpage>155</fpage>–<lpage>160</lpage>. (<pub-id pub-id-type="doi">10.1002/ajmg.a.30709</pub-id>)<pub-id pub-id-type="pmid">15880753</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C259">
<label>259</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frenkel</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Bear</surname><given-names>MF</given-names></name></person-group>
<year>2004</year>
<article-title>How monocular deprivation shifts ocular dominance in visual cortex of young mice</article-title>. <source/>Neuron
<volume>44</volume>, <fpage>917</fpage>–<lpage>923</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2004.12.003</pub-id>)<pub-id pub-id-type="pmid">15603735</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C260">
<label>260</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pacala</surname><given-names>SW</given-names></name><etal>et al.</etal></person-group>
<year>2001</year>
<article-title>Consistent land- and atmosphere-based U.S. carbon sink estimates</article-title>. <source/>Science
<volume>292</volume>, <fpage>2316</fpage>–<lpage>2320</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1057320</pub-id>)<pub-id pub-id-type="pmid">11423659</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C261">
<label>261</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amir</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Van den Veyver</surname><given-names>IB</given-names></name>, <name name-style="western"><surname>Wan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tran</surname><given-names>CQ</given-names></name>, <name name-style="western"><surname>Francke</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Zoghbi</surname><given-names>HY</given-names></name></person-group>
<year>1999</year>
<article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</article-title>. <source/>Nat. Genet.
<volume>23</volume>, <fpage>185</fpage>–<lpage>188</lpage>. (<pub-id pub-id-type="doi">10.1038/13810</pub-id>)<pub-id pub-id-type="pmid">10508514</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C262">
<label>262</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shibayama</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>
<year>2004</year>
<article-title>MECP2 structural and 3'-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism</article-title>. <source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
<volume>128B</volume>, <fpage>50</fpage>–<lpage>53</lpage>. (<pub-id pub-id-type="doi">10.1002/ajmg.b.30016</pub-id>)<pub-id pub-id-type="pmid">15211631</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C263">
<label>263</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campos</surname><given-names>M</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Abdalla</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>dos Santos</surname><given-names>AV</given-names></name>, <name name-style="western"><surname>Pestana</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>dos Santos</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Santos-Reboucas</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Pimentel</surname><given-names>MM</given-names></name></person-group>
<year>2009</year>
<article-title>A MECP2 mutation in a highly conserved aminoacid causing mental retardation in a male</article-title>. <source/>Brain Dev.
<volume>31</volume>, <fpage>176</fpage>–<lpage>178</lpage>. (<pub-id pub-id-type="doi">10.1016/j.braindev.2008.07.001</pub-id>)<pub-id pub-id-type="pmid">18678449</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C264">
<label>264</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reichwald</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Thiesen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wiehe</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Weitzel</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Poustka</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Rosenthal</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Platzer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Stratling</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Kioschis</surname><given-names>P</given-names></name></person-group>
<year>2000</year>
<article-title>Comparative sequence analysis of the MECP2-locus in human and mouse reveals new transcribed regions</article-title>. <source/>Mamm. Genome.
<volume>11</volume>, <fpage>182</fpage>–<lpage>190</lpage>. (<pub-id pub-id-type="doi">10.1007/s003350010035</pub-id>)<pub-id pub-id-type="pmid">10723722</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C265">
<label>265</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coy</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Sedlacek</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Bachner</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Delius</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Poustka</surname><given-names>A</given-names></name></person-group>
<year>1999</year>
<article-title>A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3′-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression</article-title>. <source/>Hum. Mol. Genet.
<volume>8</volume>, <fpage>1253</fpage>–<lpage>1262</lpage>. (<pub-id pub-id-type="doi">10.1093/hmg/8.7.1253</pub-id>)<pub-id pub-id-type="pmid">10369871</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C266">
<label>266</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hagberg</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Aicardi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Dias</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ramos</surname><given-names>O</given-names></name></person-group>
<year>1983</year>
<article-title>A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases</article-title>. <source/>Ann. Neurol.
<volume>14</volume>, <fpage>471</fpage>–<lpage>479</lpage>. (<pub-id pub-id-type="doi">10.1002/ana.410140412</pub-id>)<pub-id pub-id-type="pmid">6638958</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C267">
<label>267</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schonewolf-Greulich</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Stahlhut</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Larsen</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Syhler</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bisgaard</surname><given-names>AM</given-names></name></person-group>
<year>2017</year>
<article-title>Functional abilities in aging women with Rett syndrome—the Danish cohort</article-title>. <source/>Disabil. Rehabil.
<volume>39</volume>, <fpage>911</fpage>–<lpage>918</lpage>. (<pub-id pub-id-type="doi">10.3109/09638288.2016.1170896</pub-id>)<pub-id pub-id-type="pmid">27206693</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C268">
<label>268</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parisi</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Di Filippo</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Roccella</surname><given-names>M</given-names></name></person-group>
<year>2016</year>
<article-title>The quality of life in girls with Rett syndrome</article-title>. <source/>Ment Illn.
<volume>8</volume>, <fpage>6302</fpage> (<pub-id pub-id-type="doi">10.4081/mi.2016.6302</pub-id>)<pub-id pub-id-type="pmid">27403274</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C269">
<label>269</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>RZ</given-names></name>, <name name-style="western"><surname>Akbarian</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tudor</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jaenisch</surname><given-names>R</given-names></name></person-group>
<year>2001</year>
<article-title>Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice</article-title>. <source/>Nat. Genet.
<volume>27</volume>, <fpage>327</fpage>–<lpage>331</lpage>. (<pub-id pub-id-type="doi">10.1038/85906</pub-id>)<pub-id pub-id-type="pmid">11242118</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C270">
<label>270</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moretti</surname><given-names>P</given-names></name><etal>et al.</etal></person-group>
<year>2006</year>
<article-title>Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome</article-title>. <source/>J. Neurosci.
<volume>26</volume>, <fpage>319</fpage>–<lpage>327</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2623-05.2006</pub-id>)<pub-id pub-id-type="pmid">16399702</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C271">
<label>271</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gemelli</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Berton</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Perrotti</surname><given-names>LI</given-names></name>, <name name-style="western"><surname>Jaenisch</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Monteggia</surname><given-names>LM</given-names></name></person-group>
<year>2006</year>
<article-title>Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice</article-title>. <source/>Biol. Psychiatry.
<volume>59</volume>, <fpage>468</fpage>–<lpage>476</lpage>. (<pub-id pub-id-type="doi">10.1016/j.biopsych.2005.07.025</pub-id>)<pub-id pub-id-type="pmid">16199017</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C272">
<label>272</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahbazian</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yuva-Paylor</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Spencer</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Antalffy</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Noebels</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Armstrong</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Paylor</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zoghbi</surname><given-names>H</given-names></name></person-group>
<year>2002</year>
<article-title>Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3</article-title>. <source/>Neuron
<volume>35</volume>, <fpage>243</fpage>–<lpage>254</lpage>. (<pub-id pub-id-type="doi">10.1016/S0896-6273(02)00768-7</pub-id>)<pub-id pub-id-type="pmid">12160743</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C273">
<label>273</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Armstrong</surname><given-names>DD</given-names></name></person-group>
<year>2002</year>
<article-title>Neuropathology of Rett syndrome</article-title>. <source/>Ment. Retard. Dev. Disabil. Res. Rev.
<volume>8</volume>, <fpage>72</fpage>–<lpage>76</lpage>. (<pub-id pub-id-type="doi">10.1002/mrdd.10027</pub-id>)<pub-id pub-id-type="pmid">12112730</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C274">
<label>274</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chapleau</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Calfa</surname><given-names>GD</given-names></name>, <name name-style="western"><surname>Lane</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Albertson</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Larimore</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Kudo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Armstrong</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Percy</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Pozzo-Miller</surname><given-names>L</given-names></name></person-group>
<year>2009</year>
<article-title>Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations</article-title>. <source/>Neurobiol. Dis.
<volume>35</volume>, <fpage>219</fpage>–<lpage>233</lpage>. (<pub-id pub-id-type="doi">10.1016/j.nbd.2009.05.001</pub-id>)<pub-id pub-id-type="pmid">19442733</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C275">
<label>275</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kishi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Macklis</surname><given-names>JD</given-names></name></person-group>
<year>2004</year>
<article-title>MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions</article-title>. <source/>Mol. Cell. Neurosci.
<volume>27</volume>, <fpage>306</fpage>–<lpage>321</lpage>. (<pub-id pub-id-type="doi">10.1016/j.mcn.2004.07.006</pub-id>)<pub-id pub-id-type="pmid">15519245</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C276">
<label>276</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Z</given-names></name><etal>et al.</etal></person-group>
<year>2006</year>
<article-title>Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation</article-title>. <source/>Neuron
<volume>52</volume>, <fpage>255</fpage>–<lpage>269</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2006.09.037</pub-id>)<pub-id pub-id-type="pmid">17046689</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C277">
<label>277</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nelson</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Kavalali</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>Monteggia</surname><given-names>LM</given-names></name></person-group>
<year>2006</year>
<article-title>MeCP2-dependent transcriptional repression regulates excitatory neurotransmission</article-title>. <source/>Curr. Biol.
<volume>16</volume>, <fpage>710</fpage>–<lpage>716</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cub.2006.02.062</pub-id>)<pub-id pub-id-type="pmid">16581518</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C278">
<label>278</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chao</surname><given-names>HT</given-names></name>, <name name-style="western"><surname>Zoghbi</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Rosenmund</surname><given-names>C</given-names></name></person-group>
<year>2007</year>
<article-title>MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number</article-title>. <source/>Neuron
<volume>56</volume>, <fpage>58</fpage>–<lpage>65</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2007.08.018</pub-id>)<pub-id pub-id-type="pmid">17920015</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C279">
<label>279</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asaka</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Jugloff</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Eubanks</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Fitzsimonds</surname><given-names>RM</given-names></name></person-group>
<year>2006</year>
<article-title>Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome</article-title>. <source/>Neurobiol. Dis.
<volume>21</volume>, <fpage>217</fpage>–<lpage>227</lpage>. (<pub-id pub-id-type="doi">10.1016/j.nbd.2005.07.005</pub-id>)<pub-id pub-id-type="pmid">16087343</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C280">
<label>280</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Collins</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Levenson</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Vilaythong</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Richman</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Armstrong</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Noebels</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Sweatt</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Zoghbi</surname><given-names>HY</given-names></name></person-group>
<year>2004</year>
<article-title>Mild overexpression of MeCP2 causes a progressive neurological disorder in mice</article-title>. <source/>Hum. Mol. Genet.
<volume>13</volume>, <fpage>2679</fpage>–<lpage>2689</lpage>. (<pub-id pub-id-type="doi">10.1093/hmg/ddh282</pub-id>)<pub-id pub-id-type="pmid">15351775</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C281">
<label>281</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nan</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Laherty</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Eisenman</surname><given-names>RN</given-names></name>, <name name-style="western"><surname>Bird</surname><given-names>A</given-names></name></person-group>
<year>1998</year>
<article-title>Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex</article-title>. <source/>Nature
<volume>393</volume>, <fpage>386</fpage>–<lpage>389</lpage>. (<pub-id pub-id-type="doi">10.1038/30764</pub-id>)<pub-id pub-id-type="pmid">9620804</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C282">
<label>282</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fuks</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Hurd</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Nan</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Bird</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Kouzarides</surname><given-names>T</given-names></name></person-group>
<year>2003</year>
<article-title>The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation</article-title>. <source/>J. Biol. Chem.
<volume>278</volume>, <fpage>4035</fpage>–<lpage>4040</lpage>. (<pub-id pub-id-type="doi">10.1074/jbc.M210256200</pub-id>)<pub-id pub-id-type="pmid">12427740</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C283">
<label>283</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Free</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wakefield</surname><given-names>RI</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>BO</given-names></name>, <name name-style="western"><surname>Dryden</surname><given-names>DT</given-names></name>, <name name-style="western"><surname>Barlow</surname><given-names>PN</given-names></name>, <name name-style="western"><surname>Bird</surname><given-names>AP</given-names></name></person-group>
<year>2001</year>
<article-title>DNA recognition by the methyl-CpG binding domain of MeCP2</article-title>. <source/>J. Biol. Chem.
<volume>276</volume>, <fpage>3353</fpage>–<lpage>3360</lpage>. (<pub-id pub-id-type="doi">10.1074/jbc.M007224200</pub-id>)<pub-id pub-id-type="pmid">11035019</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C284">
<label>284</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>WG</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Meissner</surname><given-names>A</given-names></name>, <name name-style="western"><surname>West</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Griffith</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Jaenisch</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Greenberg</surname><given-names>ME</given-names></name></person-group>
<year>2003</year>
<article-title>Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2</article-title>. <source/>Science
<volume>302</volume>, <fpage>885</fpage>–<lpage>889</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1086446</pub-id>)<pub-id pub-id-type="pmid">14593183</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C285">
<label>285</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martinowich</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hattori</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Fouse</surname><given-names>S</given-names></name>, <name name-style="western"><surname>He</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>YE</given-names></name></person-group>
<year>2003</year>
<article-title>DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation</article-title>. <source/>Science
<volume>302</volume>, <fpage>890</fpage>–<lpage>893</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1090842</pub-id>)<pub-id pub-id-type="pmid">14593184</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C286">
<label>286</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horike</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Miyano</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Kohwi-Shigematsu</surname><given-names>T</given-names></name></person-group>
<year>2005</year>
<article-title>Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome</article-title>. <source/>Nat. Genet.
<volume>37</volume>, <fpage>31</fpage>–<lpage>40</lpage>. (<pub-id pub-id-type="doi">10.1038/ng1491</pub-id>)<pub-id pub-id-type="pmid">15608638</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C287">
<label>287</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jordan</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Kwan</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Francke</surname><given-names>U</given-names></name></person-group>
<year>2007</year>
<article-title>Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets</article-title>. <source/>BMC Med. Genet.
<volume>8</volume>, <fpage>36</fpage> (<pub-id pub-id-type="doi">10.1186/1471-2350-8-36</pub-id>)<pub-id pub-id-type="pmid">17584923</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C288">
<label>288</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harikrishnan</surname><given-names>KN</given-names></name><etal>et al.</etal></person-group>
<year>2005</year>
<article-title>Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing</article-title>. <source/>Nat. Genet.
<volume>37</volume>, <fpage>254</fpage>–<lpage>264</lpage>. (<pub-id pub-id-type="doi">10.1038/ng1516</pub-id>)<pub-id pub-id-type="pmid">15696166</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C289">
<label>289</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nan</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Hou</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Maclean</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nasir</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lafuente</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Shu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Kriaucionis</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bird</surname><given-names>A</given-names></name></person-group>
<year>2007</year>
<article-title>Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>104</volume>, <fpage>2709</fpage>–<lpage>2714</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0608056104</pub-id>)<pub-id pub-id-type="pmid">17296936</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C290">
<label>290</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lewis</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Meehan</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Henzel</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Maurer-Fogy</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Jeppesen</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Bird</surname><given-names>A</given-names></name></person-group>
<year>1992</year>
<article-title>Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA</article-title>. <source/>Cell
<volume>69</volume>, <fpage>905</fpage>–<lpage>914</lpage>. (<pub-id pub-id-type="doi">10.1016/0092-8674(92)90610-O</pub-id>)<pub-id pub-id-type="pmid">1606614</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C291">
<label>291</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nan</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Tate</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bird</surname><given-names>A</given-names></name></person-group>
<year>1996</year>
<article-title>DNA methylation specifies chromosomal localization of MeCP2</article-title>. <source/>Mol. Cell. Biol.
<volume>16</volume>, <fpage>414</fpage>–<lpage>421</lpage>. (<pub-id pub-id-type="doi">10.1128/MCB.16.1.414</pub-id>)<pub-id pub-id-type="pmid">8524323</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C292">
<label>292</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Saxena</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Christodoulou</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ravine</surname><given-names>D</given-names></name></person-group>
<year>2008</year>
<article-title>MECP2 genomic structure and function: insights from ENCODE</article-title>. <source/>Nucleic Acids Res.
<volume>36</volume>, <fpage>6035</fpage>–<lpage>6047</lpage>. (<pub-id pub-id-type="doi">10.1093/nar/gkn591</pub-id>)<pub-id pub-id-type="pmid">18820302</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C293">
<label>293</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guy</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cheval</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Selfridge</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bird</surname><given-names>A</given-names></name></person-group>
<year>2011</year>
<article-title>The role of MeCP2 in the brain</article-title>. <source/>Annu. Rev. Cell Dev. Biol.
<volume>27</volume>, <fpage>631</fpage>–<lpage>652</lpage>. (<pub-id pub-id-type="doi">10.1146/annurev-cellbio-092910-154121</pub-id>)<pub-id pub-id-type="pmid">21721946</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C294">
<label>294</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>MVC</given-names></name>, <name name-style="western"><surname>Karten</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Felice</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Mandel</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Ballas</surname><given-names>N</given-names></name></person-group>
<year>2016</year>
<article-title>Acute and crucial requirement for MeCP2 function upon transition from early to late adult stages of brain maturation</article-title>. <source/>Hum. Mol. Genet.
<volume>25</volume>, <fpage>1690</fpage>–<lpage>1702</lpage>. (<pub-id pub-id-type="doi">10.1093/hmg/ddw038</pub-id>)<pub-id pub-id-type="pmid">26908602</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C295">
<label>295</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>TL</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>XJ</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>YD</given-names></name>, <name name-style="western"><surname>Shu</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>ZL</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>XH</given-names></name></person-group>
<year>2014</year>
<article-title>Conditional deletion of Mecp2 in parvalbumin-expressing GABAergic cells results in the absence of critical period plasticity</article-title>. <source/>Nat. Commun.
<volume>5</volume>, <fpage>5036</fpage> (<pub-id pub-id-type="doi">10.1038/ncomms6036</pub-id>)<pub-id pub-id-type="pmid">25297674</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C296">
<label>296</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monteiro</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>G</given-names></name></person-group>
<year>2017</year>
<article-title>SHANK proteins: roles at the synapse and in autism spectrum disorder</article-title>. <source/>Nat. Rev. Neurosci.
<volume>18</volume>, <fpage>147</fpage>–<lpage>157</lpage>. (<pub-id pub-id-type="doi">10.1038/nrn.2016.183</pub-id>)<pub-id pub-id-type="pmid">28179641</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C297">
<label>297</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naisbitt</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Tu</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Sala</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Valtschanoff</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Weinberg</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Worley</surname><given-names>PF</given-names></name>, <name name-style="western"><surname>Sheng</surname><given-names>M</given-names></name></person-group>
<year>1999</year>
<article-title>Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin</article-title>. <source/>Neuron
<volume>23</volume>, <fpage>569</fpage>–<lpage>582</lpage>. (<pub-id pub-id-type="doi">10.1016/S0896-6273(00)80809-0</pub-id>)<pub-id pub-id-type="pmid">10433268</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C298">
<label>298</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Durand</surname><given-names>CM</given-names></name><etal>et al.</etal></person-group>
<year>2007</year>
<article-title>Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders</article-title>. <source/>Nat. Genet.
<volume>39</volume>, <fpage>25</fpage>–<lpage>27</lpage>. (<pub-id pub-id-type="doi">10.1038/ng1933</pub-id>)<pub-id pub-id-type="pmid">17173049</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C299">
<label>299</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soorya</surname><given-names>L</given-names></name><etal>et al.</etal></person-group>
<year>2013</year>
<article-title>Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency</article-title>. <source/>Mol. Autism
<volume>4</volume>, <fpage>18</fpage> (<pub-id pub-id-type="doi">10.1186/2040-2392-4-18</pub-id>)<pub-id pub-id-type="pmid">23758760</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C300">
<label>300</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leblond</surname><given-names>CS</given-names></name><etal>et al.</etal></person-group>
<year>2014</year>
<article-title>Meta-analysis of SHANK mutations in autism spectrum disorders: a gradient of severity in cognitive impairments</article-title>. <source/>PLoS Genet.
<volume>10</volume>, <fpage>e1004580</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pgen.1004580</pub-id>)<pub-id pub-id-type="pmid">25188300</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C301">
<label>301</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silverman</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Barkan</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Tolu</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Saxena</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hung</surname><given-names>AY</given-names></name>, <name name-style="western"><surname>Sheng</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Crawley</surname><given-names>JN</given-names></name></person-group>
<year>2011</year>
<article-title>Sociability and motor functions in Shank1 mutant mice</article-title>. <source/>Brain Res.
<volume>1380</volume>, <fpage>120</fpage>–<lpage>137</lpage>. (<pub-id pub-id-type="doi">10.1016/j.brainres.2010.09.026</pub-id>)<pub-id pub-id-type="pmid">20868654</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C302">
<label>302</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hung</surname><given-names>AY</given-names></name><etal>et al.</etal></person-group>
<year>2008</year>
<article-title>Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>1697</fpage>–<lpage>1708</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3032-07.2008</pub-id>)<pub-id pub-id-type="pmid">18272690</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C303">
<label>303</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Won</surname><given-names>H</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function</article-title>. <source/>Nature
<volume>486</volume>, <fpage>261</fpage>–<lpage>265</lpage>. (<pub-id pub-id-type="doi">10.1038/nature11208</pub-id>)<pub-id pub-id-type="pmid">22699620</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C304">
<label>304</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmeisser</surname><given-names>MJ</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2</article-title>. <source/>Nature
<volume>486</volume>, <fpage>256</fpage>–<lpage>260</lpage>. (<pub-id pub-id-type="doi">10.1038/nature11015</pub-id>)<pub-id pub-id-type="pmid">22699619</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C305">
<label>305</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice</article-title>. <source/>J. Neurosci.
<volume>32</volume>, <fpage>6525</fpage>–<lpage>6541</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.6107-11.2012</pub-id>)<pub-id pub-id-type="pmid">22573675</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C306">
<label>306</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roussignol</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Ango</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Romorini</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tu</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Sala</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Worley</surname><given-names>PF</given-names></name>, <name name-style="western"><surname>Bockaert</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Fagni</surname><given-names>L</given-names></name></person-group>
<year>2005</year>
<article-title>Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons</article-title>. <source/>J. Neurosci.
<volume>25</volume>, <fpage>3560</fpage>–<lpage>3570</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4354-04.2005</pub-id>)<pub-id pub-id-type="pmid">15814786</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C307">
<label>307</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verpelli</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>
<year>2011</year>
<article-title>Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses</article-title>. <source/>J. Biol. Chem.
<volume>286</volume>, <fpage>34 839</fpage>–<lpage>34 850</lpage>. (<pub-id pub-id-type="doi">10.1074/jbc.M111.258384</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C308">
<label>308</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grabrucker</surname><given-names>AM</given-names></name></person-group>
<year>2014</year>
<article-title>A role for synaptic zinc in ProSAP/Shank PSD scaffold malformation in autism spectrum disorders</article-title>. <source/>Dev. Neurobiol.
<volume>74</volume>, <fpage>136</fpage>–<lpage>146</lpage>. (<pub-id pub-id-type="doi">10.1002/dneu.22089</pub-id>)<pub-id pub-id-type="pmid">23650259</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C309">
<label>309</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheng</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>E</given-names></name></person-group>
<year>2000</year>
<article-title>The Shank family of scaffold proteins</article-title>. <source/>J. Cell Sci.
<volume>113</volume>(<issue>Pt 11</issue>), <fpage>1851</fpage>–<lpage>1856</lpage>.<pub-id pub-id-type="pmid">10806096</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C310">
<label>310</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheng</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>E</given-names></name></person-group>
<year>2011</year>
<article-title>The postsynaptic organization of synapses</article-title>. <source/>Cold Spring Harb. Perspect. Biol.
<volume>3</volume>, <fpage>a005678</fpage> (<pub-id pub-id-type="doi">10.1101/cshperspect.a005678</pub-id>)<pub-id pub-id-type="pmid">22046028</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C311">
<label>311</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Ehlers</surname><given-names>MD</given-names></name></person-group>
<year>2013</year>
<article-title>Modeling autism by SHANK gene mutations in mice</article-title>. <source/>Neuron
<volume>78</volume>, <fpage>8</fpage>–<lpage>27</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2013.03.016</pub-id>)<pub-id pub-id-type="pmid">23583105</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C312">
<label>312</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Kreienkamp</surname><given-names>HJ</given-names></name></person-group>
<year>2008</year>
<article-title>Scaffolding proteins at the postsynaptic density: shank as the architectural framework</article-title>. In <source/>Protein–protein interactions as new drug targets (eds <person-group person-group-type="editor"><name name-style="western"><surname>Klussmann</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>J</given-names></name></person-group>), pp. <fpage>365</fpage>–<lpage>380</lpage>. <comment>Handbook of Experimental Pharmacology, vol. 186.</comment>
<publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer</publisher-name>.</mixed-citation>
</ref>
<ref id="RSOB180265C313">
<label>313</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Shaw</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Dawson</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Dugas</surname><given-names>DV</given-names></name>, <name name-style="western"><surname>Al-Mohtaseb</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Hill</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Zoghbi</surname><given-names>HY</given-names></name></person-group>
<year>2011</year>
<article-title>Protein interactome reveals converging molecular pathways among autism disorders</article-title>. <source/>Sci. Transl. Med.
<volume>3</volume>, <fpage>86ra49</fpage> (<pub-id pub-id-type="doi">10.1126/scitranslmed.3002166</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C314">
<label>314</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tu</surname><given-names>JC</given-names></name><etal>et al.</etal></person-group>
<year>1999</year>
<article-title>Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins</article-title>. <source/>Neuron
<volume>23</volume>, <fpage>583</fpage>–<lpage>592</lpage>. (<pub-id pub-id-type="doi">10.1016/s0896-6273(00)80810-7</pub-id>)<pub-id pub-id-type="pmid">10433269</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C315">
<label>315</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>Altered mGluR5-Homer scaffolds and corticostriatal connectivity in a Shank3 complete knockout model of autism</article-title>. <source/>Nat. Commun.
<volume>7</volume>, <fpage>11459</fpage> (<pub-id pub-id-type="doi">10.1038/ncomms11459</pub-id>)<pub-id pub-id-type="pmid">27161151</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C316">
<label>316</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Tatavarty</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Torrado Pacheco</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Miska</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Hengen</surname><given-names>KB</given-names></name>, <name name-style="western"><surname>Wagner</surname><given-names>FF</given-names></name>, <name name-style="western"><surname>Turrigiano</surname><given-names>GG</given-names></name></person-group>
<year>2018</year>
<comment>Autism-associated Shank3 is essential for homeostatic plasticity and neuronal circuit stability. <italic>bioRxiv</italic></comment>
<fpage>365445</fpage> (<pub-id pub-id-type="doi">10.1101/365445</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C317">
<label>317</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mei</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Monteiro</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>G</given-names></name></person-group>
<year>2016</year>
<article-title>Adult restoration of Shank3 expression rescues selective autistic-like phenotypes</article-title>. <source/>Nature
<volume>530</volume>, <fpage>481</fpage>–<lpage>484</lpage>. (<pub-id pub-id-type="doi">10.1038/nature16971</pub-id>)<pub-id pub-id-type="pmid">26886798</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C318">
<label>318</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ichtchenko</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hata</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ullrich</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Missler</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Moomaw</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name></person-group>
<year>1995</year>
<article-title>Neuroligin 1: a splice site-specific ligand for beta-neurexins</article-title>. <source/>Cell
<volume>81</volume>, <fpage>435</fpage>–<lpage>443</lpage>. (<pub-id pub-id-type="doi">10.1016/0092-8674(95)90396-8</pub-id>)<pub-id pub-id-type="pmid">7736595</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C319">
<label>319</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ichtchenko</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name></person-group>
<year>1996</year>
<article-title>Structures, alternative splicing, and neurexin binding of multiple neuroligins</article-title>. <source/>J. Biol. Chem.
<volume>271</volume>, <fpage>2676</fpage>–<lpage>2682</lpage>. (<pub-id pub-id-type="doi">10.1074/jbc.271.5.2676</pub-id>)<pub-id pub-id-type="pmid">8576240</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C320">
<label>320</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ushkaryov</surname><given-names>YA</given-names></name>, <name name-style="western"><surname>Hata</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ichtchenko</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Moomaw</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Afendis</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Slaughter</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name></person-group>
<year>1994</year>
<article-title>Conserved domain structure of beta-neurexins. Unusual cleaved signal sequences in receptor-like neuronal cell-surface proteins</article-title>. <source/>J. Biol. Chem.
<volume>269</volume>, <fpage>11 987</fpage>–<lpage>11 992</lpage>.</mixed-citation>
</ref>
<ref id="RSOB180265C321">
<label>321</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ushkaryov</surname><given-names>YA</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name></person-group>
<year>1993</year>
<article-title>Neurexin III alpha: extensive alternative splicing generates membrane-bound and soluble forms</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>90</volume>, <fpage>6410</fpage>–<lpage>6414</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.90.14.6410</pub-id>)<pub-id pub-id-type="pmid">8341647</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C322">
<label>322</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ushkaryov</surname><given-names>YA</given-names></name>, <name name-style="western"><surname>Petrenko</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Geppert</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name></person-group>
<year>1992</year>
<article-title>Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin</article-title>. <source/>Science
<volume>257</volume>, <fpage>50</fpage>–<lpage>56</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1621094</pub-id>)<pub-id pub-id-type="pmid">1621094</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C323">
<label>323</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Ichtchenko</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Brose</surname><given-names>N</given-names></name></person-group>
<year>1999</year>
<article-title>Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>96</volume>, <fpage>1100</fpage>–<lpage>1105</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.96.3.1100</pub-id>)<pub-id pub-id-type="pmid">9927700</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C324">
<label>324</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siddiqui</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Pancaroglu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Rooyakkers</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Craig</surname><given-names>AM</given-names></name></person-group>
<year>2010</year>
<article-title>LRRTMs and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>7495</fpage>–<lpage>7506</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0470-10.2010</pub-id>)<pub-id pub-id-type="pmid">20519524</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C325">
<label>325</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Philibert</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Winfield</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Sandhu</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Ginns</surname><given-names>EI</given-names></name></person-group>
<year>2000</year>
<article-title>The structure and expression of the human neuroligin-3 gene</article-title>. <source/>Gene
<volume>246</volume>, <fpage>303</fpage>–<lpage>310</lpage>. (<pub-id pub-id-type="doi">10.1016/S0378-1119(00)00049-4</pub-id>)<pub-id pub-id-type="pmid">10767552</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C326">
<label>326</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bolliger</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Frei</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Winterhalter</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Gloor</surname><given-names>SM</given-names></name></person-group>
<year>2001</year>
<article-title>Identification of a novel neuroligin in humans which binds to PSD-95 and has a widespread expression</article-title>. <source/>Biochem. J.
<volume>356</volume>, <fpage>581</fpage>–<lpage>588</lpage>. (<pub-id pub-id-type="doi">10.1042/bj3560581</pub-id>)<pub-id pub-id-type="pmid">11368788</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C327">
<label>327</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Varoqueaux</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Jamain</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Brose</surname><given-names>N</given-names></name></person-group>
<year>2004</year>
<article-title>Neuroligin 2 is exclusively localized to inhibitory synapses</article-title>. <source/>Eur. J. Cell Biol.
<volume>83</volume>, <fpage>449</fpage>–<lpage>456</lpage>. (<pub-id pub-id-type="doi">10.1078/0171-9335-00410</pub-id>)<pub-id pub-id-type="pmid">15540461</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C328">
<label>328</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoon</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>
<year>2011</year>
<article-title>Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>108</volume>, <fpage>3053</fpage>–<lpage>3058</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1006946108</pub-id>)<pub-id pub-id-type="pmid">21282647</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C329">
<label>329</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Budreck</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Scheiffele</surname><given-names>P</given-names></name></person-group>
<year>2007</year>
<article-title>Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses</article-title>. <source/>Eur. J. Neurosci.
<volume>26</volume>, <fpage>1738</fpage>–<lpage>1748</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1460-9568.2007.05842.x</pub-id>)<pub-id pub-id-type="pmid">17897391</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C330">
<label>330</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Irie</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hata</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Takeuchi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ichtchenko</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Toyoda</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hirao</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Takai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Rosahl</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name></person-group>
<year>1997</year>
<article-title>Binding of neuroligins to PSD-95</article-title>. <source/>Science
<volume>277</volume>, <fpage>1511</fpage>–<lpage>1515</lpage>. (<pub-id pub-id-type="doi">10.1126/science.277.5331.1511</pub-id>)<pub-id pub-id-type="pmid">9278515</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C331">
<label>331</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meyer</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Varoqueaux</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Neeb</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Oschlies</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Brose</surname><given-names>N</given-names></name></person-group>
<year>2004</year>
<article-title>The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin</article-title>. <source/>Neuropharmacology
<volume>47</volume>, <fpage>724</fpage>–<lpage>733</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuropharm.2004.06.023</pub-id>)<pub-id pub-id-type="pmid">15458844</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C332">
<label>332</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Budreck</surname><given-names>EC</given-names></name><etal>et al.</etal></person-group>
<year>2013</year>
<article-title>Neuroligin-1 controls synaptic abundance of NMDA-type glutamate receptors through extracellular coupling</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>110</volume>, <fpage>725</fpage>–<lpage>730</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1214718110</pub-id>)<pub-id pub-id-type="pmid">23269831</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C333">
<label>333</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poulopoulos</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>
<year>2009</year>
<article-title>Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin</article-title>. <source/>Neuron
<volume>63</volume>, <fpage>628</fpage>–<lpage>642</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2009.08.023</pub-id>)<pub-id pub-id-type="pmid">19755106</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C334">
<label>334</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soykan</surname><given-names>T</given-names></name><etal>et al.</etal></person-group>
<year>2014</year>
<article-title>A conformational switch in collybistin determines the differentiation of inhibitory postsynapses</article-title>. <source/>EMBO J.
<volume>33</volume>, <fpage>2113</fpage>–<lpage>2133</lpage>. (<pub-id pub-id-type="doi">10.15252/embj.201488143</pub-id>)<pub-id pub-id-type="pmid">25082542</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C335">
<label>335</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scheiffele</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Choih</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Fetter</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Serafini</surname><given-names>T</given-names></name></person-group>
<year>2000</year>
<article-title>Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons</article-title>. <source/>Cell
<volume>101</volume>, <fpage>657</fpage>–<lpage>669</lpage>. (<pub-id pub-id-type="doi">10.1016/S0092-8674(00)80877-6</pub-id>)<pub-id pub-id-type="pmid">10892652</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C336">
<label>336</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sara</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Biederer</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Atasoy</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Chubykin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mozhayeva</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Kavalali</surname><given-names>ET</given-names></name></person-group>
<year>2005</year>
<article-title>Selective capability of SynCAM and neuroligin for functional synapse assembly</article-title>. <source/>J. Neurosci.
<volume>25</volume>, <fpage>260</fpage>–<lpage>270</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3165-04.2005</pub-id>)<pub-id pub-id-type="pmid">15634790</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C337">
<label>337</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Washbourne</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ortinski</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Vicini</surname><given-names>S</given-names></name></person-group>
<year>2003</year>
<article-title>Functional excitatory synapses in HEK293 cells expressing neuroligin and glutamate receptors</article-title>. <source/>J. Neurophysiol.
<volume>90</volume>, <fpage>3950</fpage>–<lpage>3957</lpage>. (<pub-id pub-id-type="doi">10.1152/jn.00647.2003</pub-id>)<pub-id pub-id-type="pmid">12930820</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C338">
<label>338</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Varoqueaux</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Aramuni</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Rawson</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Mohrmann</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Missler</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gottmann</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Brose</surname><given-names>N</given-names></name></person-group>
<year>2006</year>
<article-title>Neuroligins determine synapse maturation and function</article-title>. <source/>Neuron
<volume>51</volume>, <fpage>741</fpage>–<lpage>754</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuron.2006.09.003</pub-id>)<pub-id pub-id-type="pmid">16982420</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C339">
<label>339</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chih</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Engelman</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Scheiffele</surname><given-names>P</given-names></name></person-group>
<year>2005</year>
<article-title>Control of excitatory and inhibitory synapse formation by neuroligins</article-title>. <source/>Science
<volume>307</volume>, <fpage>1324</fpage>–<lpage>1328</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1107470</pub-id>)<pub-id pub-id-type="pmid">15681343</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C340">
<label>340</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prange</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>TP</given-names></name>, <name name-style="western"><surname>Gerrow</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>YT</given-names></name>, <name name-style="western"><surname>El-Husseini</surname><given-names>A</given-names></name></person-group>
<year>2004</year>
<article-title>A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>101</volume>, <fpage>13 915</fpage>–<lpage>13 920</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0405939101</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C341">
<label>341</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakanishi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nomura</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Tamada</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Arai</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bucan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Takumi</surname><given-names>T</given-names></name></person-group>
<year>2017</year>
<article-title>Functional significance of rare neuroligin 1 variants found in autism</article-title>. <source/>PLoS Genet.
<volume>13</volume>, <fpage>e1006940</fpage> (<pub-id pub-id-type="doi">10.1371/journal.pgen.1006940</pub-id>)<pub-id pub-id-type="pmid">28841651</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C342">
<label>342</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glessner</surname><given-names>JT</given-names></name><etal>et al.</etal></person-group>
<year>2009</year>
<article-title>Autism genome-wide copy number variation reveals ubiquitin and neuronal genes</article-title>. <source/>Nature
<volume>459</volume>, <fpage>569</fpage>–<lpage>573</lpage>. (<pub-id pub-id-type="doi">10.1038/nature07953</pub-id>)<pub-id pub-id-type="pmid">19404257</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C343">
<label>343</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tristan-Clavijo</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Camacho-Garcia</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Robles-Lanuza</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ruiz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>van der Zee</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Van Broeckhoven</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hernandez</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Martinez-Mir</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Scholl</surname><given-names>FG</given-names></name></person-group>
<year>2015</year>
<article-title>A truncating mutation in Alzheimer's disease inactivates neuroligin-1 synaptic function</article-title>. <source/>Neurobiol. Aging.
<volume>36</volume>, <fpage>3171</fpage>–<lpage>3175</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2015.09.004</pub-id>)<pub-id pub-id-type="pmid">26440732</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C344">
<label>344</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kilaru</surname><given-names>V</given-names></name><etal>et al.</etal></person-group>
<year>2016</year>
<article-title>Genome-wide gene-based analysis suggests an association between Neuroligin 1 (NLGN1) and post-traumatic stress disorder</article-title>. <source/>Transl Psychiatry.
<volume>6</volume>, <fpage>e820</fpage> (<pub-id pub-id-type="doi">10.1038/tp.2016.69</pub-id>)<pub-id pub-id-type="pmid">27219346</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C345">
<label>345</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parente</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Garriga</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Baskin</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Douglas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Araujo</surname><given-names>GC</given-names></name>, <name name-style="western"><surname>Shinawi</surname><given-names>M</given-names></name></person-group>
<year>2017</year>
<article-title>Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesity</article-title>. <source/>Am. J. Med. Genet. A
<volume>173</volume>, <fpage>213</fpage>–<lpage>216</lpage>. (<pub-id pub-id-type="doi">10.1002/ajmg.a.37977</pub-id>)<pub-id pub-id-type="pmid">27865048</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C346">
<label>346</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Qin</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Liao</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Koong</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>CH</given-names></name></person-group>
<year>2011</year>
<article-title>Identification and functional characterization of rare mutations of the neuroligin-2 gene (NLGN2) associated with schizophrenia</article-title>. <source/>Hum. Mol. Genet.
<volume>20</volume>, <fpage>3042</fpage>–<lpage>3051</lpage>. (<pub-id pub-id-type="doi">10.1093/hmg/ddr208</pub-id>)<pub-id pub-id-type="pmid">21551456</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C347">
<label>347</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blundell</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Blaiss</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Etherton</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Espinosa</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Tabuchi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Walz</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bolliger</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Powell</surname><given-names>CM</given-names></name></person-group>
<year>2010</year>
<article-title>Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>2115</fpage>–<lpage>2129</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4517-09.2010</pub-id>)<pub-id pub-id-type="pmid">20147539</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C348">
<label>348</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dahlhaus</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hines</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Eadie</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Kannangara</surname><given-names>TS</given-names></name>, <name name-style="western"><surname>Hines</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Christie</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>El-Husseini</surname><given-names>A</given-names></name></person-group>
<year>2010</year>
<article-title>Overexpression of the cell adhesion protein neuroligin-1 induces learning deficits and impairs synaptic plasticity by altering the ratio of excitation to inhibition in the hippocampus</article-title>. <source/>Hippocampus
<volume>20</volume>, <fpage>305</fpage>–<lpage>322</lpage>. (<pub-id pub-id-type="doi">10.1002/hipo.20630</pub-id>)<pub-id pub-id-type="pmid">19437420</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C349">
<label>349</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Polepalli</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>LY</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Malenka</surname><given-names>RC</given-names></name></person-group>
<year>2017</year>
<article-title>Conditional ablation of neuroligin-1 in CA1 pyramidal neurons blocks LTP by a cell-autonomous NMDA receptor-independent mechanism</article-title>. <source/>Mol. Psychiatry.
<volume>22</volume>, <fpage>375</fpage>–<lpage>383</lpage>. (<pub-id pub-id-type="doi">10.1038/mp.2016.80</pub-id>)<pub-id pub-id-type="pmid">27217145</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C350">
<label>350</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hines</surname><given-names>RM</given-names></name><etal>et al.</etal></person-group>
<year>2008</year>
<article-title>Synaptic imbalance, stereotypies, and impaired social interactions in mice with altered neuroligin 2 expression</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>6055</fpage>–<lpage>6067</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0032-08.2008</pub-id>)<pub-id pub-id-type="pmid">18550748</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C351">
<label>351</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Kapeller-Libermann</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Travaglia</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Inda</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Alberini</surname><given-names>CM</given-names></name></person-group>
<year>2017</year>
<article-title>Direct dorsal hippocampal-prelimbic cortex connections strengthen fear memories</article-title>. <source/>Nat. Neurosci.
<volume>20</volume>, <fpage>52</fpage>–<lpage>61</lpage>. (<pub-id pub-id-type="doi">10.1038/nn.4443</pub-id>)<pub-id pub-id-type="pmid">27869801</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C352">
<label>352</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van der Kooij</surname><given-names>MA</given-names></name><etal>et al.</etal></person-group>
<year>2014</year>
<article-title>Impaired hippocampal neuroligin-2 function by chronic stress or synthetic peptide treatment is linked to social deficits and increased aggression</article-title>. <source/>Neuropsychopharmacology
<volume>39</volume>, <fpage>1148</fpage>–<lpage>1158</lpage>. (<pub-id pub-id-type="doi">10.1038/npp.2013.315</pub-id>)<pub-id pub-id-type="pmid">24213355</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C353">
<label>353</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>YT</given-names></name>, <name name-style="western"><surname>Yee</surname><given-names>AX</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name></person-group>
<year>2015</year>
<article-title>Conditional neuroligin-2 knockout in adult medial prefrontal cortex links chronic changes in synaptic inhibition to cognitive impairments</article-title>. <source/>Mol. Psychiatry.
<volume>20</volume>, <fpage>850</fpage>–<lpage>859</lpage>. (<pub-id pub-id-type="doi">10.1038/mp.2015.31</pub-id>)<pub-id pub-id-type="pmid">25824299</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C354">
<label>354</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Durieux</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Horder</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Petrinovic</surname><given-names>MM</given-names></name></person-group>
<year>2016</year>
<article-title>Neuroligin-2 and the tightrope of excitation/inhibition balance in the prefrontal cortex</article-title>. <source/>J. Neurophysiol.
<volume>115</volume>, <fpage>5</fpage>–<lpage>7</lpage>. (<pub-id pub-id-type="doi">10.1152/jn.00703.2015</pub-id>)<pub-id pub-id-type="pmid">26224778</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C355">
<label>355</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jamain</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>
<year>2008</year>
<article-title>Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>105</volume>, <fpage>1710</fpage>–<lpage>1715</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0711555105</pub-id>)<pub-id pub-id-type="pmid">18227507</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C356">
<label>356</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name></person-group>
<year>2008</year>
<article-title>Neuroligins and neurexins link synaptic function to cognitive disease</article-title>. <source/>Nature
<volume>455</volume>, <fpage>903</fpage>–<lpage>911</lpage>. (<pub-id pub-id-type="doi">10.1038/nature07456</pub-id>)<pub-id pub-id-type="pmid">18923512</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C357">
<label>357</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>J</given-names></name><etal>et al.</etal></person-group>
<year>2008</year>
<article-title>Neuroligin-1 is required for normal expression of LTP and associative fear memory in the amygdala of adult animals</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>105</volume>, <fpage>9087</fpage>–<lpage>9092</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.0803448105</pub-id>)<pub-id pub-id-type="pmid">18579781</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C358">
<label>358</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Hom</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kudze</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>XJ</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Aramuni</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Kaplan</surname><given-names>JM</given-names></name></person-group>
<year>2012</year>
<article-title>Neurexin and neuroligin mediate retrograde synaptic inhibition in <italic>C. elegans</italic></article-title>. <source/>Science
<volume>337</volume>, <fpage>980</fpage>–<lpage>984</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1224896</pub-id>)<pub-id pub-id-type="pmid">22859820</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C359">
<label>359</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>G</given-names></name></person-group>
<year>2013</year>
<article-title>An unexpected role of neuroligin-2 in regulating KCC2 and GABA functional switch</article-title>. <source/>Mol. Brain.
<volume>6</volume>, <fpage>23</fpage> (<pub-id pub-id-type="doi">10.1186/1756-6606-6-23</pub-id>)<pub-id pub-id-type="pmid">23663753</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C360">
<label>360</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wohr</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Silverman</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Scattoni</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Saxena</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Crawley</surname><given-names>JN</given-names></name></person-group>
<year>2013</year>
<article-title>Developmental delays and reduced pup ultrasonic vocalizations but normal sociability in mice lacking the postsynaptic cell adhesion protein neuroligin2</article-title>. <source/>Behav. Brain Res.
<volume>251</volume>, <fpage>50</fpage>–<lpage>64</lpage>. (<pub-id pub-id-type="doi">10.1016/j.bbr.2012.07.024</pub-id>)<pub-id pub-id-type="pmid">22820233</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C361">
<label>361</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soler-Llavina</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Fuccillo</surname><given-names>MV</given-names></name>, <name name-style="western"><surname>Ko</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Malenka</surname><given-names>RC</given-names></name></person-group>
<year>2011</year>
<article-title>The neurexin ligands, neuroligins and leucine-rich repeat transmembrane proteins, perform convergent and divergent synaptic functions <italic>in vivo</italic></article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>108</volume>, <fpage>16 502</fpage>–<lpage>16 509</lpage>. (<pub-id pub-id-type="doi">10.1073/pnas.1114028108</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C362">
<label>362</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gutierrez</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Hung</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kertesz</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Espina</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Colicos</surname><given-names>MA</given-names></name></person-group>
<year>2009</year>
<article-title>Altered synchrony and connectivity in neuronal networks expressing an autism-related mutation of neuroligin 3</article-title>. <source/>Neuroscience
<volume>162</volume>, <fpage>208</fpage>–<lpage>221</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.04.062</pub-id>)<pub-id pub-id-type="pmid">19406211</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C363">
<label>363</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baudouin</surname><given-names>SJ</given-names></name><etal>et al.</etal></person-group>
<year>2012</year>
<article-title>Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism</article-title>. <source/>Science
<volume>338</volume>, <fpage>128</fpage>–<lpage>132</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1224159</pub-id>)<pub-id pub-id-type="pmid">22983708</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C364">
<label>364</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>
<year>2009</year>
<article-title>A neuroligin-4 missense mutation associated with autism impairs neuroligin-4 folding and endoplasmic reticulum export</article-title>. <source/>J. Neurosci.
<volume>29</volume>, <fpage>10 843</fpage>–<lpage>10 854</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1248-09.2009</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C365">
<label>365</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jamain</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>
<year>2003</year>
<article-title>Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism</article-title>. <source/>Nat. Genet.
<volume>34</volume>, <fpage>27</fpage>–<lpage>29</lpage>. (<pub-id pub-id-type="doi">10.1038/ng1136</pub-id>)<pub-id pub-id-type="pmid">12669065</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C366">
<label>366</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hata</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Butz</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name></person-group>
<year>1996</year>
<article-title>CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent protein kinase domain identified by interaction with neurexins</article-title>. <source/>J. Neurosci.
<volume>16</volume>, <fpage>2488</fpage>–<lpage>2494</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-08-02488.1996</pub-id>)<pub-id pub-id-type="pmid">8786425</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C367">
<label>367</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biederer</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sudhof</surname><given-names>TC</given-names></name></person-group>
<year>2000</year>
<article-title>Mints as adaptors. Direct binding to neurexins and recruitment of munc18</article-title>. <source/>J. Biol. Chem.
<volume>275</volume>, <fpage>39 803</fpage>–<lpage>39 806</lpage>. (<pub-id pub-id-type="doi">10.1074/jbc.C000656200</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C368">
<label>368</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dean</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Scholl</surname><given-names>FG</given-names></name>, <name name-style="western"><surname>Choih</surname><given-names>J</given-names></name>, <name name-style="western"><surname>DeMaria</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Berger</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Isacoff</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Scheiffele</surname><given-names>P</given-names></name></person-group>
<year>2003</year>
<article-title>Neurexin mediates the assembly of presynaptic terminals</article-title>. <source/>Nat. Neurosci.
<volume>6</volume>, <fpage>708</fpage>–<lpage>716</lpage>. (<pub-id pub-id-type="doi">10.1038/nn1074</pub-id>)<pub-id pub-id-type="pmid">12796785</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C369">
<label>369</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Naisbitt</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hsueh</surname><given-names>YP</given-names></name>, <name name-style="western"><surname>Rao</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rothschild</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Craig</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Sheng</surname><given-names>M</given-names></name></person-group>
<year>1997</year>
<article-title>GKAP, a novel synaptic protein that interacts with the guanylate kinase-like domain of the PSD-95/SAP90 family of channel clustering molecules</article-title>. <source/>J. Cell Biol.
<volume>136</volume>, <fpage>669</fpage>–<lpage>678</lpage>. (<pub-id pub-id-type="doi">10.1083/jcb.136.3.669</pub-id>)<pub-id pub-id-type="pmid">9024696</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C370">
<label>370</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tretter</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Jacob</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Mukherjee</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Fritschy</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Pangalos</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Moss</surname><given-names>SJ</given-names></name></person-group>
<year>2008</year>
<article-title>The clustering of GABA(A) receptor subtypes at inhibitory synapses is facilitated via the direct binding of receptor alpha 2 subunits to gephyrin</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>1356</fpage>–<lpage>1365</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5050-07.2008</pub-id>)<pub-id pub-id-type="pmid">18256255</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C371">
<label>371</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanus</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ehrensperger</surname><given-names>MV</given-names></name>, <name name-style="western"><surname>Triller</surname><given-names>A</given-names></name></person-group>
<year>2006</year>
<article-title>Activity-dependent movements of postsynaptic scaffolds at inhibitory synapses</article-title>. <source/>J. Neurosci.
<volume>26</volume>, <fpage>4586</fpage>–<lpage>4595</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5123-05.2006</pub-id>)<pub-id pub-id-type="pmid">16641238</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C372">
<label>372</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abraham</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Bear</surname><given-names>MF</given-names></name></person-group>
<year>1996</year>
<article-title>Metaplasticity: the plasticity of synaptic plasticity</article-title>. <source/>Trends Neurosci.
<volume>19</volume>, <fpage>126</fpage>–<lpage>130</lpage>. (<pub-id pub-id-type="doi">10.1016/S0166-2236(96)80018-X</pub-id>)<pub-id pub-id-type="pmid">8658594</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C373">
<label>373</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abraham</surname><given-names>WC</given-names></name></person-group>
<year>2008</year>
<article-title>Metaplasticity: tuning synapses and networks for plasticity</article-title>. <source/>Nat. Rev. Neurosci.
<volume>9</volume>, <fpage>387</fpage> (<pub-id pub-id-type="doi">10.1038/nrn2356</pub-id>)<pub-id pub-id-type="pmid">18401345</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C374">
<label>374</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Megill</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tran</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Eldred</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Hoe</surname><given-names>H-S</given-names></name>, <name name-style="western"><surname>Kirkwood</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>H-K</given-names></name></person-group>
<year>2015</year>
<article-title>Defective age-dependent metaplasticity in a mouse model of Alzheimer's disease</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>11 346</fpage>–<lpage>11 357</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5289-14.2015</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C375">
<label>375</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Antion</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Nomura</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kraniotis</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Contractor</surname><given-names>A</given-names></name></person-group>
<year>2014</year>
<article-title>Hippocampal metaplasticity is required for the formation of temporal associative memories</article-title>. <source/>J. Neurosci.
<volume>34</volume>, <fpage>16 762</fpage>–<lpage>16 773</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2869-13.2014</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C376">
<label>376</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allen</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Lyons</surname><given-names>DA</given-names></name></person-group>
<year>2018</year>
<article-title>Glia as architects of central nervous system formation and function</article-title>. <source/>Science
<volume>362</volume>, <fpage>181</fpage>–<lpage>185</lpage>. (<pub-id pub-id-type="doi">10.1126/science.aat0473</pub-id>)<pub-id pub-id-type="pmid">30309945</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C377">
<label>377</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sofroniew</surname><given-names>MV</given-names></name>, <name name-style="western"><surname>Vinters</surname><given-names>HV</given-names></name></person-group>
<year>2010</year>
<article-title>Astrocytes: biology and pathology</article-title>. <source/>Acta Neuropathol.
<volume>119</volume>, <fpage>7</fpage>–<lpage>35</lpage>. (<pub-id pub-id-type="doi">10.1007/s00401-009-0619-8</pub-id>)<pub-id pub-id-type="pmid">20012068</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C378">
<label>378</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allen</surname><given-names>NJ</given-names></name></person-group>
<year>2014</year>
<article-title>Astrocyte regulation of synaptic behavior</article-title>. <source/>Annu. Rev. Cell Dev. Biol.
<volume>30</volume>, <fpage>439</fpage>–<lpage>463</lpage>. (<pub-id pub-id-type="doi">10.1146/annurev-cellbio-100913-013053</pub-id>)<pub-id pub-id-type="pmid">25288116</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C379">
<label>379</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laywell</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Steindler</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Silver</surname><given-names>DJ</given-names></name></person-group>
<year>2007</year>
<article-title>Astrocytic stem cells in the adult brain</article-title>. <source/>Neurosurg. Clin. N. Am.
<volume>18</volume>, <fpage>21</fpage>–<lpage>30</lpage>, <comment>viii</comment> (<pub-id pub-id-type="doi">10.1016/j.nec.2006.10.003</pub-id>)<pub-id pub-id-type="pmid">17244551</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C380">
<label>380</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonzalez-Perez</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Quinones-Hinojosa</surname><given-names>A</given-names></name></person-group>
<year>2012</year>
<article-title>Astrocytes as neural stem cells in the adult brain</article-title>. <source/>J. Stem. Cells.
<volume>7</volume>, <fpage>181</fpage>–<lpage>188</lpage>. <comment>(jsc.2012.7.3.181)</comment>.<pub-id pub-id-type="pmid">23619383</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C381">
<label>381</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Higashi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fujita</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Inanobe</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tanemoto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Doi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kubo</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kurachi</surname><given-names>Y</given-names></name></person-group>
<year>2001</year>
<article-title>An inwardly rectifying K(+) channel, Kir4.1, expressed in astrocytes surrounds synapses and blood vessels in brain</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>281</volume>, <fpage>C922</fpage>–<lpage>C931</lpage>. (<pub-id pub-id-type="doi">10.1152/ajpcell.2001.281.3.C922</pub-id>)<pub-id pub-id-type="pmid">11502569</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C382">
<label>382</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verkman</surname><given-names>AS</given-names></name></person-group>
<year>2005</year>
<article-title>More than just water channels: unexpected cellular roles of aquaporins</article-title>. <source/>J. Cell Sci.
<volume>118</volume>, <fpage>3225</fpage>–<lpage>3232</lpage>. (<pub-id pub-id-type="doi">10.1242/jcs.02519</pub-id>)<pub-id pub-id-type="pmid">16079275</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C383">
<label>383</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Theis</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sohl</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Eiberger</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Willecke</surname><given-names>K</given-names></name></person-group>
<year>2005</year>
<article-title>Emerging complexities in identity and function of glial connexins</article-title>. <source/>Trends Neurosci.
<volume>28</volume>, <fpage>188</fpage>–<lpage>195</lpage>. (<pub-id pub-id-type="doi">10.1016/j.tins.2005.02.006</pub-id>)<pub-id pub-id-type="pmid">15808353</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C384">
<label>384</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bergles</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Diamond</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Jahr</surname><given-names>CE</given-names></name></person-group>
<year>1999</year>
<article-title>Clearance of glutamate inside the synapse and beyond</article-title>. <source/>Curr. Opin. Neurobiol.
<volume>9</volume>, <fpage>293</fpage>–<lpage>298</lpage>. (<pub-id pub-id-type="doi">10.1016/S0959-4388(99)80043-9</pub-id>)<pub-id pub-id-type="pmid">10395570</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C385">
<label>385</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beck</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Vinters</surname><given-names>HV</given-names></name>, <name name-style="western"><surname>Hart</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Cancilla</surname><given-names>PA</given-names></name></person-group>
<year>1984</year>
<article-title>Glial cells influence polarity of the blood-brain barrier</article-title>. <source/>J. Neuropathol. Exp. Neurol.
<volume>43</volume>, <fpage>219</fpage>–<lpage>224</lpage>. (<pub-id pub-id-type="doi">10.1097/00005072-198405000-00001</pub-id>)<pub-id pub-id-type="pmid">6726282</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C386">
<label>386</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abbott</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Rönnbäck</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hansson</surname><given-names>E</given-names></name></person-group>
<year>2006</year>
<article-title>Astrocyte–endothelial interactions at the blood–brain barrier</article-title>. <source/>Nat. Rev. Neurosci.
<volume>7</volume>, <fpage>41</fpage> (<pub-id pub-id-type="doi">10.1038/nrn1824</pub-id>)<pub-id pub-id-type="pmid">16371949</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C387">
<label>387</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Tekkök</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Ransom</surname><given-names>BR</given-names></name></person-group>
<year>2004</year>
<article-title>Energy transfer from astrocytes to axons: the role of CNS glycogen</article-title>. <source/>Neurochem. Int.
<volume>45</volume>, <fpage>529</fpage>–<lpage>536</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuint.2003.11.005</pub-id>)<pub-id pub-id-type="pmid">15186919</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C388">
<label>388</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Ransom</surname><given-names>BR</given-names></name></person-group>
<year>2007</year>
<article-title>Astrocyte glycogen and brain energy metabolism</article-title>. <source/>Glia
<volume>55</volume>, <fpage>1263</fpage>–<lpage>1271</lpage>. (<pub-id pub-id-type="doi">10.1002/glia.20557</pub-id>)<pub-id pub-id-type="pmid">17659525</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C389">
<label>389</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rothstein</surname><given-names>JD</given-names></name><etal>et al.</etal></person-group>
<year>1996</year>
<article-title>Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate</article-title>. <source/>Neuron
<volume>16</volume>, <fpage>675</fpage>–<lpage>686</lpage>. (<pub-id pub-id-type="doi">10.1016/S0896-6273(00)80086-0</pub-id>)<pub-id pub-id-type="pmid">8785064</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C390">
<label>390</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sofroniew</surname><given-names>MV</given-names></name></person-group>
<year>2009</year>
<article-title>Molecular dissection of reactive astrogliosis and glial scar formation</article-title>. <source/>Trends Neurosci.
<volume>32</volume>, <fpage>638</fpage>–<lpage>647</lpage>. (<pub-id pub-id-type="doi">10.1016/j.tins.2009.08.002</pub-id>)<pub-id pub-id-type="pmid">19782411</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C391">
<label>391</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Palay</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Webster</surname><given-names>HdeF</given-names></name></person-group>
<year>1991</year>
<comment><italic>The fine structure of the nervous system. Neurons and their supporting cells</italic>, 3rd edn.</comment>
<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>.</mixed-citation>
</ref>
<ref id="RSOB180265C392">
<label>392</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stevens</surname><given-names>B</given-names></name><etal>et al.</etal></person-group>
<year>2007</year>
<article-title>The classical complement cascade mediates CNS synapse elimination</article-title>. <source/>Cell
<volume>131</volume>, <fpage>1164</fpage>–<lpage>1178</lpage>. (<pub-id pub-id-type="doi">10.1016/j.cell.2007.10.036</pub-id>)<pub-id pub-id-type="pmid">18083105</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C393">
<label>393</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pfrieger</surname><given-names>FW</given-names></name>, <name name-style="western"><surname>Barres</surname><given-names>BA</given-names></name></person-group>
<year>1997</year>
<article-title>Synaptic efficacy enhanced by glial cells <italic>in vitro</italic></article-title>. <source/>Science
<volume>277</volume>, <fpage>1684</fpage>–<lpage>1687</lpage>. (<pub-id pub-id-type="doi">10.1126/science.277.5332.1684</pub-id>)<pub-id pub-id-type="pmid">9287225</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C394">
<label>394</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pyka</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wetzel</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Aguado</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Geissler</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hatt</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Faissner</surname><given-names>A</given-names></name></person-group>
<year>2011</year>
<article-title>Chondroitin sulfate proteoglycans regulate astrocyte-dependent synaptogenesis and modulate synaptic activity in primary embryonic hippocampal neurons</article-title>. <source/>Eur. J Neurosci.
<volume>33</volume>, <fpage>2187</fpage>–<lpage>2202</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1460-9568.2011.07690.x</pub-id>)<pub-id pub-id-type="pmid">21615557</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C395">
<label>395</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Allen</surname><given-names>NJ</given-names></name></person-group>
<year>2012</year>
<article-title>Glial control of synaptogenesis</article-title>. In <source/>Neuroglia, <comment>3rd edn</comment> (eds <person-group person-group-type="editor"><name name-style="western"><surname>Kettenmann</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ransom</surname><given-names>BR</given-names></name></person-group>), pp. <fpage>388</fpage>–<lpage>401</lpage>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>.</mixed-citation>
</ref>
<ref id="RSOB180265C396">
<label>396</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ku</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Osterhout</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Ahmadian</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name></person-group>
<year>2004</year>
<article-title>Developmentally-programmed FMRP expression in oligodendrocytes: a potential role of FMRP in regulating translation in oligodendroglia progenitors</article-title>. <source/>Hum. Mol. Genet.
<volume>13</volume>, <fpage>79</fpage>–<lpage>89</lpage>. (<pub-id pub-id-type="doi">10.1093/hmg/ddh009</pub-id>)<pub-id pub-id-type="pmid">14613971</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C397">
<label>397</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gholizadeh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Halder</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Hampson</surname><given-names>DR</given-names></name></person-group>
<year>2015</year>
<article-title>Expression of fragile X mental retardation protein in neurons and glia of the developing and adult mouse brain</article-title>. <source/>Brain Res.
<volume>1596</volume>, <fpage>22</fpage>–<lpage>30</lpage>. (<pub-id pub-id-type="doi">10.1016/j.brainres.2014.11.023</pub-id>)<pub-id pub-id-type="pmid">25446451</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C398">
<label>398</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jacobs</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Doering</surname><given-names>LC</given-names></name></person-group>
<year>2010</year>
<article-title>Astrocytes prevent abnormal neuronal development in the fragile X mouse</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>4508</fpage>–<lpage>4514</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5027-09.2010</pub-id>)<pub-id pub-id-type="pmid">20335488</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C399">
<label>399</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jacobs</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Doering</surname><given-names>LC</given-names></name></person-group>
<year>2016</year>
<article-title>Hippocampal neuronal subtypes develop abnormal dendritic arbors in the presence of fragile X astrocytes</article-title>. <source/>Neuroscience
<volume>324</volume>, <fpage>202</fpage>–<lpage>217</lpage>. (<pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.03.011</pub-id>)<pub-id pub-id-type="pmid">26968765</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C400">
<label>400</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maezawa</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Swanberg</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Harvey</surname><given-names>D</given-names></name>, <name name-style="western"><surname>LaSalle</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>LW</given-names></name></person-group>
<year>2009</year>
<article-title>Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions</article-title>. <source/>J. Neurosci.
<volume>29</volume>, <fpage>5051</fpage>–<lpage>5061</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0324-09.2009</pub-id>)<pub-id pub-id-type="pmid">19386901</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C401">
<label>401</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>XR</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>XS</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>L</given-names></name></person-group>
<year>2017</year>
<article-title>MeCP2 deficiency in neuroglia: new progress in the pathogenesis of Rett syndrome</article-title>. <source/>Front. Mol. Neurosci.
<volume>10</volume>, <fpage>316</fpage> (<pub-id pub-id-type="doi">10.3389/fnmol.2017.00316</pub-id>)<pub-id pub-id-type="pmid">29046627</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C402">
<label>402</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stogsdill</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Ramirez</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Baldwin</surname><given-names>KT</given-names></name>, <name name-style="western"><surname>Enustun</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ejikeme</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Eroglu</surname><given-names>C</given-names></name></person-group>
<year>2017</year>
<article-title>Astrocytic Neuroligins control astrocyte morphogenesis and synaptogenesis</article-title>. <source/>Nature
<volume>551</volume>, <fpage>192</fpage>–<lpage>197</lpage>. (<pub-id pub-id-type="doi">10.1038/nature24638</pub-id>)<pub-id pub-id-type="pmid">29120426</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C403">
<label>403</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ginhoux</surname><given-names>F</given-names></name><etal>et al.</etal></person-group>
<year>2010</year>
<article-title>Fate mapping analysis reveals that adult microglia derive from primitive macrophages</article-title>. <source/>Science
<volume>330</volume>, <fpage>841</fpage>–<lpage>845</lpage>. (<pub-id pub-id-type="doi">10.1126/science.1194637</pub-id>)<pub-id pub-id-type="pmid">20966214</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C404">
<label>404</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paolicelli</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Gross</surname><given-names>CT</given-names></name></person-group>
<year>2011</year>
<article-title>Microglia in development: linking brain wiring to brain environment</article-title>. <source/>Neuron Glia Biol.
<volume>7</volume>, <fpage>77</fpage>–<lpage>83</lpage>. (<pub-id pub-id-type="doi">10.1017/S1740925X12000105</pub-id>)<pub-id pub-id-type="pmid">22857738</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C405">
<label>405</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vinuesa</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>
<year>2018</year>
<article-title>Early exposure to a high-fat diet impacts on hippocampal plasticity: implication of microglia-derived exosome-like extracellular vesicles</article-title>. <source/>Mol. Neurobiol. (<pub-id pub-id-type="doi">10.1007/s12035-018-1435-8</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C406">
<label>406</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Almeida</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Lyons</surname><given-names>DA</given-names></name></person-group>
<year>2017</year>
<article-title>On myelinated axon plasticity and neuronal circuit formation and function</article-title>. <source/>J. Neurosci.
<volume>37</volume>, <fpage>10 023</fpage>–<lpage>10 034</lpage>. (<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3185-16.2017</pub-id>)</mixed-citation>
</ref>
<ref id="RSOB180265C407">
<label>407</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larson</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Mironova</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Vanderpool</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Waisman</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rash</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Agarwal</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bergles</surname><given-names>DE</given-names></name></person-group>
<year>2018</year>
<article-title>Oligodendrocytes control potassium accumulation in white matter and seizure susceptibility</article-title>. <source/>Elife
<volume>7</volume>, <fpage>e34829</fpage> (<pub-id pub-id-type="doi">10.7554/eLife.34829</pub-id>)<pub-id pub-id-type="pmid">29596047</pub-id></mixed-citation>
</ref>
<ref id="RSOB180265C408">
<label>408</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nave</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Ehrenreich</surname><given-names>H</given-names></name></person-group>
<year>2014</year>
<article-title>Myelination and oligodendrocyte functions in psychiatric diseases</article-title>. <source/>JAMA Psychiatry
<volume>71</volume>, <fpage>582</fpage>–<lpage>584</lpage>. (<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.189</pub-id>)<pub-id pub-id-type="pmid">24671770</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>